Publikationen

2022

Ahearn, T. U., H. Zhang, K. Michailidou, R. L. Milne, M. K. Bolla, J. Dennis, A. M. Dunning, et al. "Common Variants in Breast Cancer Risk Loci Predispose to Distinct Tumor Subtypes." Breast Cancer Res 24, no. 1 (Jan 4 2022): 2. https://doi.org/10.1186/s13058-021-01484-x. https://www.ncbi.nlm.nih.gov/pubmed/34983606.

Barnes, D. R., V. Silvestri, G. Leslie, L. McGuffog, J. Dennis, X. Yang, J. Adlard, et al. "Breast and Prostate Cancer Risks for Male Brca1 and Brca2 Pathogenic Variant Carriers Using Polygenic Risk Scores." J Natl Cancer Inst 114, no. 1 (Jan 11 2022): 109-22. https://doi.org/10.1093/jnci/djab147. https://www.ncbi.nlm.nih.gov/pubmed/34320204.

Berger-Hoger, B., F. Vitinius, H. Fischer, K. Beifus, J. Koberlein-Neu, A. Isselhard, M. Topper, et al. "Nurse-Led Decision Coaching by Specialized Nurses for Healthy Brca1/2 Gene Mutation Carriers - Adaptation and Pilot Testing of a Curriculum for Nurses: A Qualitative Study." BMC Nurs 21, no. 1 (Feb 10 2022): 42. https://doi.org/10.1186/s12912-022-00810-8. https://www.ncbi.nlm.nih.gov/pubmed/35139834.

Berling-Ernst, A., M. Yahiaoui-Doktor, M. Kiechle, C. Engel, J. Lammert, S. Grill, R. Dukatz, et al. "Predictors of Cardiopulmonary Fitness in Cancer-Affected and -Unaffected Women with a Pathogenic Germline Variant in the Genes Brca1/2 (Libre-1)." Sci Rep 12, no. 1 (Feb 21 2022): 2907. https://doi.org/10.1038/s41598-022-06913-1. https://www.ncbi.nlm.nih.gov/pubmed/35190584.

Breast Cancer Association, Consortium, N. Mavaddat, L. Dorling, S. Carvalho, J. Allen, A. Gonzalez-Neira, R. Keeman, et al. "Pathology of Tumors Associated with Pathogenic Germline Variants in 9 Breast Cancer Susceptibility Genes." JAMA Oncol 8, no. 3 (Mar 1 2022): e216744. https://doi.org/10.1001/jamaoncol.2021.6744. https://www.ncbi.nlm.nih.gov/pubmed/35084436.

Dennis, J., J. P. Tyrer, L. C. Walker, K. Michailidou, L. Dorling, M. K. Bolla, Q. Wang, et al. "Rare Germline Copy Number Variants (Cnvs) and Breast Cancer Risk." Commun Biol 5, no. 1 (Jan 18 2022): 65. https://doi.org/10.1038/s42003-021-02990-6. https://www.ncbi.nlm.nih.gov/pubmed/35042965.

Gerber, B., A. Schneeweiss, V. Mobus, M. Golatta, H. Tesch, D. Krug, C. Hanusch, et al. "Pathological Response in the Breast and Axillary Lymph Nodes after Neoadjuvant Systemic Treatment in Patients with Initially Node-Positive Breast Cancer Correlates with Disease Free Survival: An Exploratory Analysis of the Geparocto Trial." Cancers (Basel) 14, no. 3 (Jan 20 2022). https://doi.org/10.3390/cancers14030521. https://www.ncbi.nlm.nih.gov/pubmed/35158789.

Hauke, J., P. Harter, C. Ernst, A. Burges, S. Schmidt, A. Reuss, J. Borde, et al. "Sensitivity and Specificity of Loss of Heterozygosity Analysis for the Classification of Rare Germline Variants in Brca1/2: Results of the Observational Ago-Tr1 Study (Nct02222883)." J Med Genet 59, no. 3 (Mar 2022): 248-52. https://doi.org/10.1136/jmedgenet-2020-107353. https://www.ncbi.nlm.nih.gov/pubmed/33273034.

Kautz-Freimuth, S., M. Redaelli, A. Isselhard, A. Shukri, A. Vodermaier, K. Rhiem, R. Schmutzler, and S. Stock. "Evaluation of Two Evidence-Based Decision Aids for Female Brca1/2 Mutation Carriers in Germany: Study Protocol for a Randomised Controlled Parallel-Group Trial." Trials 23, no. 1 (Feb 16 2022): 157. https://doi.org/10.1186/s13063-022-06081-7. https://www.ncbi.nlm.nih.gov/pubmed/35172875.

Krug, K. B., C. J. Burke, K. Weiss, P. A. T. Baltzer, K. Rhiem, D. Maintz, M. Schlamann, and M. Hellmich. "Influence of Aging and Gadolinium Exposure on T1, T2, and T2*-Relaxation in Healthy Women with an Increased Risk of Breast Cancer with and without Prior Exposure to Gadoterate Meglumine at 3.0-T Brain Mr Imaging." Eur Radiol 32, no. 1 (Jan 2022): 331-45. https://doi.org/10.1007/s00330-021-08069-4. https://www.ncbi.nlm.nih.gov/pubmed/34218287.

Lesueur, F., D. F. Easton, A. L. Renault, S. V. Tavtigian, J. L. Bernstein, Z. Kote-Jarai, R. A. Eeles, et al. "First International Workshop of the Atm and Cancer Risk Group (4-5 December 2019)." Fam Cancer 21, no. 2 (Apr 2022): 211-27. https://doi.org/10.1007/s10689-021-00248-y. https://www.ncbi.nlm.nih.gov/pubmed/34125377.

Li, S., V. Silvestri, G. Leslie, T. R. Rebbeck, S. L. Neuhausen, J. L. Hopper, H. R. Nielsen, et al. "Cancer Risks Associated with Brca1 and Brca2 Pathogenic Variants." J Clin Oncol 40, no. 14 (May 10 2022): 1529-41. https://doi.org/10.1200/JCO.21.02112. https://www.ncbi.nlm.nih.gov/pubmed/35077220.

Schneeweiss, A., L. L. Michel, V. Mobus, H. Tesch, P. Klare, E. Hahnen, C. Denkert, et al. "Survival Analysis of the Randomised Phase Iii Geparocto Trial Comparing Neoadjuvant Chemotherapy of Intense Dose-Dense Epirubicin, Paclitaxel, Cyclophosphamide Versus Weekly Paclitaxel, Liposomal Doxorubicin (Plus Carboplatin in Triple-Negative Breast Cancer) for Patients with High-Risk Early Breast Cancer." Eur J Cancer 160 (Jan 2022): 100-11. https://doi.org/10.1016/j.ejca.2021.10.011. https://www.ncbi.nlm.nih.gov/pubmed/34801353.

Schrijver, L. H., T. M. Mooij, A. Pijpe, G. S. Sonke, M. J. E. Mourits, N. Andrieu, A. C. Antoniou, et al. "Oral Contraceptive Use in Brca1 and Brca2 Mutation Carriers: Absolute Cancer Risks and Benefits." J Natl Cancer Inst 114, no. 4 (Apr 11 2022): 540-52. https://doi.org/10.1093/jnci/djac004. https://www.ncbi.nlm.nih.gov/pubmed/35048954.

Stracke, C., C. Lemmen, K. Rhiem, R. Schmutzler, S. Kautz-Freimuth, and S. Stock. "Medical Knowledge and Information Needs among Women with Pathogenic Variants in Moderate-Risk Genes for Hereditary Breast Cancer Attending Genetic Counseling at an Academic Hospital in Germany-a Qualitative Approach." J Genet Couns 31, no. 3 (Jun 2022): 698-712. https://doi.org/10.1002/jgc4.1536. https://www.ncbi.nlm.nih.gov/pubmed/34837291.

Vergote, I., A. Gonzalez-Martin, I. Ray-Coquard, P. Harter, N. Colombo, P. Pujol, D. Lorusso, et al. "European Experts Consensus: Brca/Homologous Recombination Deficiency Testing in First-Line Ovarian Cancer." Ann Oncol 33, no. 3 (Mar 2022): 276-87. https://doi.org/10.1016/j.annonc.2021.11.013. https://www.ncbi.nlm.nih.gov/pubmed/34861371.

Weber-Lassalle, K., C. Ernst, A. Reuss, K. Mollenhoff, K. Baumann, C. Jackisch, J. Hauke, et al. "Clonal Hematopoiesis-Associated Gene Mutations in a Clinical Cohort of 448 Patients with Ovarian Cancer." J Natl Cancer Inst 114, no. 4 (Apr 11 2022): 565-70. https://doi.org/10.1093/jnci/djab231. https://www.ncbi.nlm.nih.gov/pubmed/34963005.

2021

Ataseven, B., D. Tripon, R. Schwameis, P. Harter, K. Rhiem, S. Schneider, S. Heikaus, et al. "Clinical Outcome in Patients with Primary Epithelial Ovarian Cancer and Germline Brca1/2-Mutation - Real Life Data." Gynecol Oncol 163, no. 3 (Dec 2021): 569-77. https://doi.org/10.1016/j.ygyno.2021.09.004. https://www.ncbi.nlm.nih.gov/pubmed/34565600.

Baxter, J. S., N. Johnson, K. Tomczyk, A. Gillespie, S. Maguire, R. Brough, L. Fachal, et al. "Functional Annotation of the 2q35 Breast Cancer Risk Locus Implicates a Structural Variant in Influencing Activity of a Long-Range Enhancer Element." Am J Hum Genet 108, no. 7 (Jul 1 2021): 1190-203. https://doi.org/10.1016/j.ajhg.2021.05.013. https://www.ncbi.nlm.nih.gov/pubmed/34146516.

Borde, J., C. Ernst, B. Wappenschmidt, D. Niederacher, K. Weber-Lassalle, G. Schmidt, J. Hauke, et al. "Performance of Breast Cancer Polygenic Risk Scores in 760 Female Chek2 Germline Mutation Carriers." J Natl Cancer Inst 113, no. 7 (Jul 1 2021): 893-99. https://doi.org/10.1093/jnci/djaa203. https://www.ncbi.nlm.nih.gov/pubmed/33372680.

Breast Cancer Association, Consortium, L. Dorling, S. Carvalho, J. Allen, A. Gonzalez-Neira, C. Luccarini, C. Wahlstrom, et al. "Breast Cancer Risk Genes - Association Analysis in More Than 113,000 Women." N Engl J Med 384, no. 5 (Feb 4 2021): 428-39. https://doi.org/10.1056/NEJMoa1913948. https://www.ncbi.nlm.nih.gov/pubmed/33471991.

Bredart, A., A. De Pauw, A. Anota, A. Tuchler, J. Dick, A. Muller, J. L. Kop, et al. "Information Needs on Breast Cancer Genetic and Non-Genetic Risk Factors in Relatives of Women with a Brca1/2 or Palb2 Pathogenic Variant." Breast 60 (Dec 2021): 38-44. https://doi.org/10.1016/j.breast.2021.08.011. https://www.ncbi.nlm.nih.gov/pubmed/34455229.

Brooks, J. D., H. H. Nabi, I. L. Andrulis, A. C. Antoniou, J. Chiquette, P. Despres, P. Devilee, et al. "Personalized Risk Assessment for Prevention and Early Detection of Breast Cancer: Integration and Implementation (Perspective I&I)." J Pers Med 11, no. 6 (Jun 4 2021). https://doi.org/10.3390/jpm11060511. https://www.ncbi.nlm.nih.gov/pubmed/34199804.

Burghardt, K., N. Baba, I. Schreyer, I. Graness, and C. A. Hubner. "Stx1b-Related Epilepsy in a 24-Month-Old Female Infant." Epilepsy Behav Rep 15 (2021): 100391. https://doi.org/10.1016/j.ebr.2020.100391. https://www.ncbi.nlm.nih.gov/pubmed/33426515.

Coignard, J., M. Lush, J. Beesley, T. A. O'Mara, J. Dennis, J. P. Tyrer, D. R. Barnes, et al. "Author Correction: A Case-Only Study to Identify Genetic Modifiers of Breast Cancer Risk for Brca1/Brca2 Mutation Carriers." Nat Commun 12, no. 1 (May 14 2021): 2986. https://doi.org/10.1038/s41467-021-23162-4. https://www.ncbi.nlm.nih.gov/pubmed/33990587.

Coignard J et al. "A Case-Only Study to Identify Genetic Modifiers of Breast Cancer Risk for Brca1/Brca2 Mutation Carriers." Nat Commun 12, no. 1 (Feb 17 2021): 1078. https://doi.org/10.1038/s41467-020-20496-3. https://www.ncbi.nlm.nih.gov/pubmed/33597508.

Dai, J. X., Q. Lin, H. J. Ba, L. Z. Ye, Z. W. Li, and J. Y. Cai. "Utility of Serum Macrophage Migration Inhibitory Factor as a Potential Biomarker for Detection of Cerebrocardiac Syndrome Following Severe Traumatic Brain Injury." Clin Chim Acta 512 (Jan 2021): 179-84. https://doi.org/10.1016/j.cca.2020.11.007. https://www.ncbi.nlm.nih.gov/pubmed/33181151.

den Ottelander, B. K., R. de Goederen, C. A. de Planque, S. J. Baart, M. L. C. van Veelen, L. J. A. Corel, K. F. M. Joosten, I. M. J. Mathijssen, and M. H. G. Dremmen. "Cervical Spinal Cord Compression and Sleep-Disordered Breathing in Syndromic Craniosynostosis." AJNR Am J Neuroradiol 42, no. 1 (Jan 2021): 201-05. https://doi.org/10.3174/ajnr.A6881. https://www.ncbi.nlm.nih.gov/pubmed/33272949.

Deng, Q., H. Li, G. Ba, T. Huo, and W. Hou. "The Pivotal Role of Defects in Fabrication of Polymeric Carbon Nitride Homojunctions with Enhanced Photocatalytic Hydrogen Evolution." J Colloid Interface Sci 586 (Mar 15 2021): 748-57. https://doi.org/10.1016/j.jcis.2020.10.144. https://www.ncbi.nlm.nih.gov/pubmed/33220957.

Denkert, C., F. Seither, A. Schneeweiss, T. Link, J. U. Blohmer, M. Just, P. Wimberger, et al. "Clinical and Molecular Characteristics of Her2-Low-Positive Breast Cancer: Pooled Analysis of Individual Patient Data from Four Prospective, Neoadjuvant Clinical Trials." Lancet Oncol 22, no. 8 (Aug 2021): 1151-61. https://doi.org/10.1016/S1470-2045(21)00301-6. https://www.ncbi.nlm.nih.gov/pubmed/34252375.

Dick, J., V. Aue, S. Wesselmann, A. Bredart, S. Dolbeault, P. Devilee, D. Stoppa-Lyonnet, R. K. Schmutzler, and K. Rhiem. "Survey on Physicians' Knowledge and Training Needs in Genetic Counseling in Germany." Breast Care (Basel) 16, no. 4 (Aug 2021): 389-95. https://doi.org/10.1159/000511136. https://www.ncbi.nlm.nih.gov/pubmed/34602945.

Ditsch, N., C. Kolberg-Liedtke, M. Friedrich, C. Jackisch, U. S. Albert, M. Banys-Paluchowski, I. Bauerfeind, et al. "Ago Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2021." Breast Care (Basel) 16, no. 3 (Jun 2021): 214-27. https://doi.org/10.1159/000516419. https://www.ncbi.nlm.nih.gov/pubmed/34248462.

Engel, C., K. Wieland, S. Zachariae, K. Bucksch, U. Enders, U. Schoenwiese, M. Yahiaoui-Doktor, et al. "[Heredicare: Documentation and It Solution of a Specialized Registry for Hereditary Breast and Ovarian Cancer]." Gesundheitswesen 83, no. S 01 (Nov 2021): S12-S17. https://doi.org/10.1055/a-1658-0313. HerediCaRe: Dokumentations- und IT-Losung eines spezialisierten Registers fur erblichen Brust- und Eierstockkrebs. https://www.ncbi.nlm.nih.gov/pubmed/34731888.

Escala-Garcia, M., S. Canisius, R. Keeman, J. Beesley, H. Anton-Culver, V. Arndt, A. Augustinsson, et al. "Germline Variants and Breast Cancer Survival in Patients with Distant Metastases at Primary Breast Cancer Diagnosis." [In English]. Scientific Reports 11, no. 1 (Oct 5 2021). https://doi.org/ARTN 19787

Fasching, P. A., T. Link, J. Hauke, F. Seither, C. Jackisch, P. Klare, S. Schmatloch, et al. "Neoadjuvant Paclitaxel/Olaparib in Comparison to Paclitaxel/Carboplatinum in Patients with Her2-Negative Breast Cancer and Homologous Recombination Deficiency (Geparola Study)." Ann Oncol 32, no. 1 (Jan 2021): 49-57. https://doi.org/10.1016/j.annonc.2020.10.471. https://www.ncbi.nlm.nih.gov/pubmed/33098995

Friedrich, M., T. Kuhn, W. Janni, V. Muller, M. Banys-Pachulowski, C. Kolberg-Liedtke, C. Jackisch, et al. "Ago Recommendations for the Surgical Therapy of the Axilla after Neoadjuvant Chemotherapy: 2021 Update." Geburtshilfe Frauenheilkd 81, no. 10 (Oct 2021): 1112-20. https://doi.org/10.1055/a-1499-8431. https://www.ncbi.nlm.nih.gov/pubmed/34629490.

Friedrich, M., T. Kuhn, W. Janni, V. Muller, M. Banys-Paluchowski, C. Kolberg-Liedtke, C. Jackisch, et al. "Correction: Ago Recommendations for the Surgical Therapy of the Axilla after Neoadjuvant Chemotherapy: 2021 Update." Geburtshilfe Frauenheilkd 81, no. 10 (Oct 2021): e31. https://doi.org/10.1055/a-1674-1114. https://www.ncbi.nlm.nih.gov/pubmed/34720743.

Furlanetto, J., V. Mobus, A. Schneeweiss, K. Rhiem, H. Tesch, J. U. Blohmer, K. Lubbe, et al. "Germline Brca1/2 Mutations and Severe Haematological Toxicities in Patients with Breast Cancer Treated with Neoadjuvant Chemotherapy." Eur J Cancer 145 (Mar 2021): 44-52. https://doi.org/10.1016/j.ejca.2020.12.007. https://www.ncbi.nlm.nih.gov/pubmed/33423006.

Grill, S., M. Yahiaoui-Doktor, M. Basrai, J. Struck, J. Schulte, A. Berling-Ernst, C. Engel, et al. "Precursor Fractions of Neurotensin and Enkephalin Might Point to Molecular Mechanisms of Cancer Risk Modulation During a Lifestyle-Intervention in Germline Brca1/2 Gene Mutation Carriers." Breast Cancer Res Treat 186, no. 3 (Apr 2021): 741-52. https://doi.org/10.1007/s10549-020-06070-x. https://www.ncbi.nlm.nih.gov/pubmed/33543354.

Huber, D., S. Seitz, K. Kast, G. Emons, and O. Ortmann. "Hormone Replacement Therapy in Brca Mutation Carriers and Risk of Ovarian, Endometrial, and Breast Cancer: A Systematic Review." J Cancer Res Clin Oncol 147, no. 7 (Jul 2021): 2035-45. https://doi.org/10.1007/s00432-021-03629-z. https://www.ncbi.nlm.nih.gov/pubmed/33885953.

Johnson, N., S. Maguire, A. Morra, P. M. Kapoor, K. Tomczyk, M. E. Jones, M. J. Schoemaker, et al. "Cyp3a7*1c Allele: Linking Premenopausal Oestrone and Progesterone Levels with Risk of Hormone Receptor-Positive Breast Cancers." Br J Cancer 124, no. 4 (Feb 2021): 842-54. https://doi.org/10.1038/s41416-020-01185-w. https://www.ncbi.nlm.nih.gov/pubmed/33495599.

K, V. A., and U. B. "A Novel Approach to Combat Covid-19 - a Risk Stratification Model with Fair Intervention." J Healthc Qual Res 36, no. 1 (Jan-Feb 2021): 55-56. https://doi.org/10.1016/j.jhqr.2020.10.005. https://www.ncbi.nlm.nih.gov/pubmed/33342757.

Kast, K., J. Hafner, E. Schrock, A. Jahn, C. Werner, C. Meisel, and P. Wimberger. "Recommendation and Acceptance of Counselling for Familial Cancer Risk in Newly Diagnosed Breast Cancer Cases." [In English]. Breast Care  (Jun 17 2021). https://doi.org/10.1159/000517021. <Go to ISI>://WOS:000665102000001.

Kautz-Freimuth, S., M. Redaelli, K. Rhiem, A. Vodermaier, L. Krassuski, K. Nicolai, M. Schnepper, et al. "Development of Decision Aids for Female Brca1 and Brca2 Mutation Carriers in Germany to Support Preference-Sensitive Decision-Making." BMC Med Inform Decis Mak 21, no. 1 (Jun 5 2021): 180. https://doi.org/10.1186/s12911-021-01528-4. https://www.ncbi.nlm.nih.gov/pubmed/34090422.

Kawaguchi, R., K. Matsumoto, T. Ishikawa, K. Ishitani, R. Okagaki, M. Ogawa, T. Oki, et al. "Guideline for Gynecological Practice in Japan: Japan Society of Obstetrics and Gynecology and Japan Association of Obstetricians and Gynecologists 2020 Edition." J Obstet Gynaecol Res 47, no. 1 (Jan 2021): 5-25. https://doi.org/10.1111/jog.14487. https://www.ncbi.nlm.nih.gov/pubmed/33145837.

Koldehoff, A., M. Danner, D. Civello, K. Rhiem, S. Stock, and D. Muller. "Cost-Effectiveness of Targeted Genetic Testing for Breast and Ovarian Cancer: A Systematic Review." Value Health 24, no. 2 (Feb 2021): 303-12. https://doi.org/10.1016/j.jval.2020.09.016. https://www.ncbi.nlm.nih.gov/pubmed/33518037.

Krassuski, L. M., S. Kautz-Freimuth, V. Vennedey, K. Rhiem, R. K. Schmutzler, and S. Stock. "Decision Aids for Preventive Treatment Alternatives for Brca1/2 Mutation Carriers: A Systematic Review." Geburtshilfe Frauenheilkd 81, no. 6 (Jun 2021): 679-98. https://doi.org/10.1055/a-1326-1792. https://www.ncbi.nlm.nih.gov/pubmed/34168381.

Kurokawa, R., A. Hagiwara, S. Amemiya, W. Gonoi, N. Fujita, M. Kurokawa, H. Yamaguchi, et al. "Imatinib-Induced Pancreatic Hypertrophy in Patients with Gastrointestinal Stromal Tumor: Association with Overall Survival." Pancreatology 21, no. 1 (Jan 2021): 246-52. https://doi.org/10.1016/j.pan.2020.11.014. https://www.ncbi.nlm.nih.gov/pubmed/33281059.

Labidi-Galy, S. I., A. Schneeweiss, H. P. Sinn, J. U. Blohmer, L. Romanens, D. M. Zahm, J. Huober, et al. "Baseline Menopausal Status, Ki-67 and Stromal Tumour-Infiltrating Lymphocytes (Tils) and Association with Outcome in Triple-Negative Breast Cancer (Tnbc): Exploratory Analysis in Geparsixto." [In English]. Annals of Oncology 32 (May 2021): S49-S50. https://doi.org/10.1016/j.annonc.2021.03.080. <Go to ISI>://WOS:000648924400068.

Lakeman, I. M. M., A. J. van den Broek, J. A. M. Vos, D. R. Barnes, J. Adlard, I. L. Andrulis, A. Arason, et al. "The Predictive Ability of the 313 Variant-Based Polygenic Risk Score for Contralateral Breast Cancer Risk Prediction in Women of European Ancestry with a Heterozygous Brca1 or Brca2 Pathogenic Variant." Genet Med 23, no. 9 (Sep 2021): 1726-37. https://doi.org/10.1038/s41436-021-01198-7. https://www.ncbi.nlm.nih.gov/pubmed/34113011.

Lepkes, L., M. Kayali, B. Blumcke, J. Weber, M. Suszynska, S. Schmidt, J. Borde, et al. "Performance of in Silico Prediction Tools for the Detection of Germline Copy Number Variations in Cancer Predisposition Genes in 4208 Female Index Patients with Familial Breast and Ovarian Cancer." Cancers (Basel) 13, no. 1 (Jan 1 2021). https://doi.org/10.3390/cancers13010118. https://www.ncbi.nlm.nih.gov/pubmed/33401422.

Lertvachirapaiboon, C., A. Baba, K. Shinbo, and K. Kato. "Dual-Mode Surface Plasmon Resonance Sensor Chip Using a Grating 3d-Printed Prism." Anal Chim Acta 1147 (Feb 22 2021): 23-29. https://doi.org/10.1016/j.aca.2020.12.027. https://www.ncbi.nlm.nih.gov/pubmed/33485581.

Li, N., M. Zethoven, S. McInerny, L. Devereux, Y. K. Huang, N. Thio, D. Cheasley, et al. "Evaluation of the Association of Heterozygous Germline Variants in Nthl1 with Breast Cancer Predisposition: An International Multi-Center Study of 47,180 Subjects." NPJ Breast Cancer 7, no. 1 (May 12 2021): 52. https://doi.org/10.1038/s41523-021-00255-3. https://www.ncbi.nlm.nih.gov/pubmed/33980861.

Lin, X., K. Lin, C. Lin, T. Liu, M. Ba, Y. Tang, J. Wang, et al. "Prognostic and Clinicopathological Value of Pd-L2 in Lung Cancer: A Meta-Analysis." Int Immunopharmacol 91 (Feb 2021): 107280. https://doi.org/10.1016/j.intimp.2020.107280. https://www.ncbi.nlm.nih.gov/pubmed/33370681.

Llop-Guevara, A., S. Loibl, G. Villacampa, V. Vladimirova, A. Schneeweiss, T. Karn, D. M. Zahm, et al. "Association of Rad51 with Homologous Recombination Deficiency (Hrd) and Clinical Outcomes in Untreated Triple-Negative Breast Cancer (Tnbc): Analysis of the Geparsixto Randomized Clinical Trial." Ann Oncol 32, no. 12 (Dec 2021): 1590-96. https://doi.org/10.1016/j.annonc.2021.09.003. https://www.ncbi.nlm.nih.gov/pubmed/34520831.

Loibl, S., A. Schneeweiss, J. B. Huober, M. Braun, J. Rey, J. U. Blohmer, J. Furlanetto, et al. "Durvalumab Improves Long-Term Outcome in Tnbc: Results from the Phase Ii Randomized Geparnuevo Study Investigating Neodjuvant Durvalumab in Addition to an Anthracycline/Taxane Based Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer (Tnbc)." [In English]. Journal of Clinical Oncology 39, no. 15 (May 20 2021). <Go to ISI>://WOS:000708120600019.

Manupati, V. K., M. Ramkumar, V. Baba, and A. Agarwal. "Selection of the Best Healthcare Waste Disposal Techniques During and Post Covid-19 Pandemic Era." J Clean Prod 281 (Jan 25 2021): 125175. https://doi.org/10.1016/j.jclepro.2020.125175. https://www.ncbi.nlm.nih.gov/pubmed/33223625.

Marme, F., C. Hanusch, J. Furlanetto, C. Denkert, T. Link, M. Untch, J. U. Blohmer, et al. "Phase Iii Post-Neoadjuvant Study Evaluating Sacituzumab Govitecan (Sg), an Antibody Drug Conjugate in Primary Her2-Negative Breast Cancer Patients with High Relapse Risk after Standard Neoadjuvant Treatment: Sascia." [In English]. Annals of Oncology 32 (2021): S443-S44. https://doi.org/10.1016/j.annonc.2021.08.480. <Go to ISI>://WOS:000700527700200.

Marme, F., C. Solbach, L. Michel, A. Schneeweiss, J. U. Blohmer, J. Huober, P. A. Fasching, et al. "Utility of the Cps + Eg Scoring System in Triple-Negative Breast Cancer Treated with Neoadjuvant Chemotherapy." Eur J Cancer 153 (Aug 2021): 203-12. https://doi.org/10.1016/j.ejca.2021.05.027. https://www.ncbi.nlm.nih.gov/pubmed/34186505.

Meier, F., A. Harney, K. Rhiem, S. Neusser, A. Neumann, M. Braun, J. Wasem, et al. "Risk-Adjusted Prevention. Perspectives on the Governance of Entitlements to Benefits in the Case of Genetic (Breast Cancer) Risks." Recent Results Cancer Res 218 (2021): 47-66. https://doi.org/10.1007/978-3-030-63749-1_5. https://www.ncbi.nlm.nih.gov/pubmed/34019162.

Min, K. J., D. H. Suh, T. Baba, X. Chen, J. W. Kim, Y. Kobayashi, J. Kwon, et al. "Time for Enhancing Government-Led Primary Prevention of Cervical Cancer." J Gynecol Oncol 32, no. 1 (Jan 2021): e12. https://doi.org/10.3802/jgo.2021.32.e12. https://www.ncbi.nlm.nih.gov/pubmed/33327045.

Minnaard, J., R. P. Kleipool, W. Baars, J. Dankelman, S. Stufkens, and T. Horeman. "A New Bone-Cutting Approach for Minimally Invasive Surgery." Med Eng Phys 87 (Jan 2021): 56-62. https://doi.org/10.1016/j.medengphy.2020.11.011. https://www.ncbi.nlm.nih.gov/pubmed/33461674.

Moriguchi, S., K. Hamanaka, M. Nakamura, M. Takaso, M. Baba, and M. Hitosugi. "Aging Is Only Significant Factor Causing Cpr-Induced Injuries and Serious Injuries." Leg Med (Tokyo) 48 (Feb 2021): 101828. https://doi.org/10.1016/j.legalmed.2020.101828. https://www.ncbi.nlm.nih.gov/pubmed/33370635.

Morra, A., M. Escala-Garcia, J. Beesley, R. Keeman, S. Canisius, T. U. Ahearn, I. L. Andrulis, et al. "Association of Germline Genetic Variants with Breast Cancer-Specific Survival in Patient Subgroups Defined by Clinic-Pathological Variables Related to Tumor Biology and Type of Systemic Treatment." Breast Cancer Res 23, no. 1 (Aug 18 2021): 86. https://doi.org/10.1186/s13058-021-01450-7. https://www.ncbi.nlm.nih.gov/pubmed/34407845.

Nabi, M. M., J. Wang, and M. Baalousha. "Episodic Surges in Titanium Dioxide Engineered Particle Concentrations in Surface Waters Following Rainfall Events." Chemosphere 263 (Jan 2021): 128261. https://doi.org/10.1016/j.chemosphere.2020.128261. https://www.ncbi.nlm.nih.gov/pubmed/33297205.

Naito, Y., H. Aburatani, T. Amano, E. Baba, T. Furukawa, T. Hayashida, E. Hiyama, et al. "Clinical Practice Guidance for Next-Generation Sequencing in Cancer Diagnosis and Treatment (Edition 2.1)." Int J Clin Oncol 26, no. 2 (Feb 2021): 233-83. https://doi.org/10.1007/s10147-020-01831-6. https://www.ncbi.nlm.nih.gov/pubmed/33249514.

Nassar, L., A. Barakat, Z. Farah, A. Baassiri, R. A. Raad, D. Mahfoud, G. Saheb, and F. G. Haddad. "Radiology Residents from Learners to Teachers: A Multi-Centric Study." Eur J Radiol 134 (Jan 2021): 109408. https://doi.org/10.1016/j.ejrad.2020.109408. https://www.ncbi.nlm.nih.gov/pubmed/33290976.

Neirich, L., M. Yahiaoui-Doktor, J. Lammert, M. Basrai, B. Seethaler, A. Berling-Ernst, J. Ramser, et al. "Physical Activity and Mediterranean Diet as Potential Modulators of Osteoprotegerin and Soluble Rankl in Gbrca1/2 Mutation Carriers: Results of the Lifestyle Intervention Pilot Study Libre-1." [In English]. Breast Cancer Research and Treatment 190, no. 3 (Dec 2021): 463-75. https://doi.org/10.1007/s10549-021-06400-7. <Go to ISI>://WOS:000701008000002.

Niang, I., N. S. Ndour, M. Ly, A. Ndong, N. B. Mar, K. N. Diouf, C. T. Diop, A. D. Diop, and S. Ba. "Malrotation of an Iliac Ectopic Kidney with Pyelo-Ureteral Duplication: An Incidental Three-in-One Congenital Anomaly." Radiol Case Rep 16, no. 3 (Mar 2021): 524-27. https://doi.org/10.1016/j.radcr.2020.12.041. https://www.ncbi.nlm.nih.gov/pubmed/33384748.

O'Neill, E. N., Z. A. Cosenza, K. Baar, and D. E. Block. "Considerations for the Development of Cost-Effective Cell Culture Media for Cultivated Meat Production." Compr Rev Food Sci Food Saf 20, no. 1 (Jan 2021): 686-709. https://doi.org/10.1111/1541-4337.12678. https://www.ncbi.nlm.nih.gov/pubmed/33325139.

Ochi, Y., T. Kubo, Y. Baba, M. Ueda, K. Miyagawa, T. Noguchi, T. Hirota, N. Yamasaki, and H. Kitaoka. "Validation of the Kumamoto Criteria for Prediction of (99m) Technetium Pyrophosphate Scintigraphy Positivity as a Strategy for Diagnosis of Transthyretin Cardiac Amyloidosis: A Retrospective Cohort Study in Kochi." J Cardiol 77, no. 2 (Feb 2021): 124-30. https://doi.org/10.1016/j.jjcc.2020.06.019. https://www.ncbi.nlm.nih.gov/pubmed/33132078.

Park, H. A., S. Neumeyer, K. Michailidou, M. K. Bolla, Q. Wang, J. Dennis, T. U. Ahearn, et al. "Mendelian Randomisation Study of Smoking Exposure in Relation to Breast Cancer Risk." Br J Cancer 125, no. 8 (Oct 2021): 1135-45. https://doi.org/10.1038/s41416-021-01432-8. https://www.ncbi.nlm.nih.gov/pubmed/34341517.

Pauly, N., T. Baert, R. Schmutzler, A. du Bois, S. Schneider, K. Rhiem, B. Schomig-Markiefka, et al. "Modern Day Screening for Lynch Syndrome in Endometrial Cancer: The Kem Experience." Arch Gynecol Obstet 304, no. 4 (Oct 2021): 975-84. https://doi.org/10.1007/s00404-021-06006-w. https://www.ncbi.nlm.nih.gov/pubmed/33710393.

Persinal-Medina, M., S. Llames, N. Vazquez, M. Chacon, A. Acebes-Huerta, E. Uribe, S. Alonso-Alonso, et al. "Xeno-Free Approach for the Expansion of Human Adipose Derived Mesenchymal Stem Cells for Ocular Therapies." Exp Eye Res 202 (Jan 2021): 108358. https://doi.org/10.1016/j.exer.2020.108358. https://www.ncbi.nlm.nih.gov/pubmed/33207223.

Puesken, M., et al. "Ex Vivo Study of Artifacts Caused by Breast Tissue Markers with Different 1.5 Tesla and 3 Tesla Mri Scanners - a Bicentric Study." Acad Radiol 28, no. 1 (Jan 2021): 77-84. https://doi.org/10.1016/j.acra.2019.12.006. https://www.ncbi.nlm.nih.gov/pubmed/32008930.

Ravi, V., M. El Baba, and P. S. Sharma. "His Bundle Pacing: Tips and Tricks." Pacing Clin Electrophysiol 44, no. 1 (Jan 2021): 26-34. https://doi.org/10.1111/pace.14108. https://www.ncbi.nlm.nih.gov/pubmed/33174216.

Riehm, K. „HEREDITÄRES ENDOMETRIUMKARZINOM Plädoyer für Genanalysen in der Regelversorgung“ Deutsches Ärzteblatt (Jan 2021). Zur Publikation.

Rhiem, K., B. Auber, S. Briest, N. Dikow, N. Ditsch, N. Dragicevic, S. Grill, et al. "Consensus Recommendations of the German Consortium for Hereditary Breast and Ovarian Cancer." [In English]. Breast Care  (Jul 19 2021). https://doi.org/10.1159/000516376. <Go to ISI>://WOS:000675440000001.

Richters, L. K. K., O. Gluz, N. Weber-Lassalle, M. Christgen, H. Haverkamp, S. Kuemmel, M. Kayali, et al. "Pathological Complete Response Rate and Survival in Patients with Brca-Associated Triple-Negative Breast Cancer after 12 Weeks of De-Escalated Neoadjuvant Chemotherapy: Translational Results of the Wsg-Adapt Tn Randomized Phase Ii Trial (Nct01815242)." [In English]. Journal of Clinical Oncology 39, no. 15 (May 20 2021). https://doi.org/10.1200/JCO.2021.39.15_suppl.579. <Go to ISI>://WOS:000708120600089.

Rippinger, N., C. Fischer, H. P. Sinn, N. Dikow, C. Sutter, K. Rhiem, S. Grill, et al. "Breast Cancer Characteristics and Surgery among Women with Li-Fraumeni Syndrome in Germany-a Retrospective Cohort Study." [In English]. Cancer Medicine 10, no. 21 (Nov 2021): 7747-58. https://doi.org/10.1002/cam4.4300. <Go to ISI>://WOS:000699884900001.

Sabayan, B., M. Moghadami, F. Assarzadegan, S. H. Komachali, L. Poorsaadat, Z. Babaeepour, S. A. Ebrahimzadeh, et al. "Covid-19 Respiratory Illness and Subsequent Cerebrovascular Events, the Initial Iranian Experience." J Stroke Cerebrovasc Dis 30, no. 1 (Jan 2021): 105454. https://doi.org/10.1016/j.jstrokecerebrovasdis.2020.105454. https://www.ncbi.nlm.nih.gov/pubmed/33212340.

Schmutzler,R. „MAMMAKARZINOM-STUDIE OLYMPIA Folgen für die Versorgung“ Deutsches Ärzteblatt (Feb 2021). Zur Publikation.

Schmutzler, R. K. "Quality and Quantity: How to Organize a Countrywide Genetic Counseling and Testing." Breast Care (Basel) 16, no. 3 (Jun 2021): 196-201. https://doi.org/10.1159/000515429. https://www.ncbi.nlm.nih.gov/pubmed/34248460.

Schmutzler, R. K., B. Schmitz-Luhn, B. Borisch, P. Devilee, D. Eccles, P. Hall, J. Balmana, et al. "Risk-Adjusted Cancer Screening and Prevention (Riskap): Complementing Screening for Early Disease Detection by a Learning Screening Based on Risk Factors." [In English]. Breast Care  (Aug 12 2021). https://doi.org/10.1159/000517182. <Go to ISI>://WOS:000686247600001.

Scholtes, R. A., M. H. A. Muskiet, M. J. B. van Baar, A. C. Hesp, P. J. Greasley, C. Karlsson, A. Hammarstedt, et al. "Natriuretic Effect of Two Weeks of Dapagliflozin Treatment in Patients with Type 2 Diabetes and Preserved Kidney Function During Standardized Sodium Intake: Results of the Dapasalt Trial." Diabetes Care 44, no. 2 (Feb 2021): 440-47. https://doi.org/10.2337/dc20-2604. https://www.ncbi.nlm.nih.gov/pubmed/33318125.

Schouten, P. C., L. Richters, D. J. Vis, S. Kommoss, E. van Dijk, C. Ernst, R. J. C. Kluin, et al. "Ovarian Cancer-Specific Brca-Like Copy-Number Aberration Classifiers Detect Mutations Associated with Homologous Recombination Deficiency in the Ago-Tr1 Trial." Clin Cancer Res 27, no. 23 (Dec 1 2021): 6559-69. https://doi.org/10.1158/1078-0432.CCR-21-1673. https://www.ncbi.nlm.nih.gov/pubmed/34593530.

Schrijver, L. H., A. C. Antoniou, H. Olsson, T. M. Mooij, M. J. Roos-Blom, L. Azarang, J. Adlard, et al. "Oral Contraceptive Use and Ovarian Cancer Risk for Brca1/2 Mutation Carriers: An International Cohort Study." Am J Obstet Gynecol 225, no. 1 (Jul 2021): 51 e1-51 e17. https://doi.org/10.1016/j.ajog.2021.01.014. https://www.ncbi.nlm.nih.gov/pubmed/33493488.

Schrijver, L. H., A. C. Antoniou, H. Olsson, T. M. Mooij, M. J. Roos-Blom, L. Azarang, J. Adlard, et al. "Oral Contraceptive Use and Ovarian Cancer Risk for Brca1/2 Mutation Carriers: An International Cohort Study." [In English]. American Journal of Obstetrics and Gynecology 225, no. 1 (Jul 2021). https://doi.org/ARTN 51.e1-e1710.1016/j.ajog.2021.01.014. <Go to ISI>://WOS:000670445100008.

Sghaier-Hammami, B., M. A. Castillejo, N. Baazaoui, J. V. Jorrin-Novo, and M. Escandon. "Gelc-Orbitrap/Ms and 2-De-Maldi-Tof/Tof Comparative Proteomics Analysis of Seed Cotyledons from the Non-Orthodox Quercus Ilex Tree Species." J Proteomics 233 (Feb 20 2021): 104087. https://doi.org/10.1016/j.jprot.2020.104087. https://www.ncbi.nlm.nih.gov/pubmed/33359940.

Stracke, C., C. Lemmen, K. Rhiem, R. Schmutzler, S. Kautz-Freimuth, and S. Stock. "Medical Knowledge and Information Needs among Women with Pathogenic Variants in Moderate-Risk Genes for Hereditary Breast Cancer Attending Genetic Counseling at an Academic Hospital in Germany-a Qualitative Approach." J Genet Couns  (Nov 26 2021). https://doi.org/10.1002/jgc4.1536. https://www.ncbi.nlm.nih.gov/pubmed/34837291.

2020

Ajdanian, L., M. Babaei, and H. Aroiee. "Investigation of Photosynthetic Effects, Carbohydrate and Starch Content in Cress (Lepidium Sativum) under the Influence of Blue and Red Spectrum." Heliyon 6, no. 12 (Dec 2020): e05628. https://doi.org/10.1016/j.heliyon.2020.e05628. https://www.ncbi.nlm.nih.gov/pubmed/33313433.

Alahverdi, A., E. Arefian, M. Soleimani, J. Ai, A. Yousefi-Ahmadipour, A. Babaei, M. S. Islam, and S. Ebrahimi-Barough. "Involvement of Egfr, Erk-1,2 and Akt-1,2 Activity on Human Glioma Cell Growth." Asian Pac J Cancer Prev 21, no. 12 (Dec 1 2020): 3469-75. https://doi.org/10.31557/APJCP.2020.21.12.3469. https://www.ncbi.nlm.nih.gov/pubmed/33369441

Andrews, J. C., F. D. Roy, R. B. Stein, F. Ba, and T. Sankar. "Effect of Motor State on Postactivation Depression of the Soleus H-Reflex in Parkinson's Disease During Deep Brain Stimulation and Dopaminergic Medication Treatment: A Pilot Study." J Clin Neurophysiol Publish Ahead of Print (Dec 22 2020). https://doi.org/10.1097/WNP.0000000000000808. https://www.ncbi.nlm.nih.gov/pubmed/33394822.

Ataseven, B., D. Tripon, K. Rhiem, P. Harter, S. Schneider, F. Heitz, T. Baert, et al. "Prevalence of Brca1 and Brca2 Mutations in Patients with Primary Ovarian Cancer - Does the German Checklist for Detecting the Risk of Hereditary Breast and Ovarian Cancer Adequately Depict the Need for Consultation?". Geburtshilfe Frauenheilkd 80, no. 9 (Sep 2020): 932-40. https://doi.org/10.1055/a-1222-0042. https://www.ncbi.nlm.nih.gov/pubmed/32905297.

Avci, E., A. Karabulut, A. G. Alp, B. Baba, and C. Bilgi. "Crucial Markers Showing the Risk of Coronary Artery Disease in Obesity: Adma and Neopterin." J Med Biochem 39, no. 4 (Oct 2 2020): 452-59. https://doi.org/10.5937/jomb0-24683. https://www.ncbi.nlm.nih.gov/pubmed/33312061.

B, A., A. Fernandez, S. P. Laila, A. S. Nair, and V. S. Vishnu. "Synthesis, Characterization, Molecular Docking and Anticancer Studies of Fluoroaniline Derivatives of Hydroxybenzoquinone and Hydroxynaphthoquinone." J Biomol Struct Dyn  (Dec 14 2020): 1-11. https://doi.org/10.1080/07391102.2020.1852116. https://www.ncbi.nlm.nih.gov/pubmed/33314966.

Ba, H., S. Auburn, C. G. Jacob, S. Goncalves, C. W. Duffy, L. B. Stewart, R. N. Price, et al. "Multi-Locus Genotyping Reveals Established Endemicity of a Geographically Distinct Plasmodium Vivax Population in Mauritania, West Africa." PLoS Negl Trop Dis 14, no. 12 (Dec 2020): e0008945. https://doi.org/10.1371/journal.pntd.0008945. https://www.ncbi.nlm.nih.gov/pubmed/33326439.

Baader, A., B. Kiani, N. Brunkhorst-Kanaan, S. Kittel-Schneider, A. Reif, and O. Grimm. "A within-Sample Comparison of Two Innovative Neuropsychological Tests for Assessing Adhd." Brain Sci 11, no. 1 (Dec 31 2020). https://doi.org/10.3390/brainsci11010036. https://www.ncbi.nlm.nih.gov/pubmed/33396421

Baalbaki, S., J. M. Szychowski, Y. Tang, L. Wetta, and A. Subramaniam. "Systemic Lupus Erythematosus: Perinatal Outcomes in Patients Treated with and without Hydroxychloroquine." Ochsner J 20, no. 4 (Winter 2020): 362-67. https://doi.org/10.31486/toj.20.0013. https://www.ncbi.nlm.nih.gov/pubmed/33408572.

Baali, I., C. Erten, and H. Kazan. "Driveways: A Method for Identifying Possibly Overlapping Driver Pathways in Cancer." Sci Rep 10, no. 1 (Dec 15 2020): 21971. https://doi.org/10.1038/s41598-020-78852-8. https://www.ncbi.nlm.nih.gov/pubmed/33319839.

Baams, L., A. M. Pollitt, C. Laub, and S. T. Russell. "Characteristics of Schools with and without Gay-Straight Alliances." Appl Dev Sci 24, no. 4 (2020): 354-59. https://doi.org/10.1080/10888691.2018.1510778. https://www.ncbi.nlm.nih.gov/pubmed/33488047.

Baan, F., E. M. van Meggelen, A. C. Verhulst, R. Bruggink, T. Xi, and T. J. J. Maal. "Virtual Occlusion in Orthognathic Surgery." Int J Oral Maxillofac Surg  (Dec 23 2020). https://doi.org/10.1016/j.ijom.2020.12.006. https://www.ncbi.nlm.nih.gov/pubmed/33358521.

Baaniya, B., and S. Agrawal. "Kaposi Varicelliform Eruption in a Patient with Pemphigus Vulgaris: A Case Report and Review of the Literature." Case Rep Dermatol Med 2020 (2020): 6695342. https://doi.org/10.1155/2020/6695342. https://www.ncbi.nlm.nih.gov/pubmed/33489386

Baart, V. M., M. M. Deken, M. W. Bordo, S. S. Bhairosingh, D. C. F. Salvatori, H. Hyun, M. Henary, et al. "Small Molecules for Multi-Wavelength near-Infrared Fluorescent Mapping of Regional and Sentinel Lymph Nodes in Colorectal Cancer Staging." Front Oncol 10 (2020): 586112. https://doi.org/10.3389/fonc.2020.586112. https://www.ncbi.nlm.nih.gov/pubmed/33392081.

Baba, H. A., and R. M. Bohle. "[Report of the Working Group on Cardiovascular, Renal and Transplant Pathology]." Pathologe 41, no. Suppl 2 (Dec 2020): 174-75. https://doi.org/10.1007/s00292-020-00896-4. Bericht der Arbeitsgemeinschaft Herz, Gefass, Nieren- und Transplantationspathologie. https://www.ncbi.nlm.nih.gov/pubmed/33427919.

Baba, H., H. Kanamori, R. Kakuta, H. Sakurai, K. Oshima, T. Aoyagi, and M. Kaku. "Genomic Characteristics of Listeria Monocytogenes Causing Invasive Listeriosis in Japan." Diagn Microbiol Infect Dis 99, no. 3 (Oct 6 2020): 115233. https://doi.org/10.1016/j.diagmicrobio.2020.115233. https://www.ncbi.nlm.nih.gov/pubmed/33340935

Baba, K., N. Hashida, M. Tujikawa, A. J. Quantock, and K. Nishida. "The Generation of Fluorometholone Nanocrystal Eye Drops, Their Metabolization to Dihydrofluorometholone and Penetration into Rabbit Eyes." Int J Pharm 592 (Jan 5 2021): 120067. https://doi.org/10.1016/j.ijpharm.2020.120067. https://www.ncbi.nlm.nih.gov/pubmed/33189813.

Baba, M., K. Yoshida, Y. Hanaki, M. Yamamoto, Y. Shinoda, N. Takeyasu, and A. Nogami. "Upgrade of Cardiac Resynchronization Therapy by Utilizing Additional His-Bundle Pacing in Patients with Inotrope-Dependent End-Stage Heart Failure: A Case Series." Eur Heart J Case Rep 4, no. 6 (Dec 2020): 1-9. https://doi.org/10.1093/ehjcr/ytaa303. https://www.ncbi.nlm.nih.gov/pubmed/33447714.

Baba, O., L. H. Huang, A. Elvington, M. Szpakowska, D. Sultan, G. S. Heo, X. Zhang, et al. "Cxcr4-Binding Positron Emission Tomography Tracers Link Monocyte Recruitment and Endothelial Injury in Murine Atherosclerosis." Arterioscler Thromb Vasc Biol  (Dec 17 2020): ATVBAHA120315053. https://doi.org/10.1161/ATVBAHA.120.315053. https://www.ncbi.nlm.nih.gov/pubmed/33327748.

Baba, O., G. Kaya, M. Haktanir Abul, N. Kaklikkaya, M. Cakir, and F. Orhan. "Prevalence and Characteristics of Hymenoptera Venom Allergy in Urban School Children Aged 6 to 18 Years Living in Trabzon." Turk J Med Sci  (Dec 28 2020). https://doi.org/10.3906/sag-2009-86. https://www.ncbi.nlm.nih.gov/pubmed/33356030.

Baba, S., T. Akashi, K. Kayamori, T. Ohuchi, I. Ogawa, N. Kubota, K. Nakano, et al. "Homeobox Transcription Factor Engrailed Homeobox 1 Is a Possible Diagnostic Marker for Adenoid Cystic Carcinoma and Polymorphous Adenocarcinoma." Pathol Int  (Dec 17 2020). https://doi.org/10.1111/pin.13050. https://www.ncbi.nlm.nih.gov/pubmed/33333616.

Baba, S., A. Miyoshi, S. Obara, H. Usubuchi, S. Terae, M. Sunahara, T. Oshima, et al. "A Case of Williams Syndrome with Suspected Coexisting Ectopic Aldosterone-Producing Tumor in the Liver." Endocrinol Diabetes Metab Case Rep 2020 (Sep 23 2020). https://doi.org/10.1530/EDM-20-0057. https://www.ncbi.nlm.nih.gov/pubmed/33434178.

Baba, S., R. Shiboi, J. Yokosuka, Y. Oshima, Y. Takano, H. Iwai, H. Inanami, and H. Koga. "Microendoscopic Posterior Decompression for Treating Thoracic Myelopathy Caused by Ossification of the Ligamentum Flavum: Case Series." Medicina (Kaunas) 56, no. 12 (Dec 10 2020). https://doi.org/10.3390/medicina56120684. https://www.ncbi.nlm.nih.gov/pubmed/33321989.

Baba, Y., K. Otani, K. Sakai, and R. Kawaguchi. "Sustained Compression Leading to Liner Pressure Ulcers Following Improper Surgical Mask Use in Autism Spectrum Disorder." Acute Med Surg 7, no. 1 (Jan-Dec 2020): e604. https://doi.org/10.1002/ams2.604. https://www.ncbi.nlm.nih.gov/pubmed/33318802

Babacanoglu, E., and U. Guller. "Daily Oxygen Supplementation to the Incubator at Different Stages of Embryonic Development Alters the Activity of Antioxidant Enzymes in the Lung Tissue of Broiler Chicks at a High Altitude." Br Poult Sci  (Dec 16 2020). https://doi.org/10.1080/00071668.2020.1864809. https://www.ncbi.nlm.nih.gov/pubmed/33325752.

Babaee, S. H., M. J. Nooghabi, R. Sadeghi, A. Abdollahi, A. Falsafi, M. Fakhlaei, and Z. Gholami. "Sentinel Lymph Node Mapping in Colorectal Cancers with Radioactive Tracer; Is It an Efficient Method?". J Cancer Res Ther 16, no. Supplement (Dec 2020): S160-S64. https://doi.org/10.4103/jcrt.JCRT_272_17. https://www.ncbi.nlm.nih.gov/pubmed/33380671.

Babaee, T., M. Kamyab, and M. S. Ganjavian. "Infantile Idiopathic Scoliosis: Outcomes of Brace Treatment until Skeletal Maturity or Spinal Fusion." Arch Bone Jt Surg 8, no. 6 (Nov 2020): 696-702. https://doi.org/10.22038/abjs.2020.44975.2253. https://www.ncbi.nlm.nih.gov/pubmed/33313350.

Babaeekhou, L., M. Ghane, F. Ezatzade, and S. Eftekhari Toroghi. "Streptococcus Mutans and Streptococcus Sobrinus Distribution in the Saliva and Plaque of Iranian Population: Higher Prevalence of S. Mutans Serotypes F and K." Int J Dent Hyg  (Dec 25 2020). https://doi.org/10.1111/idh.12485. https://www.ncbi.nlm.nih.gov/pubmed/33369141

Babaei, K., M. Khaleghipoor, S. M. Saadati, A. Ghodsi, N. Sadeghi, and N. Nikoo. "The Effect of Fluid Therapy before Spinal Anesthesia on Prevention of Headache after Cesarean Section: A Clinical Trial." Cureus 12, no. 11 (Nov 29 2020): e11772. https://doi.org/10.7759/cureus.11772. https://www.ncbi.nlm.nih.gov/pubmed/33409020.

Balhi, S., R. Baati, M. K. Mrabet, L. Mekki, A. Ben Mansour, and A. Mrabet. "Effectiveness of Ecg Educational Workshops among Undergraduate Medical Students." Tunis Med 98, no. 11 (Nov 2020): 783-88. https://www.ncbi.nlm.nih.gov/pubmed/33479976.

———. "Polygenic Risk Scores and Breast and Epithelial Ovarian Cancer Risks for Carriers of Brca1 and Brca2 Pathogenic Variants." Genet Med 22, no. 10 (Oct 2020): 1653-66. https://doi.org/10.1038/s41436-020-0862-x. https://www.ncbi.nlm.nih.gov/pubmed/32665703.

Barturen, G., S. Babaei, F. Catala-Moll, M. Martinez-Bueno, Z. Makowska, J. Martorell-Marugan, P. Carmona-Saez, et al. "Integrative Analysis Reveals a Molecular Stratification of Systemic Autoimmune Diseases." Arthritis Rheumatol  (Dec 8 2020). https://doi.org/10.1002/art.41610. https://www.ncbi.nlm.nih.gov/pubmed/33497037.

Barnes, D. R., M. A. Rookus, L. McGuffog, G. Leslie, T. M. Mooij, J. Dennis, N. Mavaddat, et al. "Polygenic Risk Scores and Breast and Epithelial Ovarian Cancer Risks for Carriers of Brca1 and Brca2 Pathogenic Variants." Genet Med  (Jul 15 2020). https://doi.org/10.1038/s41436-020-0862-x. https://www.ncbi.nlm.nih.gov/pubmed/32665703.

Behzadnia, B., A. Kiani, and S. Babaei. "Autonomy-Supportive Exercise Behaviors Promote Breast Cancer Survivors' Well-Being." Health Promot Perspect 10, no. 4 (2020): 409-17. https://doi.org/10.34172/hpp.2020.60. https://www.ncbi.nlm.nih.gov/pubmed/33312937.

Bhargav, E., Y. P. Reddy, and K. K. B. "Development and Optimization of Luliconazole Nanostructured Lipid Carriers Based Gel by Quality by Design Its Skin Distribution Studies, Dermatokinetic Modeling & in-Vitro and Ex-Vivo Correlation." Curr Drug Deliv  (Dec 14 2020). https://doi.org/10.2174/1567201818666201214145818. https://www.ncbi.nlm.nih.gov/pubmed/33319682.

Borde, J., C. Ernst, B. Wappenschmidt, D. Niederacher, K. Weber-Lassalle, G. Schmidt, J. Hauke, et al. "Performance of Breast Cancer Polygenic Risk Scores in 760 Female Chek2 Germline Mutation Carriers." J Natl Cancer Inst  (Dec 29 2020). https://doi.org/10.1093/jnci/djaa203. https://www.ncbi.nlm.nih.gov/pubmed/33372680.

Borojeni, S. K., H. Zolfagharian, M. Babaie, and I. Javadi. "Cytotoxic Effect of Bee (A. Mellifera) Venom on Cancer Cell Lines." J Pharmacopuncture 23, no. 4 (Dec 31 2020): 212-19. https://doi.org/10.3831/KPI.2020.23.4.212. https://www.ncbi.nlm.nih.gov/pubmed/33408897.

Boudabous, J., I. Feki, R. Sellami, I. Baati, D. Trigui, and J. Masmoudi. "Anxiety and Problematic Internet Use in Tunisian Students." Tunis Med 98, no. 10 (Oct 2020): 745-49. https://www.ncbi.nlm.nih.gov/pubmed/33479947.

Brakenhoff, S. M., M. L. Verburgh, S. B. Willemse, L. C. Baak, K. Brinkman, and M. van der Valk. "Liver Stiffness Improvement in Hepatitis C Patients after Successful Treatment." Neth J Med 78, no. 6 (Dec 2020): 368-75. https://www.ncbi.nlm.nih.gov/pubmed/33380534.

Bredart, A., A. Anota, J. Dick, A. Cano, A. De Pauw, J. L. Kop, N. K. Aaronson, et al. "The "Psychosocial Aspects in Hereditary Cancer" Questionnaire in Women Attending Breast Cancer Genetic Clinics: Psychometric Validation across French-, German- and Spanish-Language Versions." Eur J Cancer Care (Engl) 29, no. 1 (Jan 2020): e13173. https://doi.org/10.1111/ecc.13173. https://www.ncbi.nlm.nih.gov/pubmed/31571365.

Bredart, A., J. Dick, A. Cano, L. Robieux, A. De Pauw, R. Schmutzler, D. Stoppa-Lyonnet, S. Dolbeault, and J. L. Kop. "How to Facilitate Psychosocial Adjustment in Women Tested for Hereditary Breast or Ovarian Cancer Susceptibility? Insights from Network Analysis." Psychooncology 29, no. 3 (Mar 2020): 550-56. https://doi.org/10.1002/pon.5302. https://www.ncbi.nlm.nih.gov/pubmed/31823434.

Burghardt, J. P., R. Fan, M. Baas, D. Eckhardt, D. Gerlach, and P. Czermak. "Enhancing the Heterologous Fructosyltransferase Activity of Kluyveromyces Lactis: Developing a Scaled-up Process and Abolishing Invertase by Crispr/Cas9 Genome Editing." Front Bioeng Biotechnol 8 (2020): 607507. https://doi.org/10.3389/fbioe.2020.607507. https://www.ncbi.nlm.nih.gov/pubmed/33324627.

Casas, L., L. Freedman, A. Ramm, S. Correa, C. F. Baba, and M. A. Biggs. "Chilean Medical and Midwifery Faculty's Views on Conscientious Objection for Abortion Services." Int Perspect Sex Reprod Health 46, no. Suppl 1 (Dec 14 2020): 25-34. https://doi.org/10.1363/46e0620. https://www.ncbi.nlm.nih.gov/pubmed/33326397.

Chan, J. L., R. Babadjouni, W. Sacks, S. I. Bannykh, and A. Tuchman. "Symptomatic Cervical Tumoral Calcinosis Due to Cosmetic Body Contouring Mineral Oil Injections." Cureus 12, no. 11 (Nov 28 2020): e11743. https://doi.org/10.7759/cureus.11743. https://www.ncbi.nlm.nih.gov/pubmed/33403173.

Chatterjee, D., A. Kumar, P. B, and R. N. "Designing Complex Radial Heterostructures of Te/Bi2te3 and Te/Bi2-X Pb X Te3 Nanowires: Fundamental Mechanistic Insights into Nanowire Growth and Evolution." Nanotechnology 32, no. 10 (Dec 17 2020): 105601. https://doi.org/10.1088/1361-6528/abcc22. https://www.ncbi.nlm.nih.gov/pubmed/33331300.

Craenen, K., M. Verslegers, Z. Callaerts-Vegh, L. Craeghs, J. Buset, K. Govaerts, M. Neefs, et al. "Folic Acid Fortification Prevents Morphological and Behavioral Consequences of X-Ray Exposure During Neurulation." Front Behav Neurosci 14 (2020): 609660. https://doi.org/10.3389/fnbeh.2020.609660. https://www.ncbi.nlm.nih.gov/pubmed/33488367.

Das, A. K., S. Kalra, K. B, K. Sharma, M. John, T. Nair, S. Shaikh, et al. "Cardiometabolic Vigilance in Covid-19 and Resource Husbandry in Resource-Challenged Times: Clinical Practice- Based Expert Opinion." Diabetes Metab Syndr 15, no. 1 (Nov 20 2020): 55-62. https://doi.org/10.1016/j.dsx.2020.11.014. https://www.ncbi.nlm.nih.gov/pubmed/33310177.

DeBeer, B., S. Baack, K. Bongiovanni, E. Borah, C. Bryan, K. Bryant, R. Cassidy, et al. "The Veterans Affairs Patient Safety Center of Inquiry-Suicide Prevention Collaborative: Creating Novel Approaches to Suicide Prevention among Veterans Receiving Community Services." Fed Pract 37, no. 11 (Nov 2020): 512-21. https://doi.org/10.12788/fp.0071. https://www.ncbi.nlm.nih.gov/pubmed/33328717.

Dehlendorff, C., L. Baandrup, and S. K. Kjaer. "Real-World Effectiveness of Human Papillomavirus Vaccination against Vulvovaginal High-Grade Precancerous Lesions and Cancers." J Natl Cancer Inst (Dec 30 2020). https://doi.org/10.1093/jnci/djaa209. https://www.ncbi.nlm.nih.gov/pubmed/33377930

Ditsch, N., M. Untch, C. Kolberg-Liedtke, C. Jackisch, D. Krug, M. Friedrich, W. Janni, et al. "Ago Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2020." Breast Care (Basel) 15, no. 3 (Jun 2020): 294-309. https://doi.org/10.1159/000508736. https://www.ncbi.nlm.nih.gov/pubmed/32774225.

Dudipala, S. C., P. M, K. C. B, and L. K. Chenalla. "Acute Encephalopathic Presentation of 3-Methylglutaconic Aciduria Type I with a Novel Mutation in Auh Gene." Cureus 12, no. 12 (Dec 7 2020): e11951. https://doi.org/10.7759/cureus.11951. https://www.ncbi.nlm.nih.gov/pubmed/33425530.

Ebogo, M., K. Mouhammad, A. Ndiaye, F. Gislaine, H. Daramsis, K. Karl, and T. Babacar. "Sexual Dimorphism and Infra Orbital Foramen: A Computerized Tomography-Scan Study in a Coorte of Senegalese Population." Minerva Stomatol  (Dec 16 2020). https://doi.org/10.23736/S0026-4970.20.04414-3. https://www.ncbi.nlm.nih.gov/pubmed/33325452.

Ekdahl, M., A. Baar, C. Larrain, S. Lopez, and S. Flores. "Severe Joint Cartilage Degeneration after Minimally Displaced Fracture of Proximal Radius in Children: A Report of 2 Cases." JSES Int 4, no. 4 (Dec 2020): 1006-10. https://doi.org/10.1016/j.jseint.2020.08.017. https://www.ncbi.nlm.nih.gov/pubmed/33345248.

Elhadd, T., M. Bashir, K. A. Baager, H. A. Ali, D. H. S. Almohannadi, Z. Dabbous, R. A. Malik, A. B. Abou-Samra, and Profast Ramadan Study Group. "Mitigation of Hypoglycemia During Ramadan Using the Flash Glucose Monitoring System Following Dose Adjustment of Insulin and Sulphonylurea in Patients Taking Multiple Glucose-Lowering Therapies (the Profast-It Study)." Diabetes Res Clin Pract 172 (Dec 13 2020): 108589. https://doi.org/10.1016/j.diabres.2020.108589. https://www.ncbi.nlm.nih.gov/pubmed/33316309.

Engel, C., C. Fischer, S. Zachariae, K. Bucksch, K. Rhiem, J. Giesecke, N. Herold, et al. "Breast Cancer Risk in Brca1/2 Mutation Carriers and Noncarriers under Prospective Intensified Surveillance." Int J Cancer 146, no. 4 (Feb 15 2020): 999-1009. https://doi.org/10.1002/ijc.32396. https://www.ncbi.nlm.nih.gov/pubmed/31081934.

Enoki, H., S. Itamura, S. Baba, T. Okanishi, and A. Fujimoto. "Case Report: Four Cases of Panayiotopoulos Syndrome Evolving to Juvenile Myoclonic Epilepsy." Front Neurol 11 (2020): 591477. https://doi.org/10.3389/fneur.2020.591477. https://www.ncbi.nlm.nih.gov/pubmed/33343495.

Escala-Garcia, M., J. Abraham, I. L. Andrulis, H. Anton-Culver, V. Arndt, A. Ashworth, P. L. Auer, et al. "A Network Analysis to Identify Mediators of Germline-Driven Differences in Breast Cancer Prognosis." Nat Commun 11, no. 1 (Jan 16 2020): 312. https://doi.org/10.1038/s41467-019-14100-6. https://www.ncbi.nlm.nih.gov/pubmed/31949161.

Eto, K., N. Yoshida, S. Iwagami, M. Iwatsuki, and H. Baba. "Surgical Treatment for Gastrointestinal Neuroendocrine Tumors." Ann Gastroenterol Surg 4, no. 6 (Nov 2020): 652-59. https://doi.org/10.1002/ags3.12396. https://www.ncbi.nlm.nih.gov/pubmed/33319155.

Evron, E., M. Juhasz, A. Babadjouni, and N. A. Mesinkovska. "Natural Hair Supplement: Friend or Foe? Saw Palmetto, a Systematic Review in Alopecia." Skin Appendage Disord 6, no. 6 (Nov 2020): 329-37. https://doi.org/10.1159/000509905. https://www.ncbi.nlm.nih.gov/pubmed/33313047.

Fachal, L., H. Aschard, J. Beesley, D. R. Barnes, J. Allen, S. Kar, K. A. Pooley, et al. "Fine-Mapping of 150 Breast Cancer Risk Regions Identifies 191 Likely Target Genes." Nat Genet 52, no. 1 (Jan 2020): 56-73. https://doi.org/10.1038/s41588-019-0537-1. https://www.ncbi.nlm.nih.gov/pubmed/31911677.

Feng, H., A. Gusev, B. Pasaniuc, L. Wu, J. Long, Z. Abu-Full, K. Aittomaki, et al. "Transcriptome-Wide Association Study of Breast Cancer Risk by Estrogen-Receptor Status." Genet Epidemiol 44, no. 5 (Jul 2020): 442-68. https://doi.org/10.1002/gepi.22288. https://www.ncbi.nlm.nih.gov/pubmed/32115800.

Frese, C., T. Wohlrab, S. Soliman, B. Hahn, C. Busch, A. Babai, G. Krastl, and D. Wolff. "A Multicenter Trial on the Long-Term Performance of Direct Composite Buildups in the Anterior Dentition - Survival and Quality Outcome." J Adhes Dent 22, no. 6 (2020): 573-80. https://doi.org/10.3290/j.jad.a45514. https://www.ncbi.nlm.nih.gov/pubmed/33491402

Funari, M. P., E. R. Baba, J. A. Lata Guacho, and E. G. Hourneaux de Moura. "A Case of Collagenous Colitis with Endoscopic Changes Enhanced by Indigo-Carmine Chromoendoscopy." Gastrointest Endosc  (Dec 22 2020). https://doi.org/10.1016/j.gie.2020.12.018. https://www.ncbi.nlm.nih.gov/pubmed/33359259.

Gadeer, R., N. Y. Baatiah, N. Alageel, and M. Khaled. "Incidence and Risk Factors of Wound Infection in Women Who Underwent Cesarean Section in 2014 at King Abdulaziz Medical City, Jeddah." Cureus 12, no. 12 (Dec 19 2020): e12164. https://doi.org/10.7759/cureus.12164. https://www.ncbi.nlm.nih.gov/pubmed/33489576.

H, B., S. A, J. A, A. P, S. B, S. D, E. M. A, and N. M. "Radioprotective Effects of Zinc and Selenium on Mice Spermatogenesis." J Biomed Phys Eng 10, no. 6 (Dec 2020): 707-12. https://doi.org/10.31661/jbpe.v0i0.957. https://www.ncbi.nlm.nih.gov/pubmed/33364208.

Hamano, J., M. Mori, T. Ozawa, J. Sasaki, M. Kawahara, A. Nakamura, K. Hashimoto, et al. "Comparison of the Prevalence and Associated Factors of Hyperactive Delirium in Advanced Cancer Patients between Inpatient Palliative Care and Palliative Home Care." Cancer Med  (Dec 12 2020). https://doi.org/10.1002/cam4.3661. https://www.ncbi.nlm.nih.gov/pubmed/33314743.

Hauke, J., P. Harter, C. Ernst, A. Burges, S. Schmidt, A. Reuss, J. Borde, et al. "Sensitivity and Specificity of Loss of Heterozygosity Analysis for the Classification of Rare Germline Variants in Brca1/2: Results of the Observational Ago-Tr1 Study (Nct02222883)." J Med Genet  (Dec 3 2020). https://doi.org/10.1136/jmedgenet-2020-107353. https://www.ncbi.nlm.nih.gov/pubmed/33273034.

Heidari, P., B. Heidari, and M. Babaei. "Efficacy and Predictive Factors of Response to Intra-Articular Corticosteroids in Knee Osteoarthritis." Reumatologia 58, no. 6 (2020): 424-35. https://doi.org/10.5114/reum.2020.102008. https://www.ncbi.nlm.nih.gov/pubmed/33456086.

Hiyoshi, Y., A. Yamasaki, H. Miyamoto, T. Tajiri, R. Tokunaga, K. Harada, K. Eto, et al. "Needlescopic and Endoscopic Cooperative Surgery for Colonic Tumors." Dis Colon Rectum Publish Ahead of Print (Dec 7 2020). https://doi.org/10.1097/DCR.0000000000001869. https://www.ncbi.nlm.nih.gov/pubmed/33394770.

Horie, A., K. Abiko, T. Baba, M. Sunada, S. Kitamura, K. Yamanoi, N. Horikawa, et al. "A Novel Direct Approach to the Deep Uterine Vein in Laparoscopic Radical Hysterectomy." J Minim Invasive Gynecol  (Dec 23 2020). https://doi.org/10.1016/j.jmig.2020.12.018. https://www.ncbi.nlm.nih.gov/pubmed/33359218.

Hosoya, T., N. M. Shukla, Y. Fujita, S. Yao, F. S. Lao, H. Baba, S. Yasuda, et al. "Identification of Compounds with Glucocorticoid Sparing Effects on Suppression of Chemokine and Cytokine Production by Rheumatoid Arthritis Fibroblast-Like Synoviocytes." Front Pharmacol 11 (2020): 607713. https://doi.org/10.3389/fphar.2020.607713. https://www.ncbi.nlm.nih.gov/pubmed/33390996.

Houvast, R. D., M. Vankemmelbeke, L. G. Durrant, M. Wuhrer, V. M. Baart, P. J. K. Kuppen, L. F. de Geus-Oei, A. L. Vahrmeijer, and C. F. M. Sier. "Targeting Glycans and Heavily Glycosylated Proteins for Tumor Imaging." Cancers (Basel) 12, no. 12 (Dec 21 2020). https://doi.org/10.3390/cancers12123870. https://www.ncbi.nlm.nih.gov/pubmed/33371487.

Ikeda, N., T. Matsumura, H. Kono, Y. Baba, M. Hanaoka, and H. Fukayama. "Combined Use of a Gum Elastic Bougie and Video Laryngoscopy for Intubating a Patient with an Unexpected Laryngeal Papilloma." Anesth Prog 67, no. 4 (Dec 1 2020): 230-32. https://doi.org/10.2344/anpr-67-03-01. https://www.ncbi.nlm.nih.gov/pubmed/33393609.

Jaikumar, N. S., K. M. Dorn, D. Baas, B. Wilke, C. Kapp, and S. S. Snapp. "Nucleic Acid Damage and DNA Repair Are Affected by Freezing Stress in Annual Wheat (Triticum Aestivum) and by Plant Age and Freezing in Its Perennial Relative (Thinopyrum Intermedium)." Am J Bot 107, no. 12 (Dec 2020): 1693-709. https://doi.org/10.1002/ajb2.1584. https://www.ncbi.nlm.nih.gov/pubmed/33340368

Isselhard, A., M. Topper, B. Berger-Hoger, A. Steckelberg, H. Fischer, F. Vitinius, K. Beifus, et al. "Implementation and Evaluation of a Nurse-Led Decision-Coaching Program for Healthy Breast Cancer Susceptibility Gene (Brca1/2) Mutation Carriers: A Study Protocol for the Randomized Controlled Edcp-Brca Study." Trials 21, no. 1 (Jun 8 2020): 501. https://doi.org/10.1186/s13063-020-04431-x. https://www.ncbi.nlm.nih.gov/pubmed/32513307.

Jones, H. J. S., I. Al-Najami, G. Baatrup, and C. Cunningham. "Local Excision after Polypectomy for Rectal Polyp Cancer: When Is It Worthwhile?". Colorectal Dis  (Dec 11 2020). https://doi.org/10.1111/codi.15480. https://www.ncbi.nlm.nih.gov/pubmed/33306264.

Juttner, Amfm, P. C. Baars, and R. A. Valdes Olmos. "Large-Vessel Vasculitis and Giant-Cell Arteritis Accompanied by Concomitant Abnormalities on (18)F-Fdg Pet/Ct Imaging." Rev Esp Med Nucl Imagen Mol  (Dec 18 2020). https://doi.org/10.1016/j.remn.2020.10.007. https://www.ncbi.nlm.nih.gov/pubmed/33349549.

K, P. C., V. S. Bhat, A. K. B, T. Maiyalagan, G. Hegde, A. Varghese, and L. George. "Unique Host Matrix to Disperse Pd Nanoparticles for Electrochemical Sensing of Morin: Sustainable Engineering Approach." ACS Biomater Sci Eng 6, no. 9 (Sep 14 2020): 5264-73. https://doi.org/10.1021/acsbiomaterials.0c00758. https://www.ncbi.nlm.nih.gov/pubmed/33455275.

Kaku, H., T. Toyonaga, S. Tanaka, H. Takihara, S. Baba, E. Tsubouchi, Y. Ikeda, et al. "Endoscopic Submucosal Dissection Using Endotrac, a Novel Traction Device." Digestion  (Dec 22 2020): 1-8. https://doi.org/10.1159/000511731. https://www.ncbi.nlm.nih.gov/pubmed/33352560.

Kanamori, H., H. Baba, and D. J. Weber. "Rethinking One Health Approach in the Challenging Era of Covid-19 Pandemic and Natural Disasters." Infect Ecol Epidemiol 11, no. 1 (Nov 23 2020): 1852681. https://doi.org/10.1080/20008686.2020.1852681. https://www.ncbi.nlm.nih.gov/pubmed/33391632.

Keramati, M. R., B. Behboudi, S. M. Ahmadi-Tafti, A. Kazemeini, A. Keshvari, F. Salahshour, M. Aghili, et al. "Management of Colon and Rectal Cancers During Covid-19 Pandemic: A Clinical Guideline (Tums-Crc-Cov19 Guideline)." Med J Islam Repub Iran 34 (2020): 128. https://doi.org/10.34171/mjiri.34.128. https://www.ncbi.nlm.nih.gov/pubmed/33437724.

Kiemen, A., T. Baadte, M. Jablotschkin, and J. Weis. "Transfer of the Presence Seminar Concept "Peer-Support and Patient Competence" with Participation of Patients Sharing Their Experience into a Virtual Teaching Format." GMS J Med Educ 37, no. 7 (2020): Doc78. https://doi.org/10.3205/zma001371. https://www.ncbi.nlm.nih.gov/pubmed/33364357.

Kimura, M., M. Baba, S. Maruyama, S. Ogura, R. Yamamuro, T. Sakoh, T. Kishida, et al. "Reverse Transcription Loop-Mediated Isothermal Amplification Assay-Based Infection Control Strategies for Covid-19 in a Hospital under the State of Emergency Declaration in Tokyo, Japan in Spring 2020." Jpn J Infect Dis  (Dec 25 2020). https://doi.org/10.7883/yoken.JJID.2020.808. https://www.ncbi.nlm.nih.gov/pubmed/33390432.

Kimura, N., S. Yamada, H. Takami, K. Murotani, I. Yoshioka, K. Shibuya, F. Sonohara, et al. "Optimal Preoperative Multidisciplinary Treatment in Borderline Resectable Pancreatic Cancer." Cancers (Basel) 13, no. 1 (Dec 24 2020). https://doi.org/10.3390/cancers13010036. https://www.ncbi.nlm.nih.gov/pubmed/33374369.

Kiechle, M., and R. Schmutzler. "[Prevention in Familial Breast Cancer Susceptibility]." Radiologe 41, no. 4 (Apr 2001): 366-70. https://doi.org/10.1007/s001170051015. Praventive Strategien bei familiarer Brustkrebspradisposition. https://www.ncbi.nlm.nih.gov/pubmed/11388058.

Kramer, I., M. J. Hooning, N. Mavaddat, M. Hauptmann, R. Keeman, E. W. Steyerberg, D. Giardiello, et al. "Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk." Am J Hum Genet 107, no. 5 (Nov 5 2020): 837-48. https://doi.org/10.1016/j.ajhg.2020.09.001. https://www.ncbi.nlm.nih.gov/pubmed/33022221

Kubota, Y., A. Corsi, G. Authelet, H. Baba, C. Caesar, D. Calvet, A. Delbart, et al. "Surface Localization of the Dineutron in ^(Kaufman et al.)[1]Li." Phys Rev Lett 125, no. 25 (Dec 18 2020): 252501. https://doi.org/10.1103/PhysRevLett.125.252501. https://www.ncbi.nlm.nih.gov/pubmed/33416401.

Kuemmel, S., H. Harrach, R. K. Schmutzler, A. Kostara, K. Ziegler-Lohr, M. H. Dyson, O. Chiari, and M. Reinisch. "Olaparib for Metastatic Breast Cancer in a Patient with a Germline Palb2 Variant." NPJ Breast Cancer 6 (2020): 31. https://doi.org/10.1038/s41523-020-00174-9. https://www.ncbi.nlm.nih.gov/pubmed/32728620.

Kumamoto, S., K. Nakatake, S. Fukuyama, K. Yasuda, Y. Kitamura, M. Iwatsuki, H. Baba, et al. "A Dynamically Deformable Microfilter for Selective Separation of Specific Substances in Microfluidics." Biomicrofluidics 14, no. 6 (Nov 2020): 064113. https://doi.org/10.1063/5.0025927. https://www.ncbi.nlm.nih.gov/pubmed/33425088.

Lahouar, R., B. Ben Khalifa, N. E. Baba, W. Gazzah, S. Naouar, S. Braiek, and R. El Kamel. "Unusual Presentations of Urogenital Tuberculosis." Int J Surg Case Rep 77 (2020): 769-72. https://doi.org/10.1016/j.ijscr.2020.11.080. https://www.ncbi.nlm.nih.gov/pubmed/33395892.

Lasater, M. E., S. M. Murray, M. Keita, F. Souko, P. J. Surkan, N. E. Warren, P. J. Winch, et al. "Integrating Mental Health into Maternal Health Care in Rural Mali: A Qualitative Study." J Midwifery Womens Health  (Dec 16 2020). https://doi.org/10.1111/jmwh.13184. https://www.ncbi.nlm.nih.gov/pubmed/33325644.

Lc, R., S. B, A. D, H. Db, H. Pg, and P. Ar. "Assessment of Polyunsaturated Fatty Acids: A Self-Report and Biomarker Assessment with a Racially and Ethnically Diverse Sample of Women." Prostaglandins Leukot Essent Fatty Acids 164 (Jan 2021): 102214. https://doi.org/10.1016/j.plefa.2020.102214. https://www.ncbi.nlm.nih.gov/pubmed/33260027.

Legemate, C. M., P. J. Ooms, N. Trommel, E. Middelkoop, M. E. van Baar, H. Goei, and C. H. van der Vlies. "Patient-Reported Scar Quality of Donor-Sites Following Split-Skin Grafting in Burn Patients: Long-Term Results of a Prospective Cohort Study." Burns  (Dec 10 2020). https://doi.org/10.1016/j.burns.2020.12.005. https://www.ncbi.nlm.nih.gov/pubmed/33419665.

Lei, Z., J. Wang, Z. Li, B. Li, J. Luo, X. Wang, J. Wang, et al. "Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer with Peritoneal Metastasis: A Multicenter Propensity Score-Matched Cohort Study." Chin J Cancer Res 32, no. 6 (Dec 31 2020): 794-803. https://doi.org/10.21147/j.issn.1000-9604.2020.06.12. https://www.ncbi.nlm.nih.gov/pubmed/33447001.

Leman, R., P. Gaildrat, G. Le Gac, C. Ka, Y. Fichou, M. P. Audrezet, V. Caux-Moncoutier, et al. "Novel Diagnostic Tool for Prediction of Variant Spliceogenicity Derived from a Set of 395 Combined in Silico/in Vitro Studies: An International Collaborative Effort." Nucleic Acids Res 48, no. 3 (Feb 20 2020): 1600-01. https://doi.org/10.1093/nar/gkz1212. https://www.ncbi.nlm.nih.gov/pubmed/31863589.

Li, H., M. B. Terry, A. C. Antoniou, K. A. Phillips, K. Kast, T. M. Mooij, C. Engel, et al. "Alcohol Consumption, Cigarette Smoking, and Risk of Breast Cancer for Brca1 and Brca2 Mutation Carriers: Results from the Brca1 and Brca2 Cohort Consortium." Cancer Epidemiol Biomarkers Prev 29, no. 2 (Feb 2020): 368-78. https://doi.org/10.1158/1055-9965.EPI-19-0546. https://www.ncbi.nlm.nih.gov/pubmed/31792088.

Lin, H., G. Ba, R. Tang, M. Li, Z. Li, D. Li, H. Ye, and W. Zhang. "Increased Expression of Txnip Facilitates Oxidative Stress in Nasal Epithelial Cells of Patients with Chronic Rhinosinusitis with Nasal Polyps." Am J Rhinol Allergy  (Dec 29 2020): 1945892420982411. https://doi.org/10.1177/1945892420982411. https://www.ncbi.nlm.nih.gov/pubmed/33375816.

Liu, J., W. J. C. Prager-van der Smissen, J. M. Collee, M. K. Bolla, Q. Wang, K. Michailidou, J. Dennis, et al. "Germline Hoxb13 Mutations P.G84e and P.R217c Do Not Confer an Increased Breast Cancer Risk." Sci Rep 10, no. 1 (Jun 16 2020): 9688. https://doi.org/10.1038/s41598-020-65665-y. https://www.ncbi.nlm.nih.gov/pubmed/32546843.

Lohmann, S., M. Pool, K. M. Rozenberg, A. K. Keller, C. Moers, U. Moldrup, B. K. Moller, et al. "Mesenchymal Stromal Cell Treatment of Donor Kidneys During Ex-Vivo Normothermic Machine Perfusion: A Porcine Renal Autotransplantation Study." Am J Transplant  (Dec 31 2020). https://doi.org/10.1111/ajt.16473. https://www.ncbi.nlm.nih.gov/pubmed/33382194.

M, A., H. B, and B. O. "Prostate Adenocarcinoma of Secretory Type with Wide Expression of P63 and Negativity of the Basal Marker Ck5/6: Rare Subtype of Adenocarcinoma of Secretory Origin and to Be Differentiated from Basal Cell Carcinoma. Review of Literature." Rare Tumors 12 (2020): 2036361320971948. https://doi.org/10.1177/2036361320971948. https://www.ncbi.nlm.nih.gov/pubmed/33312493.

Mansour, M., F. A. Badara, L. T. Ahmed, N. Babacar, F. Maria, F. Khodia, F. Moustapha, et al. "[Zenker S Diverticulum in a Hemodialysis Patient]." Pan Afr Med J 37 (2020): 121. https://doi.org/10.11604/pamj.2020.37.121.24932. Diverticule de Zenker chez une patiente en hemodialyse. https://www.ncbi.nlm.nih.gov/pubmed/33425154.

Martin, N., A. Bergougnoux, N. Baatallah, B. Chevalier, J. Varilh, D. Baux, B. Costes, et al. "Exon Identity Influences Splicing Induced by Exonic Variants and in Silico Prediction Efficacy." J Cyst Fibros  (Dec 16 2020). https://doi.org/10.1016/j.jcf.2020.12.003. https://www.ncbi.nlm.nih.gov/pubmed/33341408.

Mavaddat, N., A. C. Antoniou, T. M. Mooij, M. J. Hooning, B. A. Heemskerk-Gerritsen, Genepso, C. Nogues, et al. "Risk-Reducing Salpingo-Oophorectomy, Natural Menopause, and Breast Cancer Risk: An International Prospective Cohort of Brca1 and Brca2 Mutation Carriers." Breast Cancer Res 22, no. 1 (Jan 16 2020): 8. https://doi.org/10.1186/s13058-020-1247-4. https://www.ncbi.nlm.nih.gov/pubmed/31948486.

———. "Correction To: Risk-Reducing Salpingo-Oophorectomy, Natural Menopause, and Breast Cancer Risk: An International Prospective Cohort of Brca1 and Brca2 Mutation Carriers." Breast Cancer Res 22, no. 1 (Feb 26 2020): 25. https://doi.org/10.1186/s13058-020-01259-w. https://www.ncbi.nlm.nih.gov/pubmed/32102695.

Meinzer, A., I. Alkatout, T. F. Krebs, J. Baastrup, K. Reischig, R. Meiksans, and R. Bergholz. "Advances and Trends in Pediatric Minimally Invasive Surgery." J Clin Med 9, no. 12 (Dec 10 2020). https://doi.org/10.3390/jcm9123999. https://www.ncbi.nlm.nih.gov/pubmed/33321836

Mimoto, F., K. Tatsumi, S. Shimizu, S. Kadono, K. Haraya, M. Nagayasu, Y. Suzuki, et al. "Exploitation of Elevated Extracellular Atp to Specifically Direct Antibody to Tumor Microenvironment." Cell Rep 33, no. 12 (Dec 22 2020): 108542. https://doi.org/10.1016/j.celrep.2020.108542. https://www.ncbi.nlm.nih.gov/pubmed/33357423.

Mitchell, T. A., G. T. Baaklini, E. L. Carpenter, and L. C. Cancio. "Degloving Penile and Scrotal Injury from a Posthole Auger." Am Surg  (Dec 22 2020): 3134820973731. https://doi.org/10.1177/0003134820973731. https://www.ncbi.nlm.nih.gov/pubmed/33350854.

Miyamoto, Y., Y. Hiyoshi, H. Sawayama, R. Tokunaga, and H. Baba. "Precision Medicine for Adjuvant Chemotherapy of Resected Colorectal Cancer." Ann Gastroenterol Surg 4, no. 6 (Nov 2020): 635-45. https://doi.org/10.1002/ags3.12397. https://www.ncbi.nlm.nih.gov/pubmed/33319153.

Molashenko, N. V., E. A. Troshina, D. M. Babaeva, N. M. Malysheva, L. V. Nikankina, and F. A. Bostanova. "[Instrumental and Laboratory Parameters of Myocardial Function in Adult Patients with Autoimmune Polyglandular Syndrome Type 2, 3]." Probl Endokrinol (Mosk) 66, no. 4 (Sep 25 2020): 16-23. https://doi.org/10.14341/probl12554. https://www.ncbi.nlm.nih.gov/pubmed/33351355.

Morohashi, K. I., M. Inoue, and T. Baba. "Coordination of Multiple Cellular Processes by Nr5a1/Nr5a1." Endocrinol Metab (Seoul) 35, no. 4 (Dec 2020): 756-64. https://doi.org/10.3803/EnM.2020.402. https://www.ncbi.nlm.nih.gov/pubmed/33397036.

———. "Correction To: Risk-Reducing Salpingo-Oophorectomy, Natural Menopause, and Breast Cancer Risk: An International Prospective Cohort of Brca1 and Brca2 Mutation Carriers." Breast Cancer Res 22, no. 1 (Feb 26 2020): 25. https://doi.org/10.1186/s13058-020-01259-w. https://www.ncbi.nlm.nih.gov/pubmed/32102695.

Muranen, T. A., S. Khan, R. Fagerholm, K. Aittomaki, J. M. Cunningham, J. Dennis, G. Leslie, et al. "Association of Germline Variation with the Survival of Women with Brca1/2 Pathogenic Variants and Breast Cancer." NPJ Breast Cancer 6 (2020): 44. https://doi.org/10.1038/s41523-020-00185-6. https://www.ncbi.nlm.nih.gov/pubmed/32964118.

Murase, H., R. Oono, T. Yoshida, Y. Suzuki, K. Hayashi, M. Nishino, T. Irie, et al. "[a Case of Metastatic Colorectal Cancer with Hyperammonemic Encephalopathy Induced by Mfolfox6 and Sox Therapy]." Gan To Kagaku Ryoho 47, no. 13 (Dec 2020): 1780-82. https://www.ncbi.nlm.nih.gov/pubmed/33468827.

Niang, I., I. Diallo, J. C. N. Diouf, M. Ly, M. H. Toure, K. N. Diouf, F. G. Niang, et al. "[Sorting and Detection of Covid-19 by Low-Dose Thoracic Ct Scan in Patients Consulting the Radiology Department of Fann Hospital (Dakar-Senegal)]." Pan Afr Med J 37, no. Suppl 1 (2020): 22. https://doi.org/10.11604/pamj.supp.2020.37.22.26140. Tri et detection du COVID-19 par TDM thoracique low-dose chez des patients tout-venant au service de radiologie de l hopital de Fann (Dakar-Senegal). https://www.ncbi.nlm.nih.gov/pubmed/33456646.

Nishiwaki, S., T. Kurobe, A. Baba, H. Nakamura, M. Iwashita, S. Adachi, H. Hatakeyama, T. Hayashi, and M. Teruo. "Prognostic Outcomes after Direct Percutaneous Endoscopic Jejunostomy in Elderly Patients: Comparison with Percutaneous Endoscopic Gastrostomy." Gastrointest Endosc  (Dec 28 2020). https://doi.org/10.1016/j.gie.2020.12.036. https://www.ncbi.nlm.nih.gov/pubmed/33383037.

Nozaki, T., A. Fujimoto, N. Ichikawa, S. Baba, H. Enoki, and T. Okanishi. "Higher Intelligence May Be a Risk Factor for Postoperative Transient Disturbance of Consciousness after Corpus Callosotomy." Epilepsy Behav  (Dec 10 2020): 107617. https://doi.org/10.1016/j.yebeh.2020.107617. https://www.ncbi.nlm.nih.gov/pubmed/33309425.

N, V. M., H. Tj, P. Y, R. B, V. T. Tg, N. S. Mwg, and V. C. Reh. "Less Than Half of Acl-Reconstructed Athletes Are Cleared for Return to Play Based on Practice Guideline Criteria: Results from a Prospective Cohort Study." Int J Sports Phys Ther 15, no. 6 (Dec 2020): 1006-18. https://doi.org/10.26603/ijspt20201006. https://www.ncbi.nlm.nih.gov/pubmed/33344017.

O'Toole, T. E., A. A. Amraotkar, A. P. DeFilippis, S. N. Rai, R. J. Keith, S. P. Baba, P. Lorkiewicz, et al. "Protocol to Assess the Efficacy of Carnosine Supplementation in Mitigating the Adverse Cardiovascular Responses to Particulate Matter (Pm) Exposure: The Nucleophilic Defense against Pm Toxicity (Neat) Trial." BMJ Open 10, no. 12 (Dec 28 2020): e039118. https://doi.org/10.1136/bmjopen-2020-039118. https://www.ncbi.nlm.nih.gov/pubmed/33372072.

Oguri, M., T. Okanishi, S. Kanai, S. Baba, M. Nishimura, K. Ogo, T. Himoto, et al. "Phase Lag Analyses on Ictal Scalp Electroencephalography May Predict Outcomes of Corpus Callosotomy for Epileptic Spasms." Front Neurol 11 (2020): 576087. https://doi.org/10.3389/fneur.2020.576087. https://www.ncbi.nlm.nih.gov/pubmed/33424739.

Ohtsuka, K., R. Baba, W. Yamasawa, R. Shirahama, Y. Hattori, H. Senoura, T. Betsuyaku, and K. Fukunaga. "The Effectiveness of Nasal Airway Stent Therapy for the Treatment of Mild-to-Moderate Obstructive Sleep Apnea Syndrome." Respiration  (Dec 28 2020): 1-8. https://doi.org/10.1159/000512319. https://www.ncbi.nlm.nih.gov/pubmed/33370725.

Ono, K., T. Horie, O. Baba, M. Kimura, S. Tsuji, R. R. Rodriguez, S. Miyagawa, and T. Kimura. "Functional Non-Coding Rnas in Vascular Diseases." FEBS J  (Dec 19 2020). https://doi.org/10.1111/febs.15678. https://www.ncbi.nlm.nih.gov/pubmed/33340430.

Pabbathi, N. P. P., A. Velidandi, P. K. Gandam, P. Koringa, S. R. Parcha, and R. R. Baadhe. "Novel Buffalo Rumen Metagenome Derived Acidic Cellulase Cel-3.1 Cloning, Characterization, and Its Application in Saccharifying Rice Straw and Corncob Biomass." Int J Biol Macromol 170 (Dec 11 2020): 239. https://doi.org/10.1016/j.ijbiomac.2020.12.041. https://www.ncbi.nlm.nih.gov/pubmed/33316338.

Pashayan, N., A. C. Antoniou, U. Ivanus, L. J. Esserman, D. F. Easton, D. French, G. Sroczynski, et al. "Personalized Early Detection and Prevention of Breast Cancer: Envision Consensus Statement." Nat Rev Clin Oncol  (Jun 18 2020). https://doi.org/10.1038/s41571-020-0388-9. https://www.ncbi.nlm.nih.gov/pubmed/32555420.

Pashayan, N., A. C. Antoniou, U. Ivanus, L. J. Esserman, D. F. Easton, D. French, G. Sroczynski, et al. "Personalized Early Detection and Prevention of Breast Cancer: Envision Consensus Statement." Nat Rev Clin Oncol 17, no. 11 (Nov 2020): 687-705. https://doi.org/10.1038/s41571-020-0388-9. https://www.ncbi.nlm.nih.gov/pubmed/32555420.

———. "Personalized Early Detection and Prevention of Breast Cancer: Envision Consensus Statement." Nat Rev Clin Oncol  (Jun 18 2020). https://doi.org/10.1038/s41571-020-0388-9. https://www.ncbi.nlm.nih.gov/pubmed/32555420.

———. "Publisher Correction: Personalized Early Detection and Prevention of Breast Cancer: Envision Consensus Statement." Nat Rev Clin Oncol  (Jun 29 2020). https://doi.org/10.1038/s41571-020-0412-0. https://www.ncbi.nlm.nih.gov/pubmed/32601456.

———. "Publisher Correction: Personalized Early Detection and Prevention of Breast Cancer: Envision Consensus Statement." Nat Rev Clin Oncol 17, no. 11 (Nov 2020): 716. https://doi.org/10.1038/s41571-020-0412-0. https://www.ncbi.nlm.nih.gov/pubmed/32601456.

Patel, V. L., E. L. Busch, T. M. Friebel, A. Cronin, G. Leslie, L. McGuffog, J. Adlard, et al. "Association of Genomic Domains in Brca1 and Brca2 with Prostate Cancer Risk and Aggressiveness." Cancer Res 80, no. 3 (Feb 1 2020): 624-38. https://doi.org/10.1158/0008-5472.CAN-19-1840. https://www.ncbi.nlm.nih.gov/pubmed/31723001.

Perlasca, P., M. Frasca, C. T. Ba, J. Gliozzo, M. Notaro, M. Pennacchioni, G. Valentini, and M. Mesiti. "Multi-Resolution Visualization and Analysis of Biomolecular Networks through Hierarchical Community Detection and Web-Based Graphical Tools." PLoS One 15, no. 12 (2020): e0244241. https://doi.org/10.1371/journal.pone.0244241. https://www.ncbi.nlm.nih.gov/pubmed/33351828

Perumal, V. K., and K. Baalann. "Spinal Dysraphism." Pan Afr Med J 37 (2020): 146. https://doi.org/10.11604/pamj.2020.37.146.26288. https://www.ncbi.nlm.nih.gov/pubmed/33425179.

Pohl-Rescigno, E., J. Hauke, S. Loibl, V. Mobus, C. Denkert, P. A. Fasching, M. Kayali, et al. "Association of Germline Variant Status with Therapy Response in High-Risk Early-Stage Breast Cancer: A Secondary Analysis of the Geparocto Randomized Clinical Trial." JAMA Oncol  (Mar 12 2020). https://doi.org/10.1001/jamaoncol.2020.0007. https://www.ncbi.nlm.nih.gov/pubmed/32163106.

Pohl-Rescigno, E., J. Hauke, S. Loibl, V. Mobus, C. Denkert, P. A. Fasching, M. Kayali, et al. "Association of Germline Variant Status with Therapy Response in High-Risk Early-Stage Breast Cancer: A Secondary Analysis of the Geparocto Randomized Clinical Trial." JAMA Oncol 6, no. 5 (May 1 2020): 744-48. https://doi.org/10.1001/jamaoncol.2020.0007. https://www.ncbi.nlm.nih.gov/pubmed/32163106.

———. "Association of Germline Variant Status with Therapy Response in High-Risk Early-Stage Breast Cancer: A Secondary Analysis of the Geparocto Randomized Clinical Trial." JAMA Oncol  (Mar 12 2020). https://doi.org/10.1001/jamaoncol.2020.0007. https://www.ncbi.nlm.nih.gov/pubmed/32163106.

Pourmotabbed, A., S. P. Moosavian, A. Hadi, H. Mohammadi, A. Dadfarma, S. Rezaei, A. Babaei, S. Moradi, and K. Mirzaei. "The Relationship between Food Insecurity and Risk of Overweight or Obesity in under 18 Years Individuals: A Systematic Review and Meta-Analysis." Int J Prev Med 11 (2020): 158. https://doi.org/10.4103/ijpvm.IJPVM_463_19. https://www.ncbi.nlm.nih.gov/pubmed/33312467.

Puesken, M., C. Unterberg-Buchwald, K. Rhiem, N. Grosse Hokamp, D. Maintz, J. Lotz, and S. Wienbeck. "Ex Vivo Study of Artifacts Caused by Breast Tissue Markers with Different 1.5 Tesla and 3 Tesla Mri Scanners - a Bicentric Study." Acad Radiol  (Jan 30 2020). https://doi.org/10.1016/j.acra.2019.12.006. https://www.ncbi.nlm.nih.gov/pubmed/32008930.

Qadi, M., N. Jaradat, S. Al-Lahham, I. Ali, M. N. Abualhasan, N. Shraim, F. Hussein, et al. "Antibacterial, Anticandidal, Phytochemical, and Biological Evaluations of Pellitory Plant." Biomed Res Int 2020 (2020): 6965306. https://doi.org/10.1155/2020/6965306. https://www.ncbi.nlm.nih.gov/pubmed/33415153.

Quante, A., Engel,C., Kiechle,M., SchmutzlerR.K., Fischer C. „Umstrukturierung der Risikoberechnung für die intensivierte Früherkennung im Deutschen Konsortium für Brust und Eierstockkrebs“ Der Gynäkologe (Feb 2020). Zur Publikation.

Rasool, A., S. Mansoor, K. M. Bhat, G. I. Hassan, T. R. Baba, M. N. Alyemeni, A. A. Alsahli, et al. "Mechanisms Underlying Graft Union Formation and Rootstock Scion Interaction in Horticultural Plants." Front Plant Sci 11 (2020): 590847. https://doi.org/10.3389/fpls.2020.590847. https://www.ncbi.nlm.nih.gov/pubmed/33362818.

Ridenour, R., C. Kowalski, D. Ba, G. Liu, J. Bible, M. Garner, D. Leslie, M. Aynardi, and A. Dhawan. "Opioid Use, Perioperative Risks, and Associated Postoperative Complications in Foot and Ankle Surgery." Foot Ankle Spec  (Dec 14 2020): 1938640020977988. https://doi.org/10.1177/1938640020977988. https://www.ncbi.nlm.nih.gov/pubmed/33307812.

Rippinger, N., C. Fischer, M. W. Haun, K. Rhiem, S. Grill, M. Kiechle, F. W. Cremer, et al. "Cancer Surveillance and Distress among Adult Pathogenic Tp53 Germline Variant Carriers in Germany: A Multicenter Feasibility and Acceptance Survey." Cancer 126, no. 17 (Sep 1 2020): 4032-41. https://doi.org/10.1002/cncr.33004. https://www.ncbi.nlm.nih.gov/pubmed/32557628.

Rippinger, N., C. Fischer, M. W. Haun, K. Rhiem, S. Grill, M. Kiechle, F. W. Cremer, et al. "Cancer Surveillance and Distress among Adult Pathogenic Tp53 Germline Variant Carriers in Germany: A Multicenter Feasibility and Acceptance Survey." Cancer  (Jun 18 2020). https://doi.org/10.1002/cncr.33004. https://www.ncbi.nlm.nih.gov/pubmed/32557628.

———. "Cancer Surveillance and Distress among Adult Pathogenic Tp53 Germline Variant Carriers in Germany: A Multicenter Feasibility and Acceptance Survey." Cancer  (Jun 18 2020). https://doi.org/10.1002/cncr.33004. https://www.ncbi.nlm.nih.gov/pubmed/32557628

Saeedi, M., M. Kamyab, T. Babaee, H. Behtash, and M. S. Ganjavian. "The Effects of Bracing on Sagittal Spinopelvic Parameters and Cobb Angle in Adolescents with Idiopathic Scoliosis: A before-after Clinical Study." Turk J Phys Med Rehabil 66, no. 4 (Dec 2020): 452-58. https://doi.org/10.5606/tftrd.2020.4955. https://www.ncbi.nlm.nih.gov/pubmed/33364566.

Sallah, K., R. Giorgi, E. H. Ba, M. Piarroux, R. Piarroux, B. Cisse, and J. Gaudart. "Targeting Malaria Hotspots to Reduce Transmission Incidence in Senegal." Int J Environ Res Public Health 18, no. 1 (Dec 24 2020). https://doi.org/10.3390/ijerph18010076. https://www.ncbi.nlm.nih.gov/pubmed/33374228.

Samman, K. N., H. Baalbaki, J. Bouchard, and M. Albert. "Continuous Renal Replacement Therapy with Oxiris(R) Membrane in Severe Ebstein-Barr Virus-Mediated Hemophagocytic Lymphohistiocytosis: A Case Report." Blood Purif  (Dec 17 2020): 1-4. https://doi.org/10.1159/000511724. https://www.ncbi.nlm.nih.gov/pubmed/33333505.

Samunuri, R., M. Toyama, R. S. Pallaka, S. Neeladri, A. K. Jha, M. Baba, and C. Bal. "Synthesis and Anti-Hbv Activity of Carbocyclic Nucleoside Hybrids with Salient Features of Entecavir and Aristeromycin." RSC Med Chem 11, no. 5 (May 1 2020): 597-601. https://doi.org/10.1039/d0md00059k. https://www.ncbi.nlm.nih.gov/pubmed/33479662.

Sarbazi, E., M. Sarbazi, S. Ghaffari-Fam, T. Babazadeh, S. Heidari, K. Aghakarimi, I. Jamali, et al. "Factors Related to Delay in Initiating Post-Exposure Prophylaxis for Rabies Prevention among Animal Bite Victims: A Cross-Sectional Study in Northwest of Iran." Bull Emerg Trauma 8, no. 4 (Oct 2020): 236-42. https://doi.org/10.30476/beat.2020.85134. https://www.ncbi.nlm.nih.gov/pubmed/33426139.

Saxena, S., A. Khurana, S. B, K. Sardana, A. Agarwal, A. Muddebihal, A. Raina, and P. Paliwal. "Severe Type 2 Leprosy Reaction with Covid-19 with a Favourable Outcome Despite Continued Use of Corticosteroids and Methotrexate and a Hypothesis on the Possible Immunological Consequences." Int J Infect Dis 103 (Dec 14 2020): 549-51. https://doi.org/10.1016/j.ijid.2020.12.024. https://www.ncbi.nlm.nih.gov/pubmed/33326870.

Scheiner, B., and S. D. Baalrud. "Viscosity of the Magnetized Strongly Coupled One-Component Plasma." Phys Rev E 102, no. 6-1 (Dec 2020): 063202. https://doi.org/10.1103/PhysRevE.102.063202. https://www.ncbi.nlm.nih.gov/pubmed/33466065.

Seidu, A. A., E. K. M. Darteh, E. Agbaglo, L. K. Dadzie, B. O. Ahinkorah, E. K. Ameyaw, J. K. Tetteh, L. Baatiema, and S. Yaya. "Barriers to Accessing Healthcare among Women in Ghana: A Multilevel Modelling." BMC Public Health 20, no. 1 (Dec 17 2020): 1916. https://doi.org/10.1186/s12889-020-10017-8. https://www.ncbi.nlm.nih.gov/pubmed/33334326.

Silvestri, V., G. Leslie, D. R. Barnes, Cimba Group and the, B. A. Agnarsson, K. Aittomaki, E. Alducci, et al. "Characterization of the Cancer Spectrum in Men with Germline Brca1 and Brca2 Pathogenic Variants: Results from the Consortium of Investigators of Modifiers of Brca1/2 (Cimba)." JAMA Oncol  (Jul 2 2020). https://doi.org/10.1001/jamaoncol.2020.2134. https://www.ncbi.nlm.nih.gov/pubmed/32614418.

Shabhay, A., P. Horumpende, Z. Shabhay, S. G. Van Baal, E. Lazaro, and K. Chilonga. "Surgical Approach in Management of Posttraumatic Diaphragmatic Hernia: Thoracotomy Versus Laparotomy." Case Rep Surg 2020 (2020): 6694990. https://doi.org/10.1155/2020/6694990. https://www.ncbi.nlm.nih.gov/pubmed/33457036.

Shigemura, T., Y. Baba, Y. Murata, Y. Yamamoto, Y. Shiratani, H. Hamano, and Y. Wada. "Is a Portable Accelerometer-Based Navigation System Useful in Total Hip Arthroplasty?: A Systematic Review and Meta-Analysis." Orthop Traumatol Surg Res  (Dec 20 2020). https://doi.org/10.1016/j.otsr.2020.08.014. https://www.ncbi.nlm.nih.gov/pubmed/33358026.

Shigeta, K., K. Matsumoto, K. Ogihara, T. Murakami, T. Anno, K. Umeda, M. Izawa, et al. "The Clinicopathological Characteristics of Muscle-Invasive Bladder Recurrence in Upper Tract Urothelial Carcinoma." Cancer Sci  (Dec 25 2020). https://doi.org/10.1111/cas.14782. https://www.ncbi.nlm.nih.gov/pubmed/33368857.

Shimizu, N., T. Baba, Y. Watanabe, and S. Yamamoto. "Self-Inflicted Transorbital Injury by Chopstick in Patient with Schizophrenia." BMJ Case Rep 13, no. 12 (Dec 17 2020). https://doi.org/10.1136/bcr-2020-239721. https://www.ncbi.nlm.nih.gov/pubmed/33334774.

Shimizu, S., S. Sakamoto, A. Fukuda, Y. Yanagi, H. Uchida, C. Baba, Y. Suzuki, et al. "The Extracorporeal Circulation with Transdiaphragmatic Approach in Living-Donor Liver Transplantation for Hb with Atrial Extension of Tumor Thrombus: A Case Report." Pediatr Transplant  (Dec 16 2020): e13948. https://doi.org/10.1111/petr.13948. https://www.ncbi.nlm.nih.gov/pubmed/33326681.

Shoji, H., M. Mizoguchi, S. Yamamoto, T. Abe, S. Oguri, and M. Baba. "[Herpes Zoster Duplex Associated with Ramsay Hunt Syndrome and Cervical Zoster Paresis. A Case Report]." Rinsho Shinkeigaku  (Dec 15 2020). https://doi.org/10.5692/clinicalneurol.cn-001526. https://www.ncbi.nlm.nih.gov/pubmed/33328423.

———. "Characterization of the Cancer Spectrum in Men with Germline Brca1 and Brca2 Pathogenic Variants: Results from the Consortium of Investigators of Modifiers of Brca1/2 (Cimba)." JAMA Oncol 6, no. 8 (Aug 1 2020): 1218-30. https://doi.org/10.1001/jamaoncol.2020.2134. https://www.ncbi.nlm.nih.gov/pubmed/32614418.

Silvestri, V., G. Leslie, D. R. Barnes, Cimba Group, B. A. Agnarsson, K. Aittomaki, E. Alducci, et al. "Characterization of the Cancer Spectrum in Men with Germline Brca1 and Brca2 Pathogenic Variants: Results from the Consortium of Investigators of Modifiers of Brca1/2 (Cimba)." JAMA Oncol 6, no. 8 (Aug 1 2020): 1218-30. https://doi.org/10.1001/jamaoncol.2020.2134. https://www.ncbi.nlm.nih.gov/pubmed/32614418.

Sirunyan, A. M., A. Tumasyan, W. Adam, F. Ambrogi, E. Asilar, T. Bergauer, J. Brandstetter, et al. "Measurement of Single-Diffractive Dijet Production in Proton-Proton Collisions at S = 8 Te with the Cms and Totem Experiments." Eur Phys J C Part Fields 80, no. 12 (2020): 1164. https://doi.org/10.1140/epjc/s10052-020-08562-y. https://www.ncbi.nlm.nih.gov/pubmed/33362286.

Sirunyan, A. M., A. Tumasyan, W. Adam, F. Ambrogi, T. Bergauer, M. Dragicevic, J. Ero, et al. "Evidence for Top Quark Production in Nucleus-Nucleus Collisions." Phys Rev Lett 125, no. 22 (Nov 27 2020): 222001. https://doi.org/10.1103/PhysRevLett.125.222001. https://www.ncbi.nlm.nih.gov/pubmed/33315428.

Sisodia, M., S. Bommanavar, R. Baad, N. Vibhute, U. Belgaumi, and V. Kadashetti. "Correlation and Comparison of Dactyloscopy and Palatoscopy with Blood Groups - an Institutional Study." Indian J Dent Res 31, no. 5 (Sep-Oct 2020): 728-33. https://doi.org/10.4103/ijdr.IJDR_368_18. https://www.ncbi.nlm.nih.gov/pubmed/33433510.

Soh, Nhbc, R. Duraisamy, and A. B. "Evaluation of Osseointegration and Crestal Bone Loss Associated with Implants Placed in Diabetic and Other Medically Compromised Patients." J Long Term Eff Med Implants 30, no. 4 (2020): 247-53. https://doi.org/10.1615/JLongTermEffMedImplants.2020035938. https://www.ncbi.nlm.nih.gov/pubmed/33463924.

Sokpe, A., M. L. K. Mensah, G. A. Koffuor, K. P. Thomford, R. Arthur, Y. Jibira, M. K. Baah, B. Adedi, and H. Y. Agbemenyah. "Hypotensive and Antihypertensive Properties and Safety for Use of Annona Muricata and Persea Americana and Their Combination Products." Evid Based Complement Alternat Med 2020 (2020): 8833828. https://doi.org/10.1155/2020/8833828. https://www.ncbi.nlm.nih.gov/pubmed/33488751.

Starikova, N. V., D. Y. Babaev, and M. N. Kharchenko. "[Creating the Conditions for Skeletal Traction in Mandibular Condyle Fracture in Children and Adolescents]." Stomatologiia (Mosk) 99, no. 6. Vyp. 2 (2020): 33-37. https://doi.org/10.17116/stomat20209906233. Sozdanie uslovii skeletnogo vytyazheniya pri perelome myshchelkovogo otrostka nizhnei chelyusti u detei i podrostkov. https://www.ncbi.nlm.nih.gov/pubmed/33416231

St, O., B. B, O. B, F. B, G. J. Lemamy, N. B, M. J, and T. Sn. "Exogenous Central Angiotensin Fails to Stimulate a Sodium Appetite in Diabetes Insipidus Brattleboro Rats." Physiol Behav 230 (Dec 30 2020): 113308. https://doi.org/10.1016/j.physbeh.2020.113308. https://www.ncbi.nlm.nih.gov/pubmed/33387586.

Stracke, C., C. Lemmen, K. Rhiem, R. Schmutzler, S. Kautz-Freimuth, and S. Stock. "Medical Knowledge and Information Needs among Women with Pathogenic Variants in Moderate-Risk Genes for Hereditary Breast Cancer Attending Genetic Counseling at an Academic Hospital in Germany-a Qualitative Approach." [In English]. Journal of Genetic Counseling  (Nov 26 2021). https://doi.org/10.1002/jgc4.1536. <Go to ISI>://WOS:000722881200001.

Sullivan, A., P. Shrestha, T. Lanham, E. Lanham, and M. Baba. "Bird Fancier's Lung: An Underdiagnosed Etiology of Dyspnea." Respir Med Case Rep 31 (2020): 101288. https://doi.org/10.1016/j.rmcr.2020.101288. https://www.ncbi.nlm.nih.gov/pubmed/33318919.

Suwatthanarak, T., I. A. Thiodorus, M. Tanaka, T. Shimada, D. Takeshita, T. Yasui, Y. Baba, and M. Okochi. "Microfluidic-Based Capture and Release of Cancer-Derived Exosomes Via Peptide-Nanowire Hybrid Interface." Lab Chip  (Dec 24 2020). https://doi.org/10.1039/d0lc00899k. https://www.ncbi.nlm.nih.gov/pubmed/33367429.

Tak, S., E. Irvine, M. Baba, V. Ghanate, and H. Khairandish. "When Marriage Hurts: A Literature Review of Embedded Jewellery Ring Injuries." Cureus 12, no. 11 (Nov 22 2020): e11624. https://doi.org/10.7759/cureus.11624. https://www.ncbi.nlm.nih.gov/pubmed/33376638

Takizawa, S., R. Asano, Y. Fukuda, M. Feng, Y. Baba, K. Abe, C. Tada, and Y. Nakai. "Change of Endoglucanase Activity and Rumen Microbial Community During Biodegradation of Cellulose Using Rumen Microbiota." Front Microbiol 11 (2020): 603818. https://doi.org/10.3389/fmicb.2020.603818. https://www.ncbi.nlm.nih.gov/pubmed/33391225.

Tanabe, Y., S. Kawamoto, T. Takaku, S. Morishita, A. Hirao, N. Komatsu, E. Hara, N. Mukaida, and T. Baba. "Expansion of Senescent Megakaryocyte-Lineage Cells Maintains Cml Cell Leukemogenesis." Blood Adv 4, no. 24 (Dec 22 2020): 6175-88. https://doi.org/10.1182/bloodadvances.2020003117. https://www.ncbi.nlm.nih.gov/pubmed/33351113.

Tatsumi, T., T. Baba, T. Iwase, T. Nizawa, G. Miura, H. Yokouchi, and S. Yamamoto. "Outcomes of Vitrectomy Combined with Scleral Buckling for Eyes with Early Recurrence of Simple Rhegmatogenous Retinal Detachment Previously Treated by Pars Plana Vitrectomy." J Ophthalmol 2020 (2020): 6637143. https://doi.org/10.1155/2020/6637143. https://www.ncbi.nlm.nih.gov/pubmed/33489337.

Ter Braake, A. D., M. G. Vervloet, J. H. F. de Baaij, and J. G. J. Hoenderop. "Magnesium to Prevent Kidney Disease-Associated Vascular Calcification: Crystal Clear?". Nephrol Dial Transplant  (Dec 29 2020). https://doi.org/10.1093/ndt/gfaa222. https://www.ncbi.nlm.nih.gov/pubmed/33374019.

Torknejad, A., S. Babaei, and M. Mirmohammadsadeghi. "Effect of an Educational Intervention Based on Basnef Model on Treatment Adherence after Coronary Artery Bypass Surgery: A Randomized Clinical Trial." ARYA Atheroscler 16, no. 3 (May 2020): 105-14. https://doi.org/10.22122/arya.v16i3.2062. https://www.ncbi.nlm.nih.gov/pubmed/33447255.

Touati, M., A. Ibrahim, K. A. K. Ousmane, M. Al-Zekri, I. Baare, and A. Morsli. "A Rare Case of Orbital Tuberculosis with Cold Abscess and Frontal Bone Lesion." Pan Afr Med J 37 (2020): 167. https://doi.org/10.11604/pamj.2020.37.167.21298. https://www.ncbi.nlm.nih.gov/pubmed/33425200.

Umashankar, A., T. B, and P. Prabhu. "Translation and Validation of the Littlears Auditory Questionnaire in Kannada." Int J Pediatr Otorhinolaryngol 142 (Dec 31 2020): 110598. https://doi.org/10.1016/j.ijporl.2020.110598. https://www.ncbi.nlm.nih.gov/pubmed/33440310.

van Baar, A. C. G., S. Meiring, P. Smeele, T. Vriend, F. Holleman, M. Barlag, N. Mostafavi, et al. "Duodenal Mucosal Resurfacing Combined with Glp-1ra to Discontinue Insulin in Type 2 Diabetes: A Feasibility Study." Gastrointest Endosc  (Dec 23 2020). https://doi.org/10.1016/j.gie.2020.12.021. https://www.ncbi.nlm.nih.gov/pubmed/33359437.

Vazquez-Blanco, R., M. Arias-Estevez, E. Baath, and D. Fernandez-Calvino. "Comparing the Effect of Cu-Based Fungicides and Pure Cu Salts on Microbial Biomass, Microbial Community Structure and Bacterial Community Tolerance to Cu." J Hazard Mater 409 (Dec 25 2020): 124960. https://doi.org/10.1016/j.jhazmat.2020.124960. https://www.ncbi.nlm.nih.gov/pubmed/33422757.

Wang, C., Y. Wang, X. Chang, X. Ba, N. Hu, Q. Liu, L. Fang, and Z. Wang. "Melanoma-Derived Exosomes Endow Fibroblasts with an Invasive Potential Via Mir-21 Target Signaling Pathway." Cancer Manag Res 12 (2020): 12965-74. https://doi.org/10.2147/CMAR.S273718. https://www.ncbi.nlm.nih.gov/pubmed/33364842.

Wang, Z., Z. Gao, X. Ba, J. Chu, P. He, and J. Niu. "Joining of Hypereutectic Al-50si Alloys Using Lead-Free Brazing Filler Glass in Air." Materials (Basel) 13, no. 24 (Dec 11 2020). https://doi.org/10.3390/ma13245658. https://www.ncbi.nlm.nih.gov/pubmed/33322423.

Wappenschmidt, B., J. Hauke, U. Faust, D. Niederacher, L. Wiesmuller, G. Schmidt, E. Gross, et al. "Criteria of the German Consortium for Hereditary Breast and Ovarian Cancer for the Classification of Germline Sequence Variants in Risk Genes for Hereditary Breast and Ovarian Cancer." Geburtshilfe Frauenheilkd 80, no. 4 (Apr 2020): 410-29. https://doi.org/10.1055/a-1110-0909. https://www.ncbi.nlm.nih.gov/pubmed/32322110.

Wentworth, A. J., J. D. Byrne, S. Orguc, J. Sands, S. Maji, C. Tov, S. Babaee, et al. "Prospective Evaluation of the Transparent, Elastomeric, Adaptable, Long-Lasting (Teal) Respirator." ACS Pharmacol Transl Sci 3, no. 6 (Dec 11 2020): 1076-82. https://doi.org/10.1021/acsptsci.0c00157. https://www.ncbi.nlm.nih.gov/pubmed/33330837.

Werutsky, G., M. Untch, C. Hanusch, P. A. Fasching, J. U. Blohmer, S. Seiler, C. Denkert, et al. "Locoregional Recurrence Risk after Neoadjuvant Chemotherapy: A Pooled Analysis of Nine Prospective Neoadjuvant Breast Cancer Trials." Eur J Cancer 130 (May 2020): 92-101. https://doi.org/10.1016/j.ejca.2020.02.015. https://www.ncbi.nlm.nih.gov/pubmed/32179450.

Wesselink, E., H. van Baar, M. van Zutphen, M. Tibosch, E. A. Kouwenhoven, E. T. P. Keulen, E. Kok D, et al. "Inflammation Is a Mediating Factor in the Association between Lifestyle and Fatigue in Colorectal Cancer Patients." Cancers (Basel) 12, no. 12 (Dec 9 2020). https://doi.org/10.3390/cancers12123701. https://www.ncbi.nlm.nih.gov/pubmed/33317113.

Wu, J., J. W. M. Heemskerk, and Ccfmj Baaten. "Platelet Membrane Receptor Proteolysis: Implications for Platelet Function." Front Cardiovasc Med 7 (2020): 608391. https://doi.org/10.3389/fcvm.2020.608391. https://www.ncbi.nlm.nih.gov/pubmed/33490118.

Wu, Y., X. Shi, X. Tang, Y. Li, N. Tong, G. Wang, J. A. Zhang, et al. "The Correlation between Metabolic Disorders and Tpoab/Tgab: A Cross-Sectional Population-Based Study." Endocr Pract 26, no. 8 (Aug 2020): 869-82. https://doi.org/10.4158/EP-2020-0008. https://www.ncbi.nlm.nih.gov/pubmed/33471678.

Yamada, Y., K. Muro, K. Takahashi, H. Baba, Y. Komatsu, T. Satoh, M. Goto, et al. "Impact of Sex and Histology on the Therapeutic Effects of Fluoropyrimidines and Oxaliplatin Plus Bevacizumab for Patients with Metastatic Colorectal Cancer in the Soft Trial." Glob Health Med 2, no. 4 (Aug 31 2020): 240-46. https://doi.org/10.35772/ghm.2020.01050. https://www.ncbi.nlm.nih.gov/pubmed/33330814.

Yamashita, Y., H. Baba, K. Okamoto, K. Joo, Y. Ochiai, and S. Tokunaga. "Unilateral Embolization of the Internal Iliac Artery for Endovascular Aortic Repair Does Not Induce Gluteal Muscle Atrophy." Ann Vasc Surg  (Dec 24 2020). https://doi.org/10.1016/j.avsg.2020.10.050. https://www.ncbi.nlm.nih.gov/pubmed/33359705.

Yamayoshi, S., Y. Sakai-Tagawa, M. Koga, O. Akasaka, I. Nakachi, H. Koh, K. Maeda, et al. "Comparison of Rapid Antigen Tests for Covid-19." Viruses 12, no. 12 (Dec 10 2020). https://doi.org/10.3390/v12121420. https://www.ncbi.nlm.nih.gov/pubmed/33322035.

Yang, X., G. Leslie, A. Doroszuk, S. Schneider, J. Allen, B. Decker, A. M. Dunning, et al. "Cancer Risks Associated with Germline Palb2 Pathogenic Variants: An International Study of 524 Families." J Clin Oncol 38, no. 7 (Mar 1 2020): 674-85. https://doi.org/10.1200/JCO.19.01907. https://www.ncbi.nlm.nih.gov/pubmed/31841383.

Yang, X., H. Song, G. Leslie, C. Engel, E. Hahnen, B. Auber, J. Horvath, et al. "Ovarian and Breast Cancer Risks Associated with Pathogenic Variants in Rad51c and Rad51d." J Natl Cancer Inst 112, no. 12 (Dec 14 2020): 1242-50. https://doi.org/10.1093/jnci/djaa030. https://www.ncbi.nlm.nih.gov/pubmed/32107557.

Yang, X., H. Song, G. Leslie, C. Engel, E. Hahnen, B. Auber, J. Horvath, et al. "Ovarian and Breast Cancer Risks Associated with Pathogenic Variants in Rad51c and Rad51d." J Natl Cancer Inst  (Feb 28 2020). https://doi.org/10.1093/jnci/djaa030. https://www.ncbi.nlm.nih.gov/pubmed/32107557.

Zhang, H., T. U. Ahearn, J. Lecarpentier, D. Barnes, J. Beesley, G. Qi, X. Jiang, et al. "Genome-Wide Association Study Identifies 32 Novel Breast Cancer Susceptibility Loci from Overall and Subtype-Specific Analyses." Nat Genet 52, no. 6 (Jun 2020): 572-81. https://doi.org/10.1038/s41588-020-0609-2. https://www.ncbi.nlm.nih.gov/pubmed/32424353

Zhuo, D., J. Z. Ning, J. W. Zhang, Y. Chen, L. Cheng, and Z. Ba. "[Role of the Lncrna H19/ Microrna-203a/Pten Axis in Ischemia-Reperfusion Injury of Mouse Gc-1 Cells and Its Mechanism]." Zhonghua Nan Ke Xue 26, no. 6 (Jun 2020): 499-504. https://www.ncbi.nlm.nih.gov/pubmed/33356037.

Zomers, P. J. W., G. Groeneweg, S. Baart, and F. J. P. Huygen. "Percutaneous Cervical Cordotomy for the Treatment of Cancer Pain: A Prospective Case Series of 52 Patients with a Long-Term Follow-Up." Pain Pract  (Dec 22 2020). https://doi.org/10.1111/papr.12991. https://www.ncbi.nlm.nih.gov/pubmed/33350042.

2019

Abdel-Qadir, H., D. Bobrowski, L. Zhou, P. C. Austin, O. Calvillo-Arguelles, E. Amir, D. S. Lee, and P. Thavendiranathan. "Statin Exposure and Risk of Heart Failure after Anthracycline- or Trastuzumab-Based Chemotherapy for Early Breast Cancer: A Propensity Scorematched Cohort Study." J Am Heart Assoc 10, no. 2 (Jan 19 2021): e018393. https://doi.org/10.1161/JAHA.119.018393. https://www.ncbi.nlm.nih.gov/pubmed/33401953.

Alakus, Hakan, Eric Hahnen, Rita Schmutzler, and Christiane Bruns. "Genetische Testung Beim Mammakarzinom." Der Onkologe 25, no. 7 (2019): 623-24. https://doi.org/10.1007/s00761-019-0555-8.

Bancroft, E. K., S. Saya, E. C. Page, K. Myhill, S. Thomas, J. Pope, A. Chamberlain, et al. "Psychosocial Impact of Undergoing Prostate Cancer Screening for Men with Brca1 or Brca2 Mutations." BJU Int 123, no. 2 (Feb 2019): 284-92. https://doi.org/10.1111/bju.14412. https://www.ncbi.nlm.nih.gov/pubmed/29802810.

Bick, U., C. Engel, B. Krug, W. Heindel, E. M. Fallenberg, K. Rhiem, D. Maintz, et al. "High-Risk Breast Cancer Surveillance with Mri: 10-Year Experience from the German Consortium for Hereditary Breast and Ovarian Cancer." Breast Cancer Res Treat 175, no. 1 (May 2019): 217-28. https://doi.org/10.1007/s10549-019-05152-9. https://www.ncbi.nlm.nih.gov/pubmed/30725383.

Bokemeyer, Carsten, Andreas Engert, Nadja Gökbuget, and Rita Schmutzler. "Gezielte Früherkennung Und Risikoadaptierte Therapie." Oncology Research and Treatment 42, no. Suppl. 3 (2019): 2-13. https://doi.org/10.1159/000500816.

Bredart, A., J. L. Kop, J. Dick, A. Cano, A. De Pauw, A. Anota, J. Brunet, et al. "Psychosocial Problems in Women Attending French, German and Spanish Genetics Clinics before and after Targeted or Multigene Testing Results: An Observational Prospective Study." BMJ Open 9, no. 9 (Sep 24 2019): e029926. https://doi.org/10.1136/bmjopen-2019-029926. https://www.ncbi.nlm.nih.gov/pubmed/31551380.

Ditsch, N., M. Untch, M. Thill, V. Muller, W. Janni, U. S. Albert, I. Bauerfeind, et al. "Ago Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2019." Breast Care (Basel) 14, no. 4 (Aug 2019): 224-45. https://doi.org/10.1159/000501000. https://www.ncbi.nlm.nih.gov/pubmed/31558897.

Dork, T., P. Peterlongo, A. Mannermaa, M. K. Bolla, Q. Wang, J. Dennis, T. Ahearn, et al. "Two Truncating Variants in Fancc and Breast Cancer Risk." Sci Rep 9, no. 1 (Aug 29 2019): 12524. https://doi.org/10.1038/s41598-019-48804-y. https://www.ncbi.nlm.nih.gov/pubmed/31467304.

Escala-Garcia, M., Q. Guo, T. Dork, S. Canisius, R. Keeman, J. Dennis, J. Beesley, et al. "Genome-Wide Association Study of Germline Variants and Breast Cancer-Specific Mortality." Br J Cancer 120, no. 6 (Mar 2019): 647-57. https://doi.org/10.1038/s41416-019-0393-x. https://www.ncbi.nlm.nih.gov/pubmed/30787463.

Ferreira, M. A., E. R. Gamazon, F. Al-Ejeh, K. Aittomaki, I. L. Andrulis, H. Anton-Culver, A. Arason, et al. "Genome-Wide Association and Transcriptome Studies Identify Target Genes and Risk Loci for Breast Cancer." Nat Commun 10, no. 1 (Apr 15 2019): 1741. https://doi.org/10.1038/s41467-018-08053-5. https://www.ncbi.nlm.nih.gov/pubmed/30988301.

Figlioli, G., M. Bogliolo, I. Catucci, L. Caleca, S. V. Lasheras, R. Pujol, J. I. Kiiski, et al. "The Fancm:P.Arg658* Truncating Variant Is Associated with Risk of Triple-Negative Breast Cancer." NPJ Breast Cancer 5 (2019): 38. https://doi.org/10.1038/s41523-019-0127-5. https://www.ncbi.nlm.nih.gov/pubmed/31700994.

Grinstein, O., B. Krug, M. Hellmic, F. Siedek, W. Malter, C. Burke, R. Schmutzler, D. Maintz, and K. Rhiem. "Residual Glandular Tissue (Rgt) in Brca1/2 Germline Mutation Carriers with Unilateral and Bilateral Prophylactic Mastectomies." Surg Oncol 29 (Jun 2019): 126-33. https://doi.org/10.1016/j.suronc.2019.04.009. https://www.ncbi.nlm.nih.gov/pubmed/31196476.https://doi.org/10.1016/s0344-0338(85)80075-3.

Hauke, J., E. Hahnen, S. Schneider, A. Reuss, L. Richters, S. Kommoss, A. Heimbach, et al. "Deleterious Somatic Variants in 473 Consecutive Individuals with Ovarian Cancer: Results of the Observational Ago-Tr1 Study (Nct02222883)." J Med Genet 56, no. 9 (Sep 2019): 574-80. https://doi.org/10.1136/jmedgenet-2018-105930. https://www.ncbi.nlm.nih.gov/pubmed/30979843.

Horn, L. C., G. Emons, S. Aretz, N. Bock, M. Follmann, S. Lax, M. Nothacker, et al. "[S3 Guidelines on the Diagnosis and Treatment of Carcinoma of the Endometrium : Requirements for Pathology]." Pathologe 40, no. 1 (Feb 2019): 21-35. https://doi.org/10.1007/s00292-019-0574-7. S3-Leitlinie Diagnostik und Therapie des Endometriumkarzinoms : Anforderungen an die Pathologie. https://www.ncbi.nlm.nih.gov/pubmed/30756154.

Keupp, K., S. Hampp, A. Hubbel, M. Maringa, S. Kostezka, K. Rhiem, A. Waha, et al. "Biallelic Germline Brca1 Mutations in a Patient with Early Onset Breast Cancer, Mild Fanconi Anemia-Like Phenotype, and No Chromosome Fragility." Mol Genet Genomic Med 7, no. 9 (Sep 2019): e863. https://doi.org/10.1002/mgg3.863. https://www.ncbi.nlm.nih.gov/pubmed/31347298

Klaschik, K., J. Hauke, G. Neidhardt, C. Trankle, H. M. Surowy, S. Heilmann-Heimbach, G. Rappl, et al. "The Gprc5a Frameshift Variant C.183del Is Not Associated with Increased Breast Cancer Risk in Brca1 Mutation Carriers." Int J Cancer 144, no. 7 (Apr 1 2019): 1761-63. https://doi.org/10.1002/ijc.32016. https://www.ncbi.nlm.nih.gov/pubmed/30474284.

Loibl, S., M. Untch, N. Burchardi, J. Huober, B. V. Sinn, J. U. Blohmer, E. M. Grischke, et al. "A Randomised Phase Ii Study Investigating Durvalumab in Addition to an Anthracycline Taxane-Based Neoadjuvant Therapy in Early Triple-Negative Breast Cancer: Clinical Results and Biomarker Analysis of Geparnuevo Study." Ann Oncol 30, no. 8 (Aug 1 2019): 1279-88. https://doi.org/10.1093/annonc/mdz158. https://www.ncbi.nlm.nih.gov/pubmed/31095287.

Mavaddat, N., K. Michailidou, J. Dennis, M. Lush, L. Fachal, A. Lee, J. P. Tyrer, et al. "Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes." Am J Hum Genet 104, no. 1 (Jan 3 2019): 21-34. https://doi.org/10.1016/j.ajhg.2018.11.002. https://www.ncbi.nlm.nih.gov/pubmed/30554720.

Moosa, S., G. L. Yamamoto, L. Garbes, K. Keupp, A. Beleza-Meireles, C. A. Moreno, E. R. Valadares, et al. "Autosomal-Recessive Mutations in Mesd Cause Osteogenesis Imperfecta." Am J Hum Genet 105, no. 4 (Oct 3 2019): 836-43. https://doi.org/10.1016/j.ajhg.2019.08.008. https://www.ncbi.nlm.nih.gov/pubmed/31564437.

Muller, D., M. Danner, R. Schmutzler, C. Engel, K. Wassermann, B. Stollenwerk, S. Stock, and K. Rhiem. "Economic Modeling of Risk-Adapted Screen-and-Treat Strategies in Women at High Risk for Breast or Ovarian Cancer." Eur J Health Econ 20, no. 5 (Jul 2019): 739-50. https://doi.org/10.1007/s10198-019-01038-1. https://www.ncbi.nlm.nih.gov/pubmed/30790097.

Neusser, S., B. Lux, C. Barth, K. Pahmeier, K. Rhiem, R. Schmutzler, C. Engel, et al. "The Budgetary Impact of Genetic Testing for Hereditary Breast Cancer for the Statutory Health Insurance." Curr Med Res Opin 35, no. 12 (Dec 2019): 2103-10. https://doi.org/10.1080/03007995.2019.1654689. https://www.ncbi.nlm.nih.gov/pubmed/31394049.

Page, E. C., E. K. Bancroft, M. N. Brook, M. Assel, M. Hassan Al Battat, S. Thomas, N. Taylor, et al. "Interim Results from the Impact Study: Evidence for Prostate-Specific Antigen Screening in Brca2 Mutation Carriers." Eur Urol 76, no. 6 (Dec 2019): 831-42. https://doi.org/10.1016/j.eururo.2019.08.019. https://www.ncbi.nlm.nih.gov/pubmed/31537406.

Parsons, M. T., E. Tudini, H. Li, E. Hahnen, B. Wappenschmidt, L. Feliubadalo, C. M. Aalfs, et al. "Large Scale Multifactorial Likelihood Quantitative Analysis of Brca1 and Brca2 Variants: An Enigma Resource to Support Clinical Variant Classification." Hum Mutat 40, no. 9 (Sep 2019): 1557-78. https://doi.org/10.1002/humu.23818. https://www.ncbi.nlm.nih.gov/pubmed/31131967.

Puesken, M., C. Unterberg-Buchwald, K. Rhiem, N. Grosse Hokamp, D. Maintz, J. Lotz, and S. Wienbeck. "Ex Vivo Study of Artifacts Caused by Breast Tissue Markers with Different 1.5 Tesla and 3 Tesla Mri Scanners - a Bicentric Study." Acad Radiol  (Jan 30 2020). https://doi.org/10.1016/j.acra.2019.12.006. https://www.ncbi.nlm.nih.gov/pubmed/32008930.

Puppe, J., M. Opdam, P. C. Schouten, K. Jozwiak, E. Lips, T. Severson, M. van de Ven, et al. "Ezh2 Is Overexpressed in Brca1-Like Breast Tumors and Predictive for Sensitivity to High-Dose Platinum-Based Chemotherapy." Clin Cancer Res 25, no. 14 (Jul 15 2019): 4351-62. https://doi.org/10.1158/1078-0432.CCR-18-4024. https://www.ncbi.nlm.nih.gov/pubmed/31036541.

Qian, F., M. A. Rookus, G. Leslie, H. A. Risch, M. H. Greene, C. M. Aalfs, M. A. Adank, et al. "Mendelian Randomisation Study of Height and Body Mass Index as Modifiers of Ovarian Cancer Risk in 22,588 Brca1 and Brca2 Mutation Carriers." Br J Cancer 121, no. 2 (Jul 2019): 180-92. https://doi.org/10.1038/s41416-019-0492-8. https://www.ncbi.nlm.nih.gov/pubmed/31213659.

Qian, F., S. Wang, J. Mitchell, L. McGuffog, D. Barrowdale, G. Leslie, J. C. Oosterwijk, et al. "Height and Body Mass Index as Modifiers of Breast Cancer Risk in Brca1/2 Mutation Carriers: A Mendelian Randomization Study." J Natl Cancer Inst 111, no. 4 (Apr 1 2019): 350-64. https://doi.org/10.1093/jnci/djy132. https://www.ncbi.nlm.nih.gov/pubmed/30312457.

Rhiem, K., H. J. Bucker-Nott, M. Hellmich, H. Fischer, B. Ataseven, C. Dittmer-Grabowski, K. Latos, et al. "Benchmarking of a Checklist for the Identification of Familial Risk for Breast and Ovarian Cancers in a Prospective Cohort." Breast J 25, no. 3 (May 2019): 455-60. https://doi.org/10.1111/tbj.13257. https://www.ncbi.nlm.nih.gov/pubmed/30953388

Schneeweiss, A., V. Mobus, H. Tesch, C. Hanusch, C. Denkert, K. Lubbe, J. Huober, et al. "Intense Dose-Dense Epirubicin, Paclitaxel, Cyclophosphamide Versus Weekly Paclitaxel, Liposomal Doxorubicin (Plus Carboplatin in Triple-Negative Breast Cancer) for Neoadjuvant Treatment of High-Risk Early Breast Cancer (Geparocto-Gbg 84): A Randomised Phase Iii Trial." Eur J Cancer 106 (Jan 2019): 181-92. https://doi.org/10.1016/j.ejca.2018.10.015. https://www.ncbi.nlm.nih.gov/pubmed/30528802.

Sepahi, I., U. Faust, M. Sturm, K. Bosse, M. Kehrer, T. Heinrich, K. Grundman-Hauser, et al. "Investigating the Effects of Additional Truncating Variants in DNA-Repair Genes on Breast Cancer Risk in Brca1-Positive Women." BMC Cancer 19, no. 1 (Aug 8 2019): 787. https://doi.org/10.1186/s12885-019-5946-0. https://www.ncbi.nlm.nih.gov/pubmed/31395037.

Singer, C. F., J. Balmana, N. Burki, S. Delaloge, M. E. Filieri, A. M. Gerdes, E. M. Grindedal, et al. "Genetic Counselling and Testing of Susceptibility Genes for Therapeutic Decision-Making in Breast Cancer-an European Consensus Statement and Expert Recommendations." Eur J Cancer 106 (Jan 2019): 54-60. https://doi.org/10.1016/j.ejca.2018.10.007. https://www.ncbi.nlm.nih.gov/pubmed/30471648.

Shu, X., L. Wu, N. K. Khankari, X. O. Shu, T. J. Wang, K. Michailidou, M. K. Bolla, et al. "Associations of Obesity and Circulating Insulin and Glucose with Breast Cancer Risk: A Mendelian Randomization Analysis." Int J Epidemiol 48, no. 3 (Jun 1 2019): 795-806. https://doi.org/10.1093/ije/dyy201. https://www.ncbi.nlm.nih.gov/pubmed/30277539.

Thill, M., C. Jackisch, W. Janni, V. Muller, U. S. Albert, I. Bauerfeind, J. Blohmer, et al. "Ago Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2019." Breast Care (Basel) 14, no. 4 (Aug 2019): 247-55. https://doi.org/10.1159/000500999. https://www.ncbi.nlm.nih.gov/pubmed/31558898.

Untch, M., C. Jackisch, A. Schneeweiss, S. Schmatloch, B. Aktas, C. Denkert, C. Schem, et al. "Nab-Paclitaxel Improves Disease-Free Survival in Early Breast Cancer: Gbg 69-Geparsepto." J Clin Oncol 37, no. 25 (Sep 1 2019): 2226-34. https://doi.org/10.1200/JCO.18.01842. https://www.ncbi.nlm.nih.gov/pubmed/31082269.

Weber-Lassalle, N., J. Borde, K. Weber-Lassalle, J. Horvath, D. Niederacher, N. Arnold, S. Kaulfuss, et al. "Germline Loss-of-Function Variants in the Bard1 Gene Are Associated with Early-Onset Familial Breast Cancer but Not Ovarian Cancer." Breast Cancer Res 21, no. 1 (Apr 29 2019): 55. https://doi.org/10.1186/s13058-019-1137-9. https://www.ncbi.nlm.nih.gov/pubmed/31036035.

2018

Governance Perspective für Leistungsansprüche bei genetischen (Brustkrebs-)Risiken
Authors: Friedhelm Meier, Anke Harney, Kerstin Rhiem, Anja Neumann, Silke Neusser, Matthias Braun, Jürgen Wasem, Rita Schmutzler, Stefan Huster, Peter Dabrock

Inhalt des essentials:

  • Eine Erörterung, warum eine sozialrechtliche Berücksichtigung von Personen mit hochgradigen und stark erhöhten (Brustkrebs-)Risiken sinnvoll ist.
  • Die Entwicklung der ‚risikoadaptierten Prävention‘ als neue sozialrechtliche Kategorie, welche Leistungsansprüche von Personen mit hohen und moderaten Risiken sozialrechtlich abzubilden vermag.
  • Gesundheitspolitische Empfehlungen, welche den Weg zur ‚risikoadaptierten Prävention‘ konturieren.
    https://www.springer.com/de/book/9783658208004

Bredart, A., A. Anota, J. Dick, V. Kuboth, O. Lareyre, A. De Pauw, A. Cano, et al. "Patient-Centered Care in Breast Cancer Genetic Clinics." Int J Environ Res Public Health 15, no. 2 (Feb 12 2018). https://doi.org/10.3390/ijerph15020319. https://www.ncbi.nlm.nih.gov/pubmed/29439543.

Catucci, I., A. Osorio, B. Arver, G. Neidhardt, M. Bogliolo, F. Zanardi, M. Riboni, et al. "Individuals with Fancm Biallelic Mutations Do Not Develop Fanconi Anemia, but Show Risk for Breast Cancer, Chemotherapy Toxicity and May Display Chromosome Fragility." Genet Med 20, no. 4 (Apr 2018): 452-57. https://doi.org/10.1038/gim.2017.123. https://www.ncbi.nlm.nih.gov/pubmed/28837162.

Cline, M. S., R. G. Liao, M. T. Parsons, B. Paten, F. Alquaddoomi, A. Antoniou, S. Baxter, et al. "Brca Challenge: Brca Exchange as a Global Resource for Variants in Brca1 and Brca2." PLoS Genet 14, no. 12 (Dec 2018): e1007752. https://doi.org/10.1371/journal.pgen.1007752. https://www.ncbi.nlm.nih.gov/pubmed/30586411.

Colombo, M., I. Lopez-Perolio, H. D. Meeks, L. Caleca, M. T. Parsons, H. Li, G. De Vecchi, et al. "The Brca2 C.68-7t > a Variant Is Not Pathogenic: A Model for Clinical Calibration of Spliceogenicity." Hum Mutat 39, no. 5 (May 2018): 729-41. https://doi.org/10.1002/humu.23411. https://www.ncbi.nlm.nih.gov/pubmed/29460995.

Du, C., D. Mark, B. Wappenschmidt, B. Bockmann, B. Pabst, S. Chan, H. Cao, et al. "A Tandem Duplication of Brca1 Exons 1-19 through Dhx8 Exon 2 in Four Families with Hereditary Breast and Ovarian Cancer Syndrome." Breast Cancer Res Treat 172, no. 3 (Dec 2018): 561-69. https://doi.org/10.1007/s10549-018-4957-x. https://www.ncbi.nlm.nih.gov/pubmed/30191368.

Ellison, G., M. Ahdesmaki, S. Luke, P. M. Waring, A. Wallace, R. Wright, B. Rothlisberger, et al. "An Evaluation of the Challenges to Developing Tumor Brca1 and Brca2 Testing Methodologies for Clinical Practice." Hum Mutat 39, no. 3 (Mar 2018): 394-405. https://doi.org/10.1002/humu.23375. https://www.ncbi.nlm.nih.gov/pubmed/29215764.

Emons, G., E. Steiner, D. Vordermark, C. Uleer, N. Bock, K. Paradies, O. Ortmann, et al. "Interdisciplinary Diagnosis, Therapy and Follow-up of Patients with Endometrial Cancer. Guideline (S3-Level, Awmf Registry Number 032/034-Ol, April 2018) - Part 2 with Recommendations on the Therapy and Follow-up of Endometrial Cancer, Palliative Care, Psycho-Oncological/Psychosocial Care/Rehabilitation/Patient Information and Healthcare Facilities." Geburtshilfe Frauenheilkd 78, no. 11 (Nov 2018): 1089-109. https://doi.org/10.1055/a-0715-2964. https://www.ncbi.nlm.nih.gov/pubmed/30581199.

Emons, G., E. Steiner, D. Vordermark, C. Uleer, N. Bock, K. Paradies, O. Ortmann, et al. "Interdisciplinary Diagnosis, Therapy and Follow-up of Patients with Endometrial Cancer. Guideline (S3-Level, Awmf Registry Nummer 032/034-Ol, April 2018) - Part 1 with Recommendations on the Epidemiology, Screening, Diagnosis and Hereditary Factors of Endometrial Cancer." Geburtshilfe Frauenheilkd 78, no. 10 (Oct 2018): 949-71. https://doi.org/10.1055/a-0713-1218. https://www.ncbi.nlm.nih.gov/pubmed/30364388.

Engel, C., K. Rhiem, E. Hahnen, S. Loibl, K. E. Weber, S. Seiler, S. Zachariae, et al. "Prevalence of Pathogenic Brca1/2 Germline Mutations among 802 Women with Unilateral Triple-Negative Breast Cancer without Family Cancer History." BMC Cancer 18, no. 1 (Mar 7 2018): 265. https://doi.org/10.1186/s12885-018-4029-y. https://www.ncbi.nlm.nih.gov/pubmed/29514593.

Ernst, C., E. Hahnen, C. Engel, M. Nothnagel, J. Weber, R. K. Schmutzler, and J. Hauke. "Performance of in Silico Prediction Tools for the Classification of Rare Brca1/2 Missense Variants in Clinical Diagnostics." BMC Med Genomics 11, no. 1 (Mar 27 2018): 35. https://doi.org/10.1186/s12920-018-0353-y. https://www.ncbi.nlm.nih.gov/pubmed/29580235.

Hauke, J., J. Horvath, E. Gross, A. Gehrig, E. Honisch, K. Hackmann, G. Schmidt, et al. "Gene Panel Testing of 5589 Brca1/2-Negative Index Patients with Breast Cancer in a Routine Diagnostic Setting: Results of the German Consortium for Hereditary Breast and Ovarian Cancer." Cancer Med 7, no. 4 (Apr 2018): 1349-58. https://doi.org/10.1002/cam4.1376. https://www.ncbi.nlm.nih.gov/pubmed/29522266.

Herold, N., B. Wappenschmidt, B. Markiefka, K. Keupp, S. Krober, E. Hahnen, R. Schmutzler, and K. Rhiem. "Non-Small Cell Neuroendocrine Carcinoma of the Ovary in a Brca2-Germline Mutation Carrier: A Case Report and Brief Review of the Literature." Oncol Lett 15, no. 4 (Apr 2018): 4093-96. https://doi.org/10.3892/ol.2018.7836. https://www.ncbi.nlm.nih.gov/pubmed/29541174.

Loibl, S., K. E. Weber, K. M. Timms, E. P. Elkin, E. Hahnen, P. A. Fasching, B. Lederer, et al. "Survival Analysis of Carboplatin Added to an Anthracycline/Taxane-Based Neoadjuvant Chemotherapy and Hrd Score as Predictor of Response-Final Results from Geparsixto." Ann Oncol 29, no. 12 (Dec 1 2018): 2341-47. https://doi.org/10.1093/annonc/mdy460. https://www.ncbi.nlm.nih.gov/pubmed/30335131.

Liedtke, C., C. Jackisch, M. Thill, C. Thomssen, V. Muller, W. Janni, and A. G. O. Breast Committee. "Ago Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2018." Breast Care (Basel) 13, no. 3 (Jul 2018): 196-208. https://doi.org/10.1159/000489329. https://www.ncbi.nlm.nih.gov/pubmed/30069181.

Lu, Y., A. Beeghly-Fadiel, L. Wu, X. Guo, B. Li, J. M. Schildkraut, H. K. Im, et al. "A Transcriptome-Wide Association Study among 97,898 Women to Identify Candidate Susceptibility Genes for Epithelial Ovarian Cancer Risk." Cancer Res 78, no. 18 (Sep 15 2018): 5419-30. https://doi.org/10.1158/0008-5472.CAN-18-0951. https://www.ncbi.nlm.nih.gov/pubmed/30054336.

Mikropoulos, C., C. G. H. Selkirk, S. Saya, E. Bancroft, E. Vertosick, T. Dadaev, C. Brendler, et al. "Prostate-Specific Antigen Velocity in a Prospective Prostate Cancer Screening Study of Men with Genetic Predisposition." Br J Cancer 118, no. 2 (Jan 2018): 266-76. https://doi.org/10.1038/bjc.2017.429. https://www.ncbi.nlm.nih.gov/pubmed/29301143.

Moghadasi, S., H. D. Meeks, M. P. Vreeswijk, L. A. Janssen, A. Borg, H. Ehrencrona, Y. Paulsson-Karlsson, et al. "The Brca1 C. 5096g>a P.Arg1699gln (R1699q) Intermediate Risk Variant: Breast and Ovarian Cancer Risk Estimation and Recommendations for Clinical Management from the Enigma Consortium." J Med Genet 55, no. 1 (Jan 2018): 15-20. https://doi.org/10.1136/jmedgenet-2017-104560. https://www.ncbi.nlm.nih.gov/pubmed/28490613.

Muller, D., M. Danner, K. Rhiem, B. Stollenwerk, C. Engel, L. Rasche, L. Borsi, R. Schmutzler, and S. Stock. "Cost-Effectiveness of Different Strategies to Prevent Breast and Ovarian Cancer in German Women with a Brca 1 or 2 Mutation." Eur J Health Econ 19, no. 3 (Apr 2018): 341-53. https://doi.org/10.1007/s10198-017-0887-5. https://www.ncbi.nlm.nih.gov/pubmed/28382503

Rebbeck, T. R., T. M. Friebel, E. Friedman, U. Hamann, D. Huo, A. Kwong, E. Olah, et al. "Mutational Spectrum in a Worldwide Study of 29,700 Families with Brca1 or Brca2 Mutations." Hum Mutat 39, no. 5 (May 2018): 593-620. https://doi.org/10.1002/humu.23406. https://www.ncbi.nlm.nih.gov/pubmed/29446198.

Rhiem, K., and R. K. Schmutzler. "Flächendeckende Versorgung Von Familien Mit Erblichem Brust- Und Eierstockkrebs." Der Gynäkologe 51, no. 5 (2018): 403-08. https://doi.org/10.1007/s00129-018-4234-4.

Terry, M. B., Y. Liao, K. Kast, A. C. Antoniou, J. A. McDonald, T. M. Mooij, C. Engel, et al. "The Influence of Number and Timing of Pregnancies on Breast Cancer Risk for Women with Brca1 or Brca2 Mutations." JNCI Cancer Spectr 2, no. 4 (Dec 2018): pky078. https://doi.org/10.1093/jncics/pky078. https://www.ncbi.nlm.nih.gov/pubmed/30873510.

Tudini, E., S. Moghadasi, M. T. Parsons, L. van der Kolk, A. M. W. van den Ouweland, D. Niederacher, L. Feliubadalo, et al. "Substantial Evidence for the Clinical Significance of Missense Variant Brca1 C.5309g>T P.(Gly1770val)." Breast Cancer Res Treat 172, no. 2 (Nov 2018): 497-503. https://doi.org/10.1007/s10549-018-4903-y. https://www.ncbi.nlm.nih.gov/pubmed/30105462.

Weber-Lassalle, K., P. Harter, J. Hauke, C. Ernst, S. Kommoss, F. Marme, N. Weber-Lassalle, et al. "Diagnosis of Li-Fraumeni Syndrome: Differentiating Tp53 Germline Mutations from Clonal Hematopoiesis: Results of the Observational Ago-Tr1 Trial." Hum Mutat 39, no. 12 (Dec 2018): 2040-46. https://doi.org/10.1002/humu.23653. https://www.ncbi.nlm.nih.gov/pubmed/30216591.

Weber-Lassalle, N., J. Hauke, J. Ramser, L. Richters, E. Gross, B. Blumcke, A. Gehrig, et al. "Brip1 Loss-of-Function Mutations Confer High Risk for Familial Ovarian Cancer, but Not Familial Breast Cancer." Breast Cancer Res 20, no. 1 (Jan 24 2018): 7. https://doi.org/10.1186/s13058-018-0935-9. https://www.ncbi.nlm.nih.gov/pubmed/29368626.

Wu, L., W. Shi, J. Long, X. Guo, K. Michailidou, J. Beesley, M. K. Bolla, et al. "A Transcriptome-Wide Association Study of 229,000 Women Identifies New Candidate Susceptibility Genes for Breast Cancer." Nat Genet 50, no. 7 (Jul 2018): 968-78. https://doi.org/10.1038/s41588-018-0132-x. https://www.ncbi.nlm.nih.gov/pubmed/29915430.

2017

Amos, C. I., J. Dennis, Z. Wang, J. Byun, F. R. Schumacher, S. A. Gayther, G. Casey, et al. "The Oncoarray Consortium: A Network for Understanding the Genetic Architecture of Common Cancers." Cancer Epidemiol Biomarkers Prev 26, no. 1 (Jan 2017): 126-35. https://doi.org/10.1158/1055-9965.EPI-16-0106. https://www.ncbi.nlm.nih.gov/pubmed/27697780.

Feng, Y. C. A., K. Cho, S. Lindstrom, P. Kraft, J. Cormack, L. M. Liang, J. A. Driver, et al. "Investigating the Genetic Relationship between Alzheimer's Disease and Cancer Using Gwas Summary Statistics." [In English]. Human Genetics 136, no. 10 (Oct 2017): 1341-51. https://doi.org/10.1007/s00439-017-1831-6. <Go to ISI>://WOS:000411250800003.

Grill, S., M. Yahiaoui-Doktor, R. Dukatz, J. Lammert, M. Ullrich, C. Engel, K. Pfeifer, et al. "Smoking and Physical Inactivity Increase Cancer Prevalence in Brca-1 and Brca-2 Mutation Carriers: Results from a Retrospective Observational Analysis." Arch Gynecol Obstet 296, no. 6 (Dec 2017): 1135-44. https://doi.org/10.1007/s00404-017-4546-y. https://www.ncbi.nlm.nih.gov/pubmed/28975393.

Hackl, A., K. Mehler, I. Gottschalk, A. Vierzig, M. Eydam, J. Hauke, B. B. Beck, et al. "Disorders of Fatty Acid Oxidation and Autosomal Recessive Polycystic Kidney Disease-Different Clinical Entities and Comparable Perinatal Renal Abnormalities." Pediatr Nephrol 32, no. 5 (May 2017): 791-800. https://doi.org/10.1007/s00467-016-3556-5. https://www.ncbi.nlm.nih.gov/pubmed/28083701.

Hahnen, E., J. Hauke, C. Engel, G. Neidhardt, K. Rhiem, and R. K. Schmutzler. "Germline Mutations in Triple-Negative Breast Cancer." Breast Care (Basel) 12, no. 1 (Mar 2017): 15-19. https://doi.org/10.1159/000455999. https://www.ncbi.nlm.nih.gov/pubmed/28611536.

Hahnen, E., B. Lederer, J. Hauke, S. Loibl, S. Krober, A. Schneeweiss, C. Denkert, et al. "Germline Mutation Status, Pathological Complete Response, and Disease-Free Survival in Triple-Negative Breast Cancer: Secondary Analysis of the Geparsixto Randomized Clinical Trial." JAMA Oncol 3, no. 10 (Oct 1 2017): 1378-85. https://doi.org/10.1001/jamaoncol.2017.1007. https://www.ncbi.nlm.nih.gov/pubmed/28715532.

Hahnen, Eric, Barbara Wappenschmidt, Kerstin Rhiem, and Rita Schmutzler. "Hereditäre Tumordiagnostik – Mammakarzinom: Brca1, Brca2 Und Derzeitiger Stand Der Multigenanalysen." Geburtshilfe und Frauenheilkunde 77, no. 01 (2017): 36-40. https://doi.org/10.1055/s-0042-122159.

Hamdi, Y., P. Soucy, K. B. Kuchenbaeker, T. Pastinen, A. Droit, A. Lemacon, J. Adlard, et al. "Association of Breast Cancer Risk in Brca1 and Brca2 Mutation Carriers with Genetic Variants Showing Differential Allelic Expression: Identification of a Modifier of Breast Cancer Risk at Locus 11q22.3." Breast Cancer Res Treat 161, no. 1 (Jan 2017): 117-34. https://doi.org/10.1007/s10549-016-4018-2. https://www.ncbi.nlm.nih.gov/pubmed/27796716.

Harter, P., J. Hauke, F. Heitz, A. Reuss, S. Kommoss, F. Marme, A. Heimbach, et al. "Prevalence of Deleterious Germline Variants in Risk Genes Including Brca1/2 in Consecutive Ovarian Cancer Patients (Ago-Tr-1)." PLoS One 12, no. 10 (2017): e0186043. https://doi.org/10.1371/journal.pone.0186043. https://www.ncbi.nlm.nih.gov/pubmed/29053726.

Jiao, X., C. Aravidis, R. Marikkannu, J. Rantala, S. Picelli, T. Adamovic, T. Liu, et al. "Phip - a Novel Candidate Breast Cancer Susceptibility Locus on 6q14.1." Oncotarget 8, no. 61 (Nov 28 2017): 102769-82. https://doi.org/10.18632/oncotarget.21800. https://www.ncbi.nlm.nih.gov/pubmed/29262523.

Kiechle, M., R. Dukatz, M. Yahiaoui-Doktor, A. Berling, M. Basrai, V. Staiger, U. Niederberger, et al. "Feasibility of Structured Endurance Training and Mediterranean Diet in Brca1 and Brca2 Mutation Carriers - an Interventional Randomized Controlled Multicenter Trial (Libre-1)." BMC Cancer 17, no. 1 (Nov 10 2017): 752. https://doi.org/10.1186/s12885-017-3732-4. https://www.ncbi.nlm.nih.gov/pubmed/29126396.

Kuchenbaecker, K. B., L. McGuffog, D. Barrowdale, A. Lee, P. Soucy, J. Dennis, S. M. Domchek, et al. "Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in Brca1 and Brca2 Mutation Carriers." J Natl Cancer Inst 109, no. 7 (Jul 1 2017). https://doi.org/10.1093/jnci/djw302. https://www.ncbi.nlm.nih.gov/pubmed/28376175.

Kuchenbaecker, K. B., J. L. Hopper, D. R. Barnes, K. A. Phillips, T. M. Mooij, M. J. Roos-Blom, S. Jervis, et al. "Risks of Breast, Ovarian, and Contralateral Breast Cancer for Brca1 and Brca2 Mutation Carriers." JAMA 317, no. 23 (Jun 20 2017): 2402-16. https://doi.org/10.1001/jama.2017.7112. https://www.ncbi.nlm.nih.gov/pubmed/28632866.

Lecarpentier, J., V. Silvestri, K. B. Kuchenbaecker, D. Barrowdale, J. Dennis, L. McGuffog, P. Soucy, et al. "Prediction of Breast and Prostate Cancer Risks in Male Brca1 and Brca2 Mutation Carriers Using Polygenic Risk Scores." J Clin Oncol 35, no. 20 (Jul 10 2017): 2240-50. https://doi.org/10.1200/JCO.2016.69.4935. https://www.ncbi.nlm.nih.gov/pubmed/28448241.

Meier, F., J. Ried, A. Harney, K. Rhiem, S. Neusser, A. Neumann, J. Wasem, et al. "[Entitlement to Prophylactic Treatment in Cases of Genetic Predisposition for Breast Cancer : Interdisciplinary Perspectives]." Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 60, no. 10 (Oct 2017): 1102-08. https://doi.org/10.1007/s00103-017-2608-8. Leistungsanspruch auf prophylaktische Behandlung bei genetischer Pradisposition fur Brustkrebs : Interdisziplinare Perspektiven. https://www.ncbi.nlm.nih.gov/pubmed/28795204.

Michailidou, K., S. Lindstrom, J. Dennis, J. Beesley, S. Hui, S. Kar, A. Lemacon, et al. "Association Analysis Identifies 65 New Breast Cancer Risk Loci." Nature 551, no. 7678 (Nov 2 2017): 92-94. https://doi.org/10.1038/nature24284. https://www.ncbi.nlm.nih.gov/pubmed/29059683.

Milne, R. L., K. B. Kuchenbaecker, K. Michailidou, J. Beesley, S. Kar, S. Lindstrom, S. Hui, et al. "Identification of Ten Variants Associated with Risk of Estrogen-Receptor-Negative Breast Cancer." Nat Genet 49, no. 12 (Dec 2017): 1767-78. https://doi.org/10.1038/ng.3785. https://www.ncbi.nlm.nih.gov/pubmed/29058716.

Muranen, T. A., D. Greco, C. Blomqvist, K. Aittomaki, S. Khan, F. Hogervorst, S. Verhoef, et al. "Genetic Modifiers of Chek2*1100delc-Associated Breast Cancer Risk." Genet Med 19, no. 5 (May 2017): 599-603. https://doi.org/10.1038/gim.2016.147. https://www.ncbi.nlm.nih.gov/pubmed/27711073.

Neidhardt, G., A. Becker, J. Hauke, J. Horvath, N. Bogdanova Markov, S. Heilmann-Heimbach, H. Hellebrand, et al. "The Rad51c Exonic Splice-Site Mutations C.404g>C and C.404g>T Are Associated with Familial Breast and Ovarian Cancer." Eur J Cancer Prev 26, no. 2 (Mar 2017): 165-69. https://doi.org/10.1097/CEJ.0000000000000240. https://www.ncbi.nlm.nih.gov/pubmed/27622768.

Neidhardt, G., J. Hauke, J. Ramser, E. Gross, A. Gehrig, C. R. Muller, A. K. Kahlert, et al. "Association between Loss-of-Function Mutations within the Fancm Gene and Early-Onset Familial Breast Cancer." JAMA Oncol 3, no. 9 (Sep 1 2017): 1245-48. https://doi.org/10.1001/jamaoncol.2016.5592. https://www.ncbi.nlm.nih.gov/pubmed/28033443

Phelan, C. M., K. B. Kuchenbaecker, J. P. Tyrer, S. P. Kar, K. Lawrenson, S. J. Winham, J. Dennis, et al. "Identification of 12 New Susceptibility Loci for Different Histotypes of Epithelial Ovarian Cancer." Nat Genet 49, no. 5 (May 2017): 680-91. https://doi.org/10.1038/ng.3826. https://www.ncbi.nlm.nih.gov/pubmed/28346442.

Reinisch, M., J. Huober, G. von Minckwitz, J. U. Blohmer, C. Denkert, C. Hanusch, C. Jackisch, et al. "Pcr Rates in Patients with Bilateral Breast Cancer after Neoadjuvant Anthracycline-Taxane Based-Chemotherapy - a Retrospective Pooled Analysis of Individual Patients Data of Four German Neoadjuvant Trials." Breast 32 (Apr 2017): 73-78. https://doi.org/10.1016/j.breast.2016.12.020. https://www.ncbi.nlm.nih.gov/pubmed/28063331.

Schmutzler, R., and K. O. Kagan. "From the Genetic Diagnosis Commission of the Dggg Requirement to the Contents in the Enlightenment in Genetic Investigations for Medical Purposes According to 23 Paragraph 2 No. 3 Genetic Diagnostics Act." [In German]. Geburtshilfe Und Frauenheilkunde 77, no. 8 (Aug 2017): 846-47. <Go to ISI>://WOS:000408314400006.

Waha, A., B. Versmold, K. Kast, M. Kiechle, N. Ditsch, A. Meindl, D. Niederacher, et al. "Consensus Recommendation of the German Consortium Family Breast and Ovarian Cancer for Dealing with Results of the Multigenic Analysis." [In German]. Geburtshilfe Und Frauenheilkunde 77, no. 7 (Jul 2017): 733-39. <Go to ISI>://WOS:000405652600007.

Walker, L. C., L. Marquart, J. F. Pearson, G. A. Wiggins, T. A. O'Mara, M. T. Parsons, Bcfr, et al. "Evaluation of Copy-Number Variants as Modifiers of Breast and Ovarian Cancer Risk for Brca1 Pathogenic Variant Carriers." Eur J Hum Genet 25, no. 4 (Apr 2017): 432-38. https://doi.org/10.1038/ejhg.2016.203. https://www.ncbi.nlm.nih.gov/pubmed/28145423.

Wockel, A., J. Festl, T. Stuber, K. Brust, M. Krockenberger, P. U. Heuschmann, S. Jiru-Hillmann, et al. "Interdisciplinary Screening, Diagnosis, Therapy and Follow-up of Breast Cancer. Guideline of the Dggg and the Dkg (S3-Level, Awmf Registry Number 032/045ol, December 2017) - Part 2 with Recommendations for the Therapy of Primary, Recurrent and Advanced Breast Cancer." Geburtshilfe Frauenheilkd 78, no. 11 (Nov 2018): 1056-88. https://doi.org/10.1055/a-0646-4630. https://www.ncbi.nlm.nih.gov/pubmed/30581198.

Wockel, A., J. Festl, T. Stuber, K. Brust, S. Stangl, P. U. Heuschmann, U. S. Albert, et al. "Interdisciplinary Screening, Diagnosis, Therapy and Follow-up of Breast Cancer. Guideline of the Dggg and the Dkg (S3-Level, Awmf Registry Number 032/045ol, December 2017) - Part 1 with Recommendations for the Screening, Diagnosis and Therapy of Breast Cancer." Geburtshilfe Frauenheilkd 78, no. 10 (Oct 2018): 927-48. https://doi.org/10.1055/a-0646-4522. https://www.ncbi.nlm.nih.gov/pubmed/30369626.

Yang, R., S. Stocker, S. Schott, J. Heil, F. Marme, K. Cuk, B. Chen, et al. "The Association between Breast Cancer and S100p Methylation in Peripheral Blood by Multicenter Case-Control Studies." Carcinogenesis 38, no. 3 (Mar 1 2017): 312-20. https://doi.org/10.1093/carcin/bgx004. https://www.ncbi.nlm.nih.gov/pubmed/28426874.

2016

Bauer, P., M. Hummel, C. von Kalle, R. Schmutzler, A. Block, M. Stroth, C. Woopen, and K. Engelke. "[Molekulargenetische Diagnostik - Was Wissen Die Maschinen? Was Wollen Wir Wissen?]." Oncol Res Treat 39 Suppl 2 (2016): 2-23. https://doi.org/10.1159/000447548. https://www.ncbi.nlm.nih.gov/pubmed/27658219.

Couch, F. J., K. B. Kuchenbaecker, K. Michailidou, G. A. Mendoza-Fandino, S. Nord, J. Lilyquist, C. Olswold, et al. "Identification of Four Novel Susceptibility Loci for Oestrogen Receptor Negative Breast Cancer." Nat Commun 7 (Apr 27 2016): 11375. https://doi.org/10.1038/ncomms11375. https://www.ncbi.nlm.nih.gov/pubmed/27117709.

Darabi, H., J. Beesley, A. Droit, S. Kar, S. Nord, M. Moradi Marjaneh, P. Soucy, et al. "Fine Scale Mapping of the 17q22 Breast Cancer Locus Using Dense Snps, Genotyped within the Collaborative Oncological Gene-Environment Study (Cogs)." Sci Rep 6 (Sep 7 2016): 32512. https://doi.org/10.1038/srep32512. https://www.ncbi.nlm.nih.gov/pubmed/27600471.

de la Hoya, M., O. Soukarieh, I. Lopez-Perolio, A. Vega, L. C. Walker, Y. van Ierland, D. Baralle, et al. "Combined Genetic and Splicing Analysis of Brca1 C.[594-2a>C; 641a>G] Highlights the Relevance of Naturally Occurring in-Frame Transcripts for Developing Disease Gene Variant Classification Algorithms." Hum Mol Genet 25, no. 11 (Jun 1 2016): 2256-68. https://doi.org/10.1093/hmg/ddw094. https://www.ncbi.nlm.nih.gov/pubmed/27008870.

Domchek, S. M., C. Aghajanian, R. Shapira-Frommer, R. K. Schmutzler, M. W. Audeh, M. Friedlander, J. Balmana, et al. "Efficacy and Safety of Olaparib Monotherapy in Germline Brca1/2 Mutation Carriers with Advanced Ovarian Cancer and Three or More Lines of Prior Therapy." Gynecol Oncol 140, no. 2 (Feb 2016): 199-203. https://doi.org/10.1016/j.ygyno.2015.12.020. https://www.ncbi.nlm.nih.gov/pubmed/26723501.

Dunning, A. M., K. Michailidou, K. B. Kuchenbaecker, D. Thompson, J. D. French, J. Beesley, C. S. Healey, et al. "Breast Cancer Risk Variants at 6q25 Display Different Phenotype Associations and Regulate Esr1, Rmnd1 and Ccdc170." Nat Genet 48, no. 4 (Apr 2016): 374-86. https://doi.org/10.1038/ng.3521. https://www.ncbi.nlm.nih.gov/pubmed/26928228.

Easton, D. F., F. Lesueur, B. Decker, K. Michailidou, J. Li, J. Allen, C. Luccarini, et al. "No Evidence That Protein Truncating Variants in Brip1 Are Associated with Breast Cancer Risk: Implications for Gene Panel Testing." J Med Genet 53, no. 5 (May 2016): 298-309. https://doi.org/10.1136/jmedgenet-2015-103529. https://www.ncbi.nlm.nih.gov/pubmed/26921362.

Fackenthal, J. D., T. Yoshimatsu, B. Zhang, G. R. de Garibay, M. Colombo, G. De Vecchi, S. C. Ayoub, et al. "Naturally Occurring Brca2 Alternative Mrna Splicing Events in Clinically Relevant Samples." J Med Genet 53, no. 8 (Aug 2016): 548-58. https://doi.org/10.1136/jmedgenet-2015-103570. https://www.ncbi.nlm.nih.gov/pubmed/27060066.

Fehringer, G., P. Kraft, P. D. Pharoah, R. A. Eeles, N. Chatterjee, F. R. Schumacher, J. M. Schildkraut, et al. "Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations." Cancer Res 76, no. 17 (Sep 1 2016): 5103-14. https://doi.org/10.1158/0008-5472.CAN-15-2980. https://www.ncbi.nlm.nih.gov/pubmed/27197191.

Forbes, J. F., I. Sestak, A. Howell, B. Bonanni, N. Bundred, C. Levy, G. von Minckwitz, et al. "Anastrozole Versus Tamoxifen for the Prevention of Locoregional and Contralateral Breast Cancer in Postmenopausal Women with Locally Excised Ductal Carcinoma in Situ (Ibis-Ii Dcis): A Double-Blind, Randomised Controlled Trial." Lancet 387, no. 10021 (Feb 27 2016): 866-73. https://doi.org/10.1016/S0140-6736(15)01129-0. https://www.ncbi.nlm.nih.gov/pubmed/26686313.

Ghoussaini, M., J. D. French, K. Michailidou, S. Nord, J. Beesley, S. Canisus, K. M. Hillman, et al. "Evidence That the 5p12 Variant Rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through Fgf10 and Mrps30 Regulation." Am J Hum Genet 99, no. 4 (Oct 6 2016): 903-11. https://doi.org/10.1016/j.ajhg.2016.07.017. https://www.ncbi.nlm.nih.gov/pubmed/27640304.

Guo, Y., S. Warren Andersen, X. O. Shu, K. Michailidou, M. K. Bolla, Q. Wang, M. Garcia-Closas, et al. "Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent." PLoS Med 13, no. 8 (Aug 2016): e1002105. https://doi.org/10.1371/journal.pmed.1002105. https://www.ncbi.nlm.nih.gov/pubmed/27551723.

Harter, P., K. Baumann, A. Heimbach, A. Reuss, C. Jackisch, J. Hauke, T. W. Park-Simon, et al. "Mutations of Risk Genes for Ovarian Cancer in Consecutive Ovarian Cancer Patients (Ago Tr-1 Study)." [In English]. International Journal of Gynecological Cancer 26 (Oct 2016): 81-82. <Go to ISI>://WOS:000387109100053.

Horne, H. N., C. C. Chung, H. Zhang, K. Yu, L. Prokunina-Olsson, K. Michailidou, M. K. Bolla, et al. "Fine-Mapping of the 1p11.2 Breast Cancer Susceptibility Locus." PLoS One 11, no. 8 (2016): e0160316. https://doi.org/10.1371/journal.pone.0160316. https://www.ncbi.nlm.nih.gov/pubmed/27556229.

Kar, S. P., J. Beesley, A. Amin Al Olama, K. Michailidou, J. Tyrer, Z. Kote-Jarai, K. Lawrenson, et al. "Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types." Cancer Discov 6, no. 9 (Sep 2016): 1052-67. https://doi.org/10.1158/2159-8290.CD-15-1227. https://www.ncbi.nlm.nih.gov/pubmed/27432226.

Kast, K., K. Rhiem, B. Wappenschmidt, E. Hahnen, J. Hauke, B. Bluemcke, V. Zarghooni, et al. "Prevalence of Brca1/2 Germline Mutations in 21 401 Families with Breast and Ovarian Cancer." J Med Genet 53, no. 7 (Jul 2016): 465-71. https://doi.org/10.1136/jmedgenet-2015-103672. https://www.ncbi.nlm.nih.gov/pubmed/26928436.

Kiechle, M., C. Engel, A. Berling, K. Hebestreit, S. C. Bischoff, R. Dukatz, M. Siniatchkin, et al. "Effects of Lifestyle Intervention in Brca1/2 Mutation Carriers on Nutrition, Bmi, and Physical Fitness (Libre Study): Study Protocol for a Randomized Controlled Trial." Trials 17 (Jul 29 2016): 368. https://doi.org/10.1186/s13063-016-1504-0. https://www.ncbi.nlm.nih.gov/pubmed/27473440.

Kiechle, M., C. Engel, A. Berling, K. Hebestreit, S. Bischoff, R. Dukatz, W. D. Gerber, et al. "Lifestyle Intervention in Brca1/2 Mutation Carriers: Study Protocol for a Prospective, Randomized, Controlled Clinical Feasibility Trial (Libre-1 Study)." Pilot Feasibility Stud 2 (2016): 74. https://doi.org/10.1186/s40814-016-0114-7. https://www.ncbi.nlm.nih.gov/pubmed/28031860.

Krug, B., M. Hellmich, A. Ulhaas, S. Kramer, K. Rhiem, V. Zarghooni, M. Pusken, et al. "Vacuum-Assisted Breast Biopsies (Vab) Carried out on an Open 1.0t Mr Imager: Influence of Patient and Target Characteristics on the Procedural and Clinical Results." Eur J Radiol 85, no. 6 (Jun 2016): 1157-66. https://doi.org/10.1016/j.ejrad.2016.02.030. https://www.ncbi.nlm.nih.gov/pubmed/27161066.

Lawrenson, K., S. Kar, K. McCue, K. Kuchenbaeker, K. Michailidou, J. Tyrer, J. Beesley, et al. "Functional Mechanisms Underlying Pleiotropic Risk Alleles at the 19p13.1 Breast-Ovarian Cancer Susceptibility Locus." Nat Commun 7 (Sep 7 2016): 12675. https://doi.org/10.1038/ncomms12675. https://www.ncbi.nlm.nih.gov/pubmed/27601076.

Lei, J., A. Rudolph, K. B. Moysich, S. Behrens, E. L. Goode, M. K. Bolla, J. Dennis, et al. "Genetic Variation in the Immunosuppression Pathway Genes and Breast Cancer Susceptibility: A Pooled Analysis of 42,510 Cases and 40,577 Controls from the Breast Cancer Association Consortium." Hum Genet 135, no. 1 (Jan 2016): 137-54. https://doi.org/10.1007/s00439-015-1616-8. https://www.ncbi.nlm.nih.gov/pubmed/26621531.

Madorsky-Feldman, D., M. Sklair-Levy, T. Perri, Y. Laitman, S. Paluch-Shimon, R. Schmutzler, K. Rhiem, et al. "An International Survey of Surveillance Schemes for Unaffected Brca1 and Brca2 Mutation Carriers." Breast Cancer Res Treat 157, no. 2 (Jun 2016): 319-27. https://doi.org/10.1007/s10549-016-3805-0. https://www.ncbi.nlm.nih.gov/pubmed/27117159.

Ovarian Cancer Association Consortium, Breast Cancer Association Consortium, Brca Consortium of Modifiers of, Brca, A. Hollestelle, F. H. van der Baan, A. Berchuck, S. E. Johnatty, et al. "No Clinical Utility of Kras Variant Rs61764370 for Ovarian or Breast Cancer." Gynecol Oncol 141, no. 2 (May 2016): 386-401. https://doi.org/10.1016/j.ygyno.2015.04.034. https://www.ncbi.nlm.nih.gov/pubmed/25940428.

Pelttari, L. M., S. Khan, M. Vuorela, J. I. Kiiski, S. Vilske, V. Nevanlinna, S. Ranta, et al. "Rad51b in Familial Breast Cancer." PLoS One 11, no. 5 (2016): e0153788. https://doi.org/10.1371/journal.pone.0153788. https://www.ncbi.nlm.nih.gov/pubmed/27149063.

Petridis, C., M. N. Brook, V. Shah, K. Kohut, P. Gorman, M. Caneppele, D. Levi, et al. "Genetic Predisposition to Ductal Carcinoma in Situ of the Breast." Breast Cancer Res 18, no. 1 (Feb 17 2016): 22. https://doi.org/10.1186/s13058-016-0675-7. https://www.ncbi.nlm.nih.gov/pubmed/26884359.

Schmidt, M. K., F. Hogervorst, R. van Hien, S. Cornelissen, A. Broeks, M. A. Adank, H. Meijers, et al. "Age- and Tumor Subtype-Specific Breast Cancer Risk Estimates for Chek2*1100delc Carriers." J Clin Oncol 34, no. 23 (Aug 10 2016): 2750-60. https://doi.org/10.1200/JCO.2016.66.5844. https://www.ncbi.nlm.nih.gov/pubmed/27269948.

Rebbeck, T. R., T. M. Friebel, N. Mitra, F. Wan, S. Chen, I. L. Andrulis, P. Apostolou, et al. "Inheritance of Deleterious Mutations at Both Brca1 and Brca2 in an International Sample of 32,295 Women." [In English]. Breast Cancer Research 18 (Nov 11 2016). https://doi.org/ARTN 112 10.1186/s13058-016-0768-3. <Go to ISI>://WOS:000390899600001.

Shi, J., Y. Zhang, W. Zheng, K. Michailidou, M. Ghoussaini, M. K. Bolla, Q. Wang, et al. "Fine-Scale Mapping of 8q24 Locus Identifies Multiple Independent Risk Variants for Breast Cancer." Int J Cancer 139, no. 6 (Sep 15 2016): 1303-17. https://doi.org/10.1002/ijc.30150. https://www.ncbi.nlm.nih.gov/pubmed/27087578.

Silvestri, V., D. Barrowdale, A. M. Mulligan, S. L. Neuhausen, S. Fox, B. Y. Karlan, G. Mitchell, et al. "Male Breast Cancer in Brca1 and Brca2 Mutation Carriers: Pathology Data from the Consortium of Investigators of Modifiers of Brca1/2." Breast Cancer Res 18, no. 1 (Feb 9 2016): 15. https://doi.org/10.1186/s13058-016-0671-y. https://www.ncbi.nlm.nih.gov/pubmed/26857456.

Tang, Q., T. Holland-Letz, A. Slynko, K. Cuk, F. Marme, S. Schott, J. Heil, et al. "DNA Methylation Array Analysis Identifies Breast Cancer Associated Rptor, Mgrn1 and Rapsn Hypomethylation in Peripheral Blood DNA." Oncotarget 7, no. 39 (Sep 27 2016): 64191-202. https://doi.org/10.18632/oncotarget.11640. https://www.ncbi.nlm.nih.gov/pubmed/27577081.

Vigorito, E., K. B. Kuchenbaecker, J. Beesley, J. Adlard, B. A. Agnarsson, I. L. Andrulis, B. K. Arun, et al. "Fine-Scale Mapping at 9p22.2 Identifies Candidate Causal Variants That Modify Ovarian Cancer Risk in Brca1 and Brca2 Mutation Carriers." PLoS One 11, no. 7 (2016): e0158801. https://doi.org/10.1371/journal.pone.0158801. https://www.ncbi.nlm.nih.gov/pubmed/27463617.

Wyszynski, A., C. C. Hong, K. Lam, K. Michailidou, C. Lytle, S. Yao, Y. Zhang, et al. "An Intergenic Risk Locus Containing an Enhancer Deletion in 2q35 Modulates Breast Cancer Risk by Deregulating Igfbp5 Expression." Hum Mol Genet 25, no. 17 (Sep 1 2016): 3863-76. https://doi.org/10.1093/hmg/ddw223. https://www.ncbi.nlm.nih.gov/pubmed/27402876.

Zeng, C., X. Guo, J. Long, K. B. Kuchenbaecker, A. Droit, K. Michailidou, M. Ghoussaini, et al. "Identification of Independent Association Signals and Putative Functional Variants for Breast Cancer Risk through Fine-Scale Mapping of the 12p11 Locus." Breast Cancer Res 18, no. 1 (Jun 21 2016): 64. https://doi.org/10.1186/s13058-016-0718-0. https://www.ncbi.nlm.nih.gov/pubmed/27459855.

Zhao, Z., W. Wen, K. Michailidou, M. K. Bolla, Q. Wang, B. Zhang, J. Long, et al. "Association of Genetic Susceptibility Variants for Type 2 Diabetes with Breast Cancer Risk in Women of European Ancestry." Cancer Causes Control 27, no. 5 (May 2016): 679-93. https://doi.org/10.1007/s10552-016-0741-6. https://www.ncbi.nlm.nih.gov/pubmed/27053251.

2015

Becker, M., K. Oehler, C. J. Partsch, U. Ulmen, R. Schmutzler, H. Cammann, and V. Hesse. "Hormonal 'Minipuberty' Influences the Somatic Development of Boys but Not of Girls up to the Age of 6 Years." Clin Endocrinol (Oxf) 83, no. 5 (Nov 2015): 694-701. https://doi.org/10.1111/cen.12827. https://www.ncbi.nlm.nih.gov/pubmed/26031777.

Blanco, I., K. Kuchenbaecker, D. Cuadras, X. Wang, D. Barrowdale, G. R. de Garibay, P. Librado, et al. "Assessing Associations between the Aurka-Hmmr-Tpx2-Tubg1 Functional Module and Breast Cancer Risk in Brca1/2 Mutation Carriers." PLoS One 10, no. 4 (2015): e0120020. https://doi.org/10.1371/journal.pone.0120020. https://www.ncbi.nlm.nih.gov/pubmed/25830658.

Blein, S., C. Bardel, V. Danjean, L. McGuffog, S. Healey, D. Barrowdale, A. Lee, et al. "An Original Phylogenetic Approach Identified Mitochondrial Haplogroup T1a1 as Inversely Associated with Breast Cancer Risk in Brca2 Mutation Carriers." Breast Cancer Res 17 (Apr 25 2015): 61. https://doi.org/10.1186/s13058-015-0567-2. https://www.ncbi.nlm.nih.gov/pubmed/25925750.

Darabi, H., K. McCue, J. Beesley, K. Michailidou, S. Nord, S. Kar, K. Humphreys, et al. "Polymorphisms in a Putative Enhancer at the 10q21.2 Breast Cancer Risk Locus Regulate Nrbf2 Expression." Am J Hum Genet 97, no. 1 (Jul 2 2015): 22-34. https://doi.org/10.1016/j.ajhg.2015.05.002. https://www.ncbi.nlm.nih.gov/pubmed/26073781.

Day, F. R., K. S. Ruth, D. J. Thompson, K. L. Lunetta, N. Pervjakova, D. I. Chasman, L. Stolk, et al. "Large-Scale Genomic Analyses Link Reproductive Aging to Hypothalamic Signaling, Breast Cancer Susceptibility and Brca1-Mediated DNA Repair." Nat Genet 47, no. 11 (Nov 2015): 1294-303. https://doi.org/10.1038/ng.3412. https://www.ncbi.nlm.nih.gov/pubmed/26414677.

Day, Felix R., Katherine S. Ruth, Deborah J. Thompson, Kathryn L. Lunetta, Natalia Pervjakova, Daniel I. Chasman, Lisette Stolk, et al. "Large-Scale Genomic Analyses Link Reproductive Aging to Hypothalamic Signaling, Breast Cancer Susceptibility, and Brca1-Mediated DNA Repair." Obstetrical & Gynecological Survey 70, no. 12 (2015): 758-62. https://doi.org/10.1097/01.ogx.0000473766.71624.99.

Eccles, D. M., G. Mitchell, A. N. Monteiro, R. Schmutzler, F. J. Couch, A. B. Spurdle, E. B. Gomez-Garcia, and Enigma Clinical Working Group. "Brca1 and Brca2 Genetic Testing-Pitfalls and Recommendations for Managing Variants of Uncertain Clinical Significance." Ann Oncol 26, no. 10 (Oct 2015): 2057-65. https://doi.org/10.1093/annonc/mdv278. https://www.ncbi.nlm.nih.gov/pubmed/26153499.

Glubb, D. M., M. J. Maranian, K. Michailidou, K. A. Pooley, K. B. Meyer, S. Kar, S. Carlebur, et al. "Fine-Scale Mapping of the 5q11.2 Breast Cancer Locus Reveals at Least Three Independent Risk Variants Regulating Map3k1." Am J Hum Genet 96, no. 1 (Jan 8 2015): 5-20. https://doi.org/10.1016/j.ajhg.2014.11.009. https://www.ncbi.nlm.nih.gov/pubmed/25529635.

Guo, X., J. Long, C. Zeng, K. Michailidou, M. Ghoussaini, M. K. Bolla, Q. Wang, et al. "Fine-Scale Mapping of the 4q24 Locus Identifies Two Independent Loci Associated with Breast Cancer Risk." Cancer Epidemiol Biomarkers Prev 24, no. 11 (Nov 2015): 1680-91. https://doi.org/10.1158/1055-9965.EPI-15-0363. https://www.ncbi.nlm.nih.gov/pubmed/26354892.

Huster, Stefan; Schmutzler, Rita K. "Rechtliche Aspekte Aktueller Entwicklungen in Der Molekulargenetischen Tumordiagnostik." Der Gynäkologe 48, no. 9 (2015): 630-31. https://doi.org/10.1007/s00129-015-3776-y.

Kaufman, B., R. Shapira-Frommer, R. K. Schmutzler, M. W. Audeh, M. Friedlander, J. Balmana, G. Mitchell, et al. "Olaparib Monotherapy in Patients with Advanced Cancer and a Germline Brca1/2 Mutation." J Clin Oncol 33, no. 3 (Jan 20 2015): 244-50. https://doi.org/10.1200/JCO.2014.56.2728. https://www.ncbi.nlm.nih.gov/pubmed/25366685.

Kuchenbaecker, K. B., S. J. Ramus, J. Tyrer, A. Lee, H. C. Shen, J. Beesley, K. Lawrenson, et al. "Identification of Six New Susceptibility Loci for Invasive Epithelial Ovarian Cancer." Nat Genet 47, no. 2 (Feb 2015): 164-71. https://doi.org/10.1038/ng.3185. https://www.ncbi.nlm.nih.gov/pubmed/25581431.

Lin, W. Y., N. J. Camp, M. Ghoussaini, J. Beesley, K. Michailidou, J. L. Hopper, C. Apicella, et al. "Identification and Characterization of Novel Associations in the Casp8/Als2cr12 Region on Chromosome 2 with Breast Cancer Risk." Hum Mol Genet 24, no. 1 (Jan 1 2015): 285-98. https://doi.org/10.1093/hmg/ddu431. https://www.ncbi.nlm.nih.gov/pubmed/25168388.

Mavaddat, N., P. D. Pharoah, K. Michailidou, J. Tyrer, M. N. Brook, M. K. Bolla, Q. Wang, et al. "Prediction of Breast Cancer Risk Based on Profiling with Common Genetic Variants." J Natl Cancer Inst 107, no. 5 (May 2015). https://doi.org/10.1093/jnci/djv036. https://www.ncbi.nlm.nih.gov/pubmed/25855707.

Michailidou, K., J. Beesley, S. Lindstrom, S. Canisius, J. Dennis, M. J. Lush, M. J. Maranian, et al. "Genome-Wide Association Analysis of More Than 120,000 Individuals Identifies 15 New Susceptibility Loci for Breast Cancer." Nat Genet 47, no. 4 (Apr 2015): 373-80. https://doi.org/10.1038/ng.3242. https://www.ncbi.nlm.nih.gov/pubmed/25751625.

Orr, N., F. Dudbridge, N. Dryden, S. Maguire, D. Novo, E. Perrakis, N. Johnson, et al. "Fine-Mapping Identifies Two Additional Breast Cancer Susceptibility Loci at 9q31.2." Hum Mol Genet 24, no. 10 (May 15 2015): 2966-84. https://doi.org/10.1093/hmg/ddv035. https://www.ncbi.nlm.nih.gov/pubmed/25652398.

Peterlongo, P., I. Catucci, M. Colombo, L. Caleca, E. Mucaki, M. Bogliolo, M. Marin, et al. "Fancm C.5791c>T Nonsense Mutation (Rs144567652) Induces Exon Skipping, Affects DNA Repair Activity and Is a Familial Breast Cancer Risk Factor." Hum Mol Genet 24, no. 18 (Sep 15 2015): 5345-55. https://doi.org/10.1093/hmg/ddv251. https://www.ncbi.nlm.nih.gov/pubmed/26130695.

Peterlongo, P., J. Chang-Claude, K. B. Moysich, A. Rudolph, R. K. Schmutzler, J. Simard, P. Soucy, et al. "Candidate Genetic Modifiers for Breast and Ovarian Cancer Risk in Brca1 and Brca2 Mutation Carriers." Cancer Epidemiol Biomarkers Prev 24, no. 1 (Jan 2015): 308-16. https://doi.org/10.1158/1055-9965.EPI-14-0532. https://www.ncbi.nlm.nih.gov/pubmed/25336561.

Rebbeck, T. R., N. Mitra, F. Wan, O. M. Sinilnikova, S. Healey, L. McGuffog, S. Mazoyer, et al. "Association of Type and Location of Brca1 and Brca2 Mutations with Risk of Breast and Ovarian Cancer." JAMA 313, no. 13 (Apr 7 2015): 1347-61. https://doi.org/10.1001/jama.2014.5985. https://www.ncbi.nlm.nih.gov/pubmed/25849179.

Rhiem, K. and R.K. Schmutzler. "Risikofaktoren Und Prävention Des Mammakarzinoms." Der Onkologe 21, no. 3 (2015): 202-10. https://doi.org/10.1007/s00761-014-2837-5.

Roessler, J., O. Ammerpohl, J. Gutwein, D. Steinemann, B. Schlegelberger, V. Weyer, M. Sariyar, et al. "The Cpg Island Methylator Phenotype in Breast Cancer Is Associated with the Lobular Subtype." Epigenomics 7, no. 2 (2015): 187-99. https://doi.org/10.2217/epi.14.74. https://www.ncbi.nlm.nih.gov/pubmed/25347269.

———. "Mitteilungen Des Netzwerk Gegen Darmkebs E.V." Der Gastroenterologe 10, no. 4 (2015): 360-62. https://doi.org/10.1007/s11377-015-1053-1.

 ADDIN EN.CITE.DATA (Cuzick et al., 2014; Kaufman et al., 2015; " Ovarian Cancer Association Consortium, B.C.A.C., et al., No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer," 2015; Rebbeck et al., 2015; " Risikoprädiktion: Vom Umgang mit dem Krankheitsrisiko," 2015; Schmutzler, 2015; Vilhjalmsson et al., 2015)[1-7]

Schmutzler, R.K. "New Avenues in Secondary and Tertiary Prevention of Breast Cancer." Breast Care (Basel) 10, no. 1 (Feb 2015): 6. https://doi.org/10.1159/000380984. https://www.ncbi.nlm.nih.gov/pubmed/25960718.

Schmutzler, Rita Katharina, and Alfons Meindl. "Erste Zielgerichtete Therapie Bei Ovarialkarzinom Für Brca1/2-Mutationsträgerinnen Zugelassen." Medizinische Genetik 27, no. 2 (2015): 228-30. https://doi.org/10.1007/s11825-015-0047-1.

Vilhjalmsson, B. J., J. Yang, H. K. Finucane, A. Gusev, S. Lindstrom, S. Ripke, G. Genovese, et al. "Modeling Linkage Disequilibrium Increases Accuracy of Polygenic Risk Scores." Am J Hum Genet 97, no. 4 (Oct 1 2015): 576-92. https://doi.org/10.1016/j.ajhg.2015.09.001. https://www.ncbi.nlm.nih.gov/pubmed/26430803.

Yang, R., K. Pfutze, M. Zucknick, C. Sutter, B. Wappenschmidt, F. Marme, B. Qu, et al. "DNA Methylation Array Analyses Identified Breast Cancer-Associated Hyal2 Methylation in Peripheral Blood." Int J Cancer 136, no. 8 (Apr 15 2015): 1845-55. https://doi.org/10.1002/ijc.29205. https://www.ncbi.nlm.nih.gov/pubmed/25213452.

Zhang, B., X. O. Shu, R. J. Delahanty, C. Zeng, K. Michailidou, M. K. Bolla, Q. Wang, et al. "Height and Breast Cancer Risk: Evidence from Prospective Studies and Mendelian Randomization." J Natl Cancer Inst 107, no. 11 (Nov 2015). https://doi.org/10.1093/jnci/djv219. https://www.ncbi.nlm.nih.gov/pubmed/26296642.

2014

Ahsan, H., J. Halpern, M. G. Kibriya, B. L. Pierce, L. Tong, E. Gamazon, V. McGuire, et al. "A Genome-Wide Association Study of Early-Onset Breast Cancer Identifies Pfkm as a Novel Breast Cancer Gene and Supports a Common Genetic Spectrum for Breast Cancer at Any Age." Cancer Epidemiol Biomarkers Prev 23, no. 4 (Apr 2014): 658-69. https://doi.org/10.1158/1055-9965.EPI-13-0340. https://www.ncbi.nlm.nih.gov/pubmed/24493630.

Bancroft, E. K., E. C. Page, E. Castro, H. Lilja, A. Vickers, D. Sjoberg, M. Assel, et al. "Targeted Prostate Cancer Screening in Brca1 and Brca2 Mutation Carriers: Results from the Initial Screening Round of the Impact Study." Eur Urol 66, no. 3 (Sep 2014): 489-99. https://doi.org/10.1016/j.eururo.2014.01.003. https://www.ncbi.nlm.nih.gov/pubmed/24484606.

Bosse, K., M. Graeser, A. Gossmann, M. Hackenbroch, R. K. Schmutzler, and K. Rhiem. "Supplemental Screening Ultrasound Increases Cancer Detection Yield in Brca1 and Brca2 Mutation Carriers." Arch Gynecol Obstet 289, no. 3 (Mar 2014): 663-70. https://doi.org/10.1007/s00404-013-3022-6. https://www.ncbi.nlm.nih.gov/pubmed/24045978.

Cuzick, J., I. Sestak, J. F. Forbes, M. Dowsett, J. Knox, S. Cawthorn, C. Saunders, et al. "Anastrozole for Prevention of Breast Cancer in High-Risk Postmenopausal Women (Ibis-Ii): An International, Double-Blind, Randomised Placebo-Controlled Trial." Lancet 383, no. 9922 (Mar 22 2014): 1041-8. https://doi.org/10.1016/S0140-6736(13)62292-8. https://www.ncbi.nlm.nih.gov/pubmed/24333009.

Gevensleben, H., V. Bossung, A. Meindl, B. Wappenschmidt, N. de Gregorio, A. Osorio, A. Romero, et al. "Pathological Features of Breast and Ovarian Cancers in Rad51c Germline Mutation Carriers." Virchows Arch 465, no. 3 (Sep 2014): 365-9. https://doi.org/10.1007/s00428-014-1619-1. https://www.ncbi.nlm.nih.gov/pubmed/24993905.

Johnson, N., F. Dudbridge, N. Orr, L. Gibson, M. E. Jones, M. J. Schoemaker, E. J. Folkerd, et al. "Genetic Variation at Cyp3a Is Associated with Age at Menarche and Breast Cancer Risk: A Case-Control Study." Breast Cancer Res 16, no. 3 (May 26 2014): R51. https://doi.org/10.1186/bcr3662. https://www.ncbi.nlm.nih.gov/pubmed/24887515

Kast, K., R. K. Schmutzler, K. Rhiem, M. Kiechle, C. Fischer, D. Niederacher, N. Arnold, et al. "Validation of the Manchester Scoring System for Predicting Brca1/2 Mutations in 9,390 Families Suspected of Having Hereditary Breast and Ovarian Cancer." Int J Cancer 135, no. 10 (Nov 15 2014): 2352-61. https://doi.org/10.1002/ijc.28875. https://www.ncbi.nlm.nih.gov/pubmed/24700448.

Kaufman, B., R. Shapira-Frommer, R. K. Schmutzler, M. W. Audeh, M. Friedlander, J. Balmana, G. Mitchell, et al. "Olaparib Monotherapy in Patients with Advanced Cancer and a Germline Brca1/2 Mutation." J Clin Oncol 33, no. 3 (Jan 20 2015): 244-50. https://doi.org/10.1200/JCO.2014.56.2728. https://www.ncbi.nlm.nih.gov/pubmed/25366685.

Khan, S., D. Greco, K. Michailidou, R. L. Milne, T. A. Muranen, T. Heikkinen, K. Aaltonen, et al. "Microrna Related Polymorphisms and Breast Cancer Risk." PLoS One 9, no. 11 (2014): e109973. https://doi.org/10.1371/journal.pone.0109973. https://www.ncbi.nlm.nih.gov/pubmed/25390939

Killick, E., M. Tymrakiewicz, C. Cieza-Borrella, P. Smith, D. J. Thompson, K. A. Pooley, D. F. Easton, et al. "Telomere Length Shows No Association with Brca1 and Brca2 Mutation Status." [In English]. Plos One 9, no. 1 (Jan 29 2014). https://doi.org/ARTN e86659

Kuchenbaecker, K. B., S. L. Neuhausen, M. Robson, D. Barrowdale, L. McGuffog, A. M. Mulligan, I. L. Andrulis, et al. "Associations of Common Breast Cancer Susceptibility Alleles with Risk of Breast Cancer Subtypes in Brca1 and Brca2 Mutation Carriers." Breast Cancer Res 16, no. 6 (Dec 31 2014): 3416. https://doi.org/10.1186/s13058-014-0492-9. https://www.ncbi.nlm.nih.gov/pubmed/25919761.

Osorio, A., R. L. Milne, K. Kuchenbaecker, T. Vaclova, G. Pita, R. Alonso, P. Peterlongo, et al. "DNA Glycosylases Involved in Base Excision Repair May Be Associated with Cancer Risk in Brca1 and Brca2 Mutation Carriers." PLoS Genet 10, no. 4 (Apr 2014): e1004256. https://doi.org/10.1371/journal.pgen.1004256. https://www.ncbi.nlm.nih.gov/pubmed/24698998.

Rhiem, K., and R. Schmutzler. "Impact of Prophylactic Mastectomy in Brca1/2 Mutation Carriers." Breast Care (Basel) 9, no. 6 (Dec 2014): 385-9. https://doi.org/10.1159/000369592. https://www.ncbi.nlm.nih.gov/pubmed/25759620.

Rhiem, K. and R.K. Schmutzler. "[Risk-Adapted Surveillance: Focus on Familial Breast and Ovarian Cancer]." Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 57, no. 3 (Mar 2014): 307-11. https://doi.org/10.1007/s00103-013-1910-3. Risikoadaptierte Fruherkennung : Schwerpunkt: Familiarer Brust- und Eierstockkrebs. https://www.ncbi.nlm.nih.gov/pubmed/24562705.

Sawyer, E., R. Roylance, C. Petridis, M. N. Brook, S. Nowinski, E. Papouli, O. Fletcher, et al. "Genetic Predisposition to in Situ and Invasive Lobular Carcinoma of the Breast." PLoS Genet 10, no. 4 (Apr 2014): e1004285. https://doi.org/10.1371/journal.pgen.1004285. https://www.ncbi.nlm.nih.gov/pubmed/24743323.

Schellong, G., M. Riepenhausen, K. Ehlert, J. Bramswig, W. Dorffel, Disease German Working Group on the Long-Term Sequelae of Hodgkin's, R. K. Schmutzler, et al. "Breast Cancer in Young Women after Treatment for Hodgkin's Disease During Childhood or Adolescence--an Observational Study with up to 33-Year Follow-Up." Dtsch Arztebl Int 111, no. 1-2 (Jan 6 2014): 3-9. https://doi.org/10.3238/arztebl.2014.0003. https://www.ncbi.nlm.nih.gov/pubmed/24565270.

Spurdle, A. B., F. J. Couch, M. T. Parsons, L. McGuffog, D. Barrowdale, M. K. Bolla, Q. Wang, et al. "Refined Histopathological Predictors of Brca1 and Brca2 Mutation Status: A Large-Scale Analysis of Breast Cancer Characteristics from the Bcac, Cimba, and Enigma Consortia." Breast Cancer Res 16, no. 6 (Dec 23 2014): 3419. https://doi.org/10.1186/s13058-014-0474-y. https://www.ncbi.nlm.nih.gov/pubmed/25857409.

Wockel, A., W. Janni, F. Porzsolt, and R. Schmutzler. "Benefits and Risks of Breast Cancer Screening." Oncol Res Treat 37 Suppl 3 (2014): 21-8. https://doi.org/10.1159/000363595. https://www.ncbi.nlm.nih.gov/pubmed/25195829

2013

Bojesen, S. E., K. A. Pooley, S. E. Johnatty, J. Beesley, K. Michailidou, J. P. Tyrer, S. L. Edwards, et al. "Multiple Independent Variants at the Tert Locus Are Associated with Telomere Length and Risks of Breast and Ovarian Cancer." Nat Genet 45, no. 4 (Apr 2013): 371-84, 84e1-2. https://doi.org/10.1038/ng.2566. https://www.ncbi.nlm.nih.gov/pubmed/23535731.

Complexo, M. C. Southey, D. J. Park, T. Nguyen-Dumont, I. Campbell, E. Thompson, A. H. Trainer, et al. "Complexo: Identifying the Missing Heritability of Breast Cancer Via Next Generation Collaboration." Breast Cancer Res 15, no. 3 (Jun 21 2013): 402. https://doi.org/10.1186/bcr3434. https://www.ncbi.nlm.nih.gov/pubmed/23809231.

Couch, F. J., X. Wang, L. McGuffog, A. Lee, C. Olswold, K. B. Kuchenbaecker, P. Soucy, et al. "Genome-Wide Association Study in Brca1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk." PLoS Genet 9, no. 3 (2013): e1003212. https://doi.org/10.1371/journal.pgen.1003212. https://www.ncbi.nlm.nih.gov/pubmed/23544013.

French, J. D., M. Ghoussaini, S. L. Edwards, K. B. Meyer, K. Michailidou, S. Ahmed, S. Khan, et al. "Functional Variants at the 11q13 Risk Locus for Breast Cancer Regulate Cyclin D1 Expression through Long-Range Enhancers." Am J Hum Genet 92, no. 4 (Apr 4 2013): 489-503. https://doi.org/10.1016/j.ajhg.2013.01.002. https://www.ncbi.nlm.nih.gov/pubmed/23540573.

Garcia-Closas, M., F. J. Couch, S. Lindstrom, K. Michailidou, M. K. Schmidt, M. N. Brook, N. Orr, et al. "Genome-Wide Association Studies Identify Four Er Negative-Specific Breast Cancer Risk Loci." Nat Genet 45, no. 4 (Apr 2013): 392-8, 98e1-2. https://doi.org/10.1038/ng.2561. https://www.ncbi.nlm.nih.gov/pubmed/23535733.

Gaudet, M. M., K. B. Kuchenbaecker, J. Vijai, R. J. Klein, T. Kirchhoff, L. McGuffog, D. Barrowdale, et al. "Identification of a Brca2-Specific Modifier Locus at 6p24 Related to Breast Cancer Risk." PLoS Genet 9, no. 3 (2013): e1003173. https://doi.org/10.1371/journal.pgen.1003173. https://www.ncbi.nlm.nih.gov/pubmed/23544012.

Guidugli, L., V. S. Pankratz, N. Singh, J. Thompson, C. A. Erding, C. Engel, R. Schmutzler, et al. "A Classification Model for Brca2 DNA Binding Domain Missense Variants Based on Homology-Directed Repair Activity." Cancer Res 73, no. 1 (Jan 1 2013): 265-75. https://doi.org/10.1158/0008-5472.CAN-12-2081. https://www.ncbi.nlm.nih.gov/pubmed/23108138.

Meindl, A., K. Rhiem, C. Engel, N. Ditsch, K. Kast, E. Hahnen, and R. K. Schmutzler. "Klinik Und Genetik Des Familiären Brust- Und Eierstockkrebses." Medizinische Genetik 25, no. 2 (2013): 259-77. https://doi.org/10.1007/s11825-013-0390-z.

Meyer, K. B., M. O'Reilly, K. Michailidou, S. Carlebur, S. L. Edwards, J. D. French, R. Prathalingham, et al. "Fine-Scale Mapping of the Fgfr2 Breast Cancer Risk Locus: Putative Functional Variants Differentially Bind Foxa1 and E2f1." Am J Hum Genet 93, no. 6 (Dec 5 2013): 1046-60. https://doi.org/10.1016/j.ajhg.2013.10.026. https://www.ncbi.nlm.nih.gov/pubmed/24290378.

Michailidou, K., P. Hall, A. Gonzalez-Neira, M. Ghoussaini, J. Dennis, R. L. Milne, M. K. Schmidt, et al. "Large-Scale Genotyping Identifies 41 New Loci Associated with Breast Cancer Risk." Nat Genet 45, no. 4 (Apr 2013): 353-61, 61e1-2. https://doi.org/10.1038/ng.2563. https://www.ncbi.nlm.nih.gov/pubmed/23535729.

Reintjes, N., Y. Li, A. Becker, E. Rohmann, R. Schmutzler, and B. Wollnik. "Activating Somatic Fgfr2 Mutations in Breast Cancer." PLoS One 8, no. 3 (2013): e60264. https://doi.org/10.1371/journal.pone.0060264. https://www.ncbi.nlm.nih.gov/pubmed/23527311.

Schmutzler, R. K., K. Rhiem, and C. Engel. "Contralateral Breast Cancer Risk in Brca1/2-Positive Families Needs to Be Adjusted for Phenocopy Rates Particularly in Second-Degree Untested Relatives Response." [In English]. Breast Cancer Research 15, no. 1 (2013). <Go to ISI>://WOS:000320158100009.

Schnurbein, G., J. Hauke, B. Wappenschmidt, N. Weber-Lassalle, S. Engert, H. Hellebrand, L. Garbes, et al. "Rad51c Deletion Screening Identifies a Recurrent Gross Deletion in Breast Cancer and Ovarian Cancer Families." Breast Cancer Res 15, no. 6 (Dec 20 2013): R120. https://doi.org/10.1186/bcr3589. https://www.ncbi.nlm.nih.gov/pubmed/24359560.

2012

Antoniou, A. C., K. B. Kuchenbaecker, P. Soucy, J. Beesley, X. Chen, L. McGuffog, A. Lee, et al. "Common Variants at 12p11, 12q24, 9p21, 9q31.2 and in Znf365 Are Associated with Breast Cancer Risk for Brca1 and/or Brca2 Mutation Carriers." Breast Cancer Res 14, no. 1 (Feb 20 2012): R33. https://doi.org/10.1186/bcr3121. https://www.ncbi.nlm.nih.gov/pubmed/22348646.

Becker, A. A., M. K. Graeser, C. Landwehr, T. Hilger, W. Baus, B. Wappenschmidt, A. Meindl, R. G. Weber, and R. K. Schmutzler. "A 24-Color Metaphase-Based Radiation Assay Discriminates Heterozygous Brca2 Mutation Carriers from Controls by Chromosomal Radiosensitivity." Breast Cancer Res Treat 135, no. 1 (Aug 2012): 167-75. https://doi.org/10.1007/s10549-012-2119-0. https://www.ncbi.nlm.nih.gov/pubmed/22729890.

Couch, F. J., M. M. Gaudet, A. C. Antoniou, S. J. Ramus, K. B. Kuchenbaecker, P. Soucy, J. Beesley, et al. "Common Variants at the 19p13.1 and Znf365 Loci Are Associated with Er Subtypes of Breast Cancer and Ovarian Cancer Risk in Brca1 and Brca2 Mutation Carriers." Cancer Epidemiol Biomarkers Prev 21, no. 4 (Apr 2012): 645-57. https://doi.org/10.1158/1055-9965.EPI-11-0888. https://www.ncbi.nlm.nih.gov/pubmed/22351618.

Dick, M. G., B. Versmold, C. Engel, A. Meindl, N. Arnold, R. Varon-Mateeva, C. Sutter, et al. "Association of Death Receptor 4 Variant (683a > C) with Ovarian Cancer Risk in Brca1 Mutation Carriers." Int J Cancer 130, no. 6 (Mar 15 2012): 1314-8. https://doi.org/10.1002/ijc.26134. https://www.ncbi.nlm.nih.gov/pubmed/21484799.

Ding, Y. C., L. McGuffog, S. Healey, E. Friedman, Y. Laitman, S. Paluch-Shimon, B. Kaufman, et al. "A Nonsynonymous Polymorphism in Irs1 Modifies Risk of Developing Breast and Ovarian Cancers in Brca1 and Ovarian Cancer in Brca2 Mutation Carriers." Cancer Epidemiol Biomarkers Prev 21, no. 8 (Aug 2012): 1362-70. https://doi.org/10.1158/1055-9965.EPI-12-0229. https://www.ncbi.nlm.nih.gov/pubmed/22729394.

Fischer, C., C. Engel, C. Sutter, S. Zachariae, R. Schmutzler, A. Meindl, S. Heidemann, et al. "Brca1/2 Testing: Uptake, Phenocopies, and Strategies to Improve Detection Rates in Initially Negative Families." Clin Genet 82, no. 5 (Nov 2012): 478-83. https://doi.org/10.1111/j.1399-0004.2011.01788.x. https://www.ncbi.nlm.nih.gov/pubmed/21919902.

Fischer, C., K. Kuchenbacker, C. Engel, S. Zachariae, K. Rhiem, A. Meindl, N. Rahner, et al. "Evaluating the Performance of the Breast Cancer Genetic Risk Models Boadicea, Ibis, Brcapro and Claus for Predicting Brca1/2 Mutation Carrier Probabilities: A Study Based on 7352 Families from the German Hereditary Breast and Ovarian Cancer Consortium." J Med Genet 50, no. 6 (Jun 2013): 360-7. https://doi.org/10.1136/jmedgenet-2012-101415. https://www.ncbi.nlm.nih.gov/pubmed/23564750.

Ghoussaini, M., O. Fletcher, K. Michailidou, C. Turnbull, M. K. Schmidt, E. Dicks, J. Dennis, et al. "Genome-Wide Association Analysis Identifies Three New Breast Cancer Susceptibility Loci." Nat Genet 44, no. 3 (Jan 22 2012): 312-8. https://doi.org/10.1038/ng.1049. https://www.ncbi.nlm.nih.gov/pubmed/22267197.

Heidemann, S., C. Fischer, C. Engel, B. Fischer, L. Harder, B. Schlegelberger, D. Niederacher, et al. "Double Heterozygosity for Mutations in Brca1 and Brca2 in German Breast Cancer Patients: Implications on Test Strategies and Clinical Management." Breast Cancer Res Treat 134, no. 3 (Aug 2012): 1229-39. https://doi.org/10.1007/s10549-012-2050-4. https://www.ncbi.nlm.nih.gov/pubmed/22535016.

Hein, R., M. Maranian, J. L. Hopper, M. K. Kapuscinski, M. C. Southey, D. J. Park, M. K. Schmidt, et al. "Comparison of 6q25 Breast Cancer Hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (Bcac)." PLoS One 7, no. 8 (2012): e42380. https://doi.org/10.1371/journal.pone.0042380. https://www.ncbi.nlm.nih.gov/pubmed/22879957.

Jakubowska, A., D. Rozkrut, A. Antoniou, U. Hamann, R. J. Scott, L. McGuffog, S. Healy, et al. "Association of Phb 1630 C>T and Mthfr 677 C>T Polymorphisms with Breast and Ovarian Cancer Risk in Brca1/2 Mutation Carriers: Results from a Multicenter Study." Br J Cancer 106, no. 12 (Jun 5 2012): 2016-24. https://doi.org/10.1038/bjc.2012.160. https://www.ncbi.nlm.nih.gov/pubmed/22669161.

Laitman, Y., K. B. Kuchenbaecker, J. Rantala, F. Hogervorst, S. Peock, A. K. Godwin, A. Arason, et al. "The Kl-Vs Sequence Variant of Klotho and Cancer Risk in Brca1 and Brca2 Mutation Carriers." Breast Cancer Res Treat 132, no. 3 (Apr 2012): 1119-26. https://doi.org/10.1007/s10549-011-1938-8. https://www.ncbi.nlm.nih.gov/pubmed/22212556.

Lambrechts, D., T. Truong, C. Justenhoven, M. K. Humphreys, J. Wang, J. L. Hopper, G. S. Dite, et al. "11q13 Is a Susceptibility Locus for Hormone Receptor Positive Breast Cancer." Hum Mutat 33, no. 7 (Jul 2012): 1123-32. https://doi.org/10.1002/humu.22089. https://www.ncbi.nlm.nih.gov/pubmed/22461340.

Mavaddat, N., D. Barrowdale, I. L. Andrulis, S. M. Domchek, D. Eccles, H. Nevanlinna, S. J. Ramus, et al. "Pathology of Breast and Ovarian Cancers among Brca1 and Brca2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of Brca1/2 (Cimba)." Cancer Epidemiol Biomarkers Prev 21, no. 1 (Jan 2012): 134-47. https://doi.org/10.1158/1055-9965.EPI-11-0775. https://www.ncbi.nlm.nih.gov/pubmed/22144499.

Meindl, Alfons, Katharina Eirich, Stefanie Engert, Alexandra Becker, Daniela Endt, Nina Ditsch, Rita K. Schmutzler, and Detlev Schindler. "Germline Rad51c Mutations Confer Susceptibility to Ovarian Cancer." Nature Genetics 44, no. 5 (2012): 476-76. https://doi.org/10.1038/ng.2223.

Osorio, A., D. Endt, F. Fernandez, K. Eirich, M. de la Hoya, R. Schmutzler, T. Caldes, et al. "Predominance of Pathogenic Missense Variants in the Rad51c Gene Occurring in Breast and Ovarian Cancer Families." Hum Mol Genet 21, no. 13 (Jul 1 2012): 2889-98. https://doi.org/10.1093/hmg/dds115. https://www.ncbi.nlm.nih.gov/pubmed/22451500.

Ramus, S. J., A. C. Antoniou, K. B. Kuchenbaecker, P. Soucy, J. Beesley, X. Chen, L. McGuffog, et al. "Ovarian Cancer Susceptibility Alleles and Risk of Ovarian Cancer in Brca1 and Brca2 Mutation Carriers." Hum Mutat 33, no. 4 (Apr 2012): 690-702. https://doi.org/10.1002/humu.22025. https://www.ncbi.nlm.nih.gov/pubmed/22253144.

Rhiem, K., C. Engel, M. Graeser, S. Zachariae, K. Kast, M. Kiechle, N. Ditsch, et al. "The Risk of Contralateral Breast Cancer in Patients from Brca1/2 Negative High Risk Families as Compared to Patients from Brca1 or Brca2 Positive Families: A Retrospective Cohort Study." Breast Cancer Res 14, no. 6 (Dec 7 2012): R156. https://doi.org/10.1186/bcr3369. https://www.ncbi.nlm.nih.gov/pubmed/23216834.

Rhiem, K., K. Pfeifer, R. K. Schmutzler, and M. Kiechle. "Risk-Reducing Surgery in Women at Risk for Familial Breast or Ovarian Cancer." Geburtshilfe Frauenheilkd 72, no. 9 (Sep 2012): 833-39. https://doi.org/10.1055/s-0032-1315362. https://www.ncbi.nlm.nih.gov/pubmed/26640291

———. "Research Commission." [In German]. Geburtshilfe Und Frauenheilkunde 72, no. 9 (Sep 2012): 781-81. <Go to ISI>://WOS:000309603000004.

Schmutzler, R.K., Dietz, D., Jöckel K-H. „Hoffnung und Fluch der Genanalyse.“ Deutsches Ärzteblatt, (Jun 2012) Zur Publikation.

Siddiq, A., F. J. Couch, G. K. Chen, S. Lindstrom, D. Eccles, R. C. Millikan, K. Michailidou, et al. "A Meta-Analysis of Genome-Wide Association Studies of Breast Cancer Identifies Two Novel Susceptibility Loci at 6q14 and 20q11." Hum Mol Genet 21, no. 24 (Dec 15 2012): 5373-84. https://doi.org/10.1093/hmg/dds381. https://www.ncbi.nlm.nih.gov/pubmed/22976474.

Spurdle, A. B., P. J. Whiley, B. Thompson, B. Feng, S. Healey, M. A. Brown, C. Pettigrew, et al. "Brca1 R1699q Variant Displaying Ambiguous Functional Abrogation Confers Intermediate Breast and Ovarian Cancer Risk." J Med Genet 49, no. 8 (Aug 2012): 525-32. https://doi.org/10.1136/jmedgenet-2012-101037. https://www.ncbi.nlm.nih.gov/pubmed/22889855.

Stevens, K. N., Z. Fredericksen, C. M. Vachon, X. Wang, S. Margolin, A. Lindblom, H. Nevanlinna, et al. "19p13.1 Is a Triple-Negative-Specific Breast Cancer Susceptibility Locus." Cancer Res 72, no. 7 (Apr 1 2012): 1795-803. https://doi.org/10.1158/0008-5472.CAN-11-3364. https://www.ncbi.nlm.nih.gov/pubmed/22331459.

Wappenschmidt, B., A. A. Becker, J. Hauke, U. Weber, S. Engert, J. Kohler, K. Kast, et al. "Analysis of 30 Putative Brca1 Splicing Mutations in Hereditary Breast and Ovarian Cancer Families Identifies Exonic Splice Site Mutations That Escape in Silico Prediction." PLoS One 7, no. 12 (2012): e50800. https://doi.org/10.1371/journal.pone.0050800. https://www.ncbi.nlm.nih.gov/pubmed/23239986.

Warren, H., F. Dudbridge, O. Fletcher, N. Orr, N. Johnson, J. L. Hopper, C. Apicella, et al. "9q31.2-Rs865686 as a Susceptibility Locus for Estrogen Receptor-Positive Breast Cancer: Evidence from the Breast Cancer Association Consortium." Cancer Epidemiol Biomarkers Prev 21, no. 10 (Oct 2012): 1783-91. https://doi.org/10.1158/1055-9965.EPI-12-0526. https://www.ncbi.nlm.nih.gov/pubmed/22859399.

2011

Antoniou, A. C., C. Kartsonaki, O. M. Sinilnikova, P. Soucy, L. McGuffog, S. Healey, A. Lee, et al. "Common Alleles at 6q25.1 and 1p11.2 Are Associated with Breast Cancer Risk for Brca1 and Brca2 Mutation Carriers." Hum Mol Genet 20, no. 16 (Aug 15 2011): 3304-21. https://doi.org/10.1093/hmg/ddr226. https://www.ncbi.nlm.nih.gov/pubmed/21593217

Cox, D. G., J. Simard, D. Sinnett, Y. Hamdi, P. Soucy, M. Ouimet, L. Barjhoux, et al. "Common Variants of the Brca1 Wild-Type Allele Modify the Risk of Breast Cancer in Brca1 Mutation Carriers." Hum Mol Genet 20, no. 23 (Dec 1 2011): 4732-47. https://doi.org/10.1093/hmg/ddr388. https://www.ncbi.nlm.nih.gov/pubmed/21890493.

Domchek, S. M., G. Mitchell, G. J. Lindeman, N. M. Tung, J. Balmana, S. J. Isakoff, R. Schmutzler, et al. "Challenges to the Development of New Agents for Molecularly Defined Patient Subsets: Lessons from Brca1/2-Associated Breast Cancer." J Clin Oncol 29, no. 32 (Nov 10 2011): 4224-6. https://doi.org/10.1200/JCO.2011.36.8134. https://www.ncbi.nlm.nih.gov/pubmed/21931031.

Hellebrand, H., C. Sutter, E. Honisch, E. Gross, B. Wappenschmidt, C. Schem, H. Deissler, et al. "Germline Mutations in the Palb2 Gene Are Population Specific and Occur with Low Frequencies in Familial Breast Cancer." Hum Mutat 32, no. 6 (Jun 2011): E2176-88. https://doi.org/10.1002/humu.21478. https://www.ncbi.nlm.nih.gov/pubmed/21618343.

Im, K. M., T. Kirchhoff, X. Wang, T. Green, C. Y. Chow, J. Vijai, J. Korn, et al. "Haplotype Structure in Ashkenazi Jewish Brca1 and Brca2 Mutation Carriers." Hum Genet 130, no. 5 (Nov 2011): 685-99. https://doi.org/10.1007/s00439-011-1003-z. https://www.ncbi.nlm.nih.gov/pubmed/21597964.

Kast, K., Meindl, A., Schmutzler, R." Familiärer Brust- Und Eierstockkrebs – Was Gibt Es Neues?." Best practice Onkologie (Jan 2011) Zur Publikation.

Maxwell, C. A., J. Benitez, L. Gomez-Baldo, A. Osorio, N. Bonifaci, R. Fernandez-Ramires, S. V. Costes, et al. "Interplay between Brca1 and Rhamm Regulates Epithelial Apicobasal Polarization and May Influence Risk of Breast Cancer." PLoS Biol 9, no. 11 (Nov 2011): e1001199. https://doi.org/10.1371/journal.pbio.1001199. https://www.ncbi.nlm.nih.gov/pubmed/22110403.

Meindl, A., N. Ditsch, K. Kast, K. Rhiem, and R. K. Schmutzler. "Hereditary Breast and Ovarian Cancer: New Genes, New Treatments, New Concepts." Dtsch Arztebl Int 108, no. 19 (May 2011): 323-30. https://doi.org/10.3238/arztebl.2011.0323. https://www.ncbi.nlm.nih.gov/pubmed/21637635.

Milne, R. L., E. L. Goode, M. Garcia-Closas, F. J. Couch, G. Severi, R. Hein, Z. Fredericksen, et al. "Confirmation of 5p12 as a Susceptibility Locus for Progesterone-Receptor-Positive, Lower Grade Breast Cancer." Cancer Epidemiol Biomarkers Prev 20, no. 10 (Oct 2011): 2222-31. https://doi.org/10.1158/1055-9965.EPI-11-0569. https://www.ncbi.nlm.nih.gov/pubmed/21795498.

Mulligan, A. M., F. J. Couch, D. Barrowdale, S. M. Domchek, D. Eccles, H. Nevanlinna, S. J. Ramus, et al. "Common Breast Cancer Susceptibility Alleles Are Associated with Tumour Subtypes in Brca1 and Brca2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of Brca1/2." Breast Cancer Res 13, no. 6 (2011): R110. https://doi.org/10.1186/bcr3052. https://www.ncbi.nlm.nih.gov/pubmed/22053997.

Ramus, S. J., C. Kartsonaki, S. A. Gayther, P. D. Pharoah, O. M. Sinilnikova, J. Beesley, X. Chen, et al. "Genetic Variation at 9p22.2 and Ovarian Cancer Risk for Brca1 and Brca2 Mutation Carriers." J Natl Cancer Inst 103, no. 2 (Jan 19 2011): 105-16. https://doi.org/10.1093/jnci/djq494. https://www.ncbi.nlm.nih.gov/pubmed/21169536.

Rhiem, K., D. Foth, B. Wappenschmidt, H. Gevensleben, R. Buttner, U. Ulrich, and R. K. Schmutzler. "Risk-Reducing Salpingo-Oophorectomy in Brca1 and Brca2 Mutation Carriers." Arch Gynecol Obstet 283, no. 3 (Mar 2011): 623-7. https://doi.org/10.1007/s00404-010-1476-3. https://www.ncbi.nlm.nih.gov/pubmed/20428881.

Rhiem, K., Schmutzler, R.K. " Hereditäre Mamma- Und Genitalkarzinome." Frauenheilkunde up2date  (Jun 2011) zur Publikation.

Schmutzler, Rita; Domchek, Susan M. "Preventive Surgery." Breast Care 6, no. 2 (2011): 153-53. https://doi.org/10.1159/000329015.

Stevens, K. N., M. Garcia-Closas, Z. Fredericksen, M. Kosel, V. S. Pankratz, J. L. Hopper, G. S. Dite, et al. "Evaluation of Variation in the Phosphoinositide-3-Kinase Catalytic Subunit Alpha Oncogene and Breast Cancer Risk." Br J Cancer 105, no. 12 (Dec 6 2011): 1934-9. https://doi.org/10.1038/bjc.2011.448. https://www.ncbi.nlm.nih.gov/pubmed/22033276.

von Minckwitz, G., S. Loibl, C. Jackisch, S. Paepke, C. Nestle-Kraemling, M. P. Lux, N. Maass, et al. "The Giss Trial: A Phase Ii Prevention Trial of Screening Plus Goserelin, Ibandronate, Versus Screening Alone in Premenopausal Women at Increased Risk of Breast Cancer." Cancer Epidemiol Biomarkers Prev 20, no. 10 (Oct 2011): 2141-9. https://doi.org/10.1158/1055-9965.EPI-11-0222. https://www.ncbi.nlm.nih.gov/pubmed/21795500.

Wang, F., Z. Hu, R. Yang, J. Tang, Y. Liu, K. Hemminki, C. Sutter, et al. "A Variant Affecting Mirnas Binding in the Circadian Gene Neuronal Pas Domain Protein 2 (Npas2) Is Not Associated with Breast Cancer Risk." Breast Cancer Res Treat 127, no. 3 (Jun 2011): 769-75. https://doi.org/10.1007/s10549-010-1157-8. https://www.ncbi.nlm.nih.gov/pubmed/21140207.

Wang, F. R., Z. B. Hu, R. X. Yang, J. H. Tang, Y. Liu, K. Hemminki, C. Sutter, et al. "Further Studies Based on Better Design Are Needed to Explore the Association of Npas2 Gene Polymorphisms with Breast Cancer Rebuttal." [In English]. Breast Cancer Research and Treatment 127, no. 2 (Jun 2011): 567-68. <Go to ISI>://WOS:000290227900029.

Yang, R., M. Dick, F. Marme, A. Schneeweiss, A. Langheinz, K. Hemminki, C. Sutter, et al. "Genetic Variants within Mir-126 and Mir-335 Are Not Associated with Breast Cancer Risk." Breast Cancer Res Treat 127, no. 2 (Jun 2011): 549-54. https://doi.org/10.1007/s10549-010-1244-x. https://www.ncbi.nlm.nih.gov/pubmed/21046227.

2010

Antoniou, A. C., J. Beesley, L. McGuffog, O. M. Sinilnikova, S. Healey, S. L. Neuhausen, Y. C. Ding, et al. "Common Breast Cancer Susceptibility Alleles and the Risk of Breast Cancer for Brca1 and Brca2 Mutation Carriers: Implications for Risk Prediction." Cancer Res 70, no. 23 (Dec 1 2010): 9742-54. https://doi.org/10.1158/0008-5472.CAN-10-1907. https://www.ncbi.nlm.nih.gov/pubmed/21118973.

Antoniou, A. C., X. Wang, Z. S. Fredericksen, L. McGuffog, R. Tarrell, O. M. Sinilnikova, S. Healey, et al. "A Locus on 19p13 Modifies Risk of Breast Cancer in Brca1 Mutation Carriers and Is Associated with Hormone Receptor-Negative Breast Cancer in the General Population." Nat Genet 42, no. 10 (Oct 2010): 885-92. https://doi.org/10.1038/ng.669. https://www.ncbi.nlm.nih.gov/pubmed/20852631.

Audeh, M. William, James Carmichael, Richard T. Penson, Michael Friedlander, Bethan Powell, Katherine M. Bell-McGuinn, Clare Scott, et al. "Oral Poly(Adp-Ribose) Polymerase Inhibitor Olaparib in Patients with Brca1 or Brca2 Mutations and Recurrent Ovarian Cancer: A Proof-of-Concept Trial." The Lancet 376, no. 9737 (2010): 245-51. https://doi.org/10.1016/s0140-6736(10)60893-8.

Catucci, I., R. Yang, P. Verderio, S. Pizzamiglio, L. Heesen, K. Hemminki, C. Sutter, et al. "Evaluation of Snps in Mir-146a, Mir196a2 and Mir-499 as Low-Penetrance Alleles in German and Italian Familial Breast Cancer Cases." Hum Mutat 31, no. 1 (Jan 2010): E1052-7. https://doi.org/10.1002/humu.21141. https://www.ncbi.nlm.nih.gov/pubmed/19847796.

Engel, C., B. Versmold, B. Wappenschmidt, J. Simard, D. F. Easton, S. Peock, M. Cook, et al. "Association of the Variants Casp8 D302h and Casp10 V410i with Breast and Ovarian Cancer Risk in Brca1 and Brca2 Mutation Carriers." Cancer Epidemiol Biomarkers Prev 19, no. 11 (Nov 2010): 2859-68. https://doi.org/10.1158/1055-9965.EPI-10-0517. https://www.ncbi.nlm.nih.gov/pubmed/20978178.

Fletcher, O., N. Johnson, I. dos Santos Silva, N. Orr, A. Ashworth, H. Nevanlinna, T. Heikkinen, et al. "Missense Variants in Atm in 26,101 Breast Cancer Cases and 29,842 Controls." Cancer Epidemiol Biomarkers Prev 19, no. 9 (Sep 2010): 2143-51. https://doi.org/10.1158/1055-9965.EPI-10-0374. https://www.ncbi.nlm.nih.gov/pubmed/20826828.

Flucke, U., M. T. Flucke, L. Hoy, E. Breuer, R. Goebbels, K. Rhiem, R. Schmutzler, et al. "Distinguishing Medullary Carcinoma of the Breast from High-Grade Hormone Receptor-Negative Invasive Ductal Carcinoma: An Immunohistochemical Approach." Histopathology 56, no. 7 (Jun 2010): 852-9. https://doi.org/10.1111/j.1365-2559.2010.03555.x. https://www.ncbi.nlm.nih.gov/pubmed/20636789

Gaudet, M. M., T. Kirchhoff, T. Green, J. Vijai, J. M. Korn, C. Guiducci, A. V. Segre, et al. "Common Genetic Variants and Modification of Penetrance of Brca2-Associated Breast Cancer." PLoS Genet 6, no. 10 (Oct 28 2010): e1001183. https://doi.org/10.1371/journal.pgen.1001183. https://www.ncbi.nlm.nih.gov/pubmed/21060860.

Hemminki, K., B. Muller-Myhsok, P. Lichtner, C. Engel, B. Chen, B. Burwinkel, A. Forsti, et al. "Low-Risk Variants Fgfr2, Tnrc9 and Lsp1 in German Familial Breast Cancer Patients." Int J Cancer 126, no. 12 (Jun 15 2010): 2858-62. https://doi.org/10.1002/ijc.24986. https://www.ncbi.nlm.nih.gov/pubmed/19856316.

Kast, K., W. Distler, and R. Schmutzler. "Aktuelle Empfehlungen Zur Prävention Und Therapie Des Familiären Mammakarzinoms." Geburtshilfe und Frauenheilkunde 70, no. 08 (2010): 634-39. https://doi.org/10.1055/s-0030-1250167.

Liedtke, Cornelia. "Tripel-Negatives Mammakarzinom." Breast Care 5, no. 5 (2010): 359-63. https://doi.org/10.1159/000321918.

Meindl, A., H. Hellebrand, C. Wiek, V. Erven, B. Wappenschmidt, D. Niederacher, M. Freund, et al. "Germline Mutations in Breast and Ovarian Cancer Pedigrees Establish Rad51c as a Human Cancer Susceptibility Gene." Nat Genet 42, no. 5 (May 2010): 410-4. https://doi.org/10.1038/ng.569. https://www.ncbi.nlm.nih.gov/pubmed/20400964.

Rhiem, K., Schmutzler, R.K. " Das Familiäre Mammakarzinom." Der Gynäkologe (Jan2010) Zur Publikation.

Rhiem, K., U. Todt, B. Wappenschmidt, A. Klein, E. Wardelmann, and R. K. Schmutzler. "Sporadic Breast Carcinomas with Somatic Brca1 Gene Deletions Share Genotype/Phenotype Features with Familial Breast Carcinomas." Anticancer Res 30, no. 9 (Sep 2010): 3445-9. https://www.ncbi.nlm.nih.gov/pubmed/20944121.

Schmutzler, R. K., C. Engel, and I. Schreer. "Screening in Women at Elevated Risk for Breast Cancer." J Clin Oncol 28, no. 30 (Oct 20 2010): e607-8; author reply e09-10. https://doi.org/10.1200/JCO.2010.29.8034. https://www.ncbi.nlm.nih.gov/pubmed/20855835.

Tchatchou, S., A. Riedel, S. Lyer, J. Schmutzhard, O. Strobel-Freidekind, S. Gronert-Sum, C. Mietag, et al. "Identification of a Dmbt1 Polymorphism Associated with Increased Breast Cancer Risk and Decreased Promoter Activity." Hum Mutat 31, no. 1 (Jan 2010): 60-6. https://doi.org/10.1002/humu.21134. https://www.ncbi.nlm.nih.gov/pubmed/19830809.

Tutt, A., M. Robson, J. E. Garber, S. M. Domchek, M. W. Audeh, J. N. Weitzel, M. Friedlander, et al. "The Future Is 'Parp' - Phase-Ii-Activity of Parp Inhibitor among Patients with Brca-Deficient Breast Cancer." [In English]. Breast Care 5, no. 5 (2010): 364-65. <Go to ISI>://WOS:000283857600014.

Tutt, Andrew, Mark Robson, Judy E. Garber, Susan M. Domchek, M. William Audeh, Jeffrey N. Weitzel, Michael Friedlander, et al. "Oral Poly(Adp-Ribose) Polymerase Inhibitor Olaparib in Patients with Brca1 or Brca2 Mutations and Advanced Breast Cancer: A Proof-of-Concept Trial." The Lancet 376, no. 9737 (2010): 235-44. https://doi.org/10.1016/s0140-6736(10)60892-6.

Verderio, P., S. Pizzamiglio, M. C. Southey, A. B. Spurdle, J. L. Hopper, X. Chen, J. Beesley, et al. "A Brca1 Promoter Variant (Rs11655505) and Breast Cancer Risk." J Med Genet 47, no. 4 (Apr 2010): 268-70. https://doi.org/10.1136/jmg.2009.073544. https://www.ncbi.nlm.nih.gov/pubmed/20413709.

Walker, L. C., Z. S. Fredericksen, X. Wang, R. Tarrell, V. S. Pankratz, N. M. Lindor, J. Beesley, et al. "Evidence for Smad3 as a Modifier of Breast Cancer Risk in Brca2 Mutation Carriers." Breast Cancer Res 12, no. 6 (2010): R102. https://doi.org/10.1186/bcr2785. https://www.ncbi.nlm.nih.gov/pubmed/21114847.

Wang, X., V. S. Pankratz, Z. Fredericksen, R. Tarrell, M. Karaus, L. McGuffog, P. D. Pharaoh, et al. "Common Variants Associated with Breast Cancer in Genome-Wide Association Studies Are Modifiers of Breast Cancer Risk in Brca1 and Brca2 Mutation Carriers." Hum Mol Genet 19, no. 14 (Jul 15 2010): 2886-97. https://doi.org/10.1093/hmg/ddq174. https://www.ncbi.nlm.nih.gov/pubmed/20418484.

Yang, R., B. Schlehe, K. Hemminki, C. Sutter, P. Bugert, B. Wappenschmidt, J. Volkmann, et al. "A Genetic Variant in the Pre-Mir-27a Oncogene Is Associated with a Reduced Familial Breast Cancer Risk." Breast Cancer Res Treat 121, no. 3 (Jun 2010): 693-702. https://doi.org/10.1007/s10549-009-0633-5. https://www.ncbi.nlm.nih.gov/pubmed/19921425.

2009

Ahmed, S., G. Thomas, M. Ghoussaini, C. S. Healey, M. K. Humphreys, R. Platte, J. Morrison, et al. "Newly Discovered Breast Cancer Susceptibility Loci on 3p24 and 17q23.2." Nat Genet 41, no. 5 (May 2009): 585-90. https://doi.org/10.1038/ng.354. https://www.ncbi.nlm.nih.gov/pubmed/19330027.

Antoniou, A. C., O. M. Sinilnikova, L. McGuffog, S. Healey, H. Nevanlinna, T. Heikkinen, J. Simard, et al. "Common Variants in Lsp1, 2q35 and 8q24 and Breast Cancer Risk for Brca1 and Brca2 Mutation Carriers." Hum Mol Genet 18, no. 22 (Nov 15 2009): 4442-56. https://doi.org/10.1093/hmg/ddp372. https://www.ncbi.nlm.nih.gov/pubmed/19656774.

Dunning, A. M., C. S. Healey, C. Baynes, A. T. Maia, S. Scollen, A. Vega, R. Rodriguez, et al. "Association of Esr1 Gene Tagging Snps with Breast Cancer Risk." Hum Mol Genet 18, no. 6 (Mar 15 2009): 1131-9. https://doi.org/10.1093/hmg/ddn429. https://www.ncbi.nlm.nih.gov/pubmed/19126777.

Gaudet, M. M., R. L. Milne, A. Cox, N. J. Camp, E. L. Goode, M. K. Humphreys, A. M. Dunning, et al. "Five Polymorphisms and Breast Cancer Risk: Results from the Breast Cancer Association Consortium." Cancer Epidemiol Biomarkers Prev 18, no. 5 (May 2009): 1610-6. https://doi.org/10.1158/1055-9965.EPI-08-0745. https://www.ncbi.nlm.nih.gov/pubmed/19423537.

Graeser, M., K. Bosse, M. Brosig, C. Engel, R. K. Schmutzler, Breast German Consortium for Hereditary, and Cancer Ovarian. "Association of Hormone Receptor Status with Grading, Age of Onset, and Tumor Size in Brca1-Associated Breast Cancer." Virchows Arch 454, no. 5 (May 2009): 519-24. https://doi.org/10.1007/s00428-009-0760-8. https://www.ncbi.nlm.nih.gov/pubmed/19381686.

Graeser, M. K., C. Engel, K. Rhiem, D. Gadzicki, U. Bick, K. Kast, U. G. Froster, et al. "Contralateral Breast Cancer Risk in Brca1 and Brca2 Mutation Carriers." J Clin Oncol 27, no. 35 (Dec 10 2009): 5887-92. https://doi.org/10.1200/JCO.2008.19.9430. https://www.ncbi.nlm.nih.gov/pubmed/19858402.

Hartmaier, R. J., S. Tchatchou, A. S. Richter, J. Wang, S. E. McGuire, T. C. Skaar, J. M. Rae, et al. "Nuclear Receptor Coregulator Snp Discovery and Impact on Breast Cancer Risk." BMC Cancer 9 (Dec 14 2009): 438. https://doi.org/10.1186/1471-2407-9-438. https://www.ncbi.nlm.nih.gov/pubmed/20003447.

Kast, K., Distler, W.,  Schmutzler, R.K. "Risiko Für Brust- Und Eierstockkrebs: Bedeutung, Beratung, Genetische Testung Und Klinische Empfehlungen Zur Prävention. "Der Gynäkologe (Nov 2009) Zur Publikation.

Klein, A., C. Olendrowitz, R. Schmutzler, J. Hampl, P. M. Schlag, N. Maass, N. Arnold, et al. "Identification of Brain- and Bone-Specific Breast Cancer Metastasis Genes." Cancer Lett 276, no. 2 (Apr 18 2009): 212-20. https://doi.org/10.1016/j.canlet.2008.11.017. https://www.ncbi.nlm.nih.gov/pubmed/19114293.

Milne, R. L., J. Benitez, H. Nevanlinna, T. Heikkinen, K. Aittomaki, C. Blomqvist, J. I. Arias, et al. "Risk of Estrogen Receptor-Positive and -Negative Breast Cancer and Single-Nucleotide Polymorphism 2q35-Rs13387042." J Natl Cancer Inst 101, no. 14 (Jul 15 2009): 1012-8. https://doi.org/10.1093/jnci/djp167. https://www.ncbi.nlm.nih.gov/pubmed/19567422.

Osorio, A., R. L. Milne, G. Pita, P. Peterlongo, T. Heikkinen, J. Simard, G. Chenevix-Trench, et al. "Evaluation of a Candidate Breast Cancer Associated Snp in Ercc4 as a Risk Modifier in Brca1 and Brca2 Mutation Carriers. Results from the Consortium of Investigators of Modifiers of Brca1/Brca2 (Cimba)." Br J Cancer 101, no. 12 (Dec 15 2009): 2048-54. https://doi.org/10.1038/sj.bjc.6605416. https://www.ncbi.nlm.nih.gov/pubmed/19920816.

Rebbeck, T. R., A. C. Antoniou, T. C. Llopis, H. Nevanlinna, K. Aittomaki, J. Simard, A. B. Spurdle, et al. "No Association of Tgfb1 L10p Genotypes and Breast Cancer Risk in Brca1 and Brca2 Mutation Carriers: A Multi-Center Cohort Study." Breast Cancer Res Treat 115, no. 1 (May 2009): 185-92. https://doi.org/10.1007/s10549-008-0064-8. https://www.ncbi.nlm.nih.gov/pubmed/18523885.

Rhiem, K., B. Wappenschmidt, K. Bosse, H. Koppler, A. N. Tutt, and R. K. Schmutzler. "Platinum Sensitivity in a Brca1 Mutation Carrier with Advanced Breast Cancer." Clin Oncol (R Coll Radiol) 21, no. 6 (Aug 2009): 448-50. https://doi.org/10.1016/j.clon.2009.01.006. https://www.ncbi.nlm.nih.gov/pubmed/19249193.

Sadr-Nabavi, A., J. Ramser, J. Volkmann, J. Naehrig, F. Wiesmann, B. Betz, H. Hellebrand, et al. "Decreased Expression of Angiogenesis Antagonist Efemp1 in Sporadic Breast Cancer Is Caused by Aberrant Promoter Methylation and Points to an Impact of Efemp1 as Molecular Biomarker." Int J Cancer 124, no. 7 (Apr 1 2009): 1727-35. https://doi.org/10.1002/ijc.24108. https://www.ncbi.nlm.nih.gov/pubmed/19115204.

Shephard, N. D., R. Abo, S. H. Rigas, B. Frank, W. Y. Lin, I. W. Brock, A. Shippen, et al. "A Breast Cancer Risk Haplotype in the Caspase-8 Gene." Cancer Res 69, no. 7 (Apr 1 2009): 2724-8. https://doi.org/10.1158/0008-5472.CAN-08-4266. https://www.ncbi.nlm.nih.gov/pubmed/19318553.

Sinilnikova, O. M., A. C. Antoniou, J. Simard, S. Healey, M. Leone, D. Sinnett, A. B. Spurdle, et al. "The Tp53 Arg72pro and Mdm2 309g>T Polymorphisms Are Not Associated with Breast Cancer Risk in Brca1 and Brca2 Mutation Carriers." Br J Cancer 101, no. 8 (Oct 20 2009): 1456-60. https://doi.org/10.1038/sj.bjc.6605279. https://www.ncbi.nlm.nih.gov/pubmed/19707196.

Stang, A., and R. K. Schmutzler. "The Epidemiology and Aetiology of Female Breast Cancer." Breast Care (Basel) 4, no. 2 (2009): 73-74. https://doi.org/10.1159/000212103. https://www.ncbi.nlm.nih.gov/pubmed/20847882.

Tchatchou, S., A. Jung, K. Hemminki, C. Sutter, B. Wappenschmidt, P. Bugert, B. H. Weber, et al. "A Variant Affecting a Putative Mirna Target Site in Estrogen Receptor (Esr) 1 Is Associated with Breast Cancer Risk in Premenopausal Women." Carcinogenesis 30, no. 1 (Jan 2009): 59-64. https://doi.org/10.1093/carcin/bgn253. https://www.ncbi.nlm.nih.gov/pubmed/19028706.

Yang, R., B. Chen, K. Hemminki, B. Wappenschmidt, C. Engel, C. Sutter, N. Ditsch, et al. "Polymorphisms in Brca2 Resulting in Aberrant Codon-Usage and Their Analysis on Familial Breast Cancer Risk." Breast Cancer Res Treat 118, no. 2 (Nov 2009): 407-13. https://doi.org/10.1007/s10549-009-0348-7. https://www.ncbi.nlm.nih.gov/pubmed/19229607.

2008

Albert, U. S., H. Altland, V. Duda, J. Engel, M. Geraedts, S. Heywang-Kobrunner, D. Holzel, et al. "2008 Update of the Guideline: Early Detection of Breast Cancer in Germany." J Cancer Res Clin Oncol 135, no. 3 (Mar 2009): 339-54. https://doi.org/10.1007/s00432-008-0450-y. https://www.ncbi.nlm.nih.gov/pubmed/18661152.

"[Guideline for the Early Detection of Breast Cancer in Germany 2008. Recommendations from the Short Version]." Chirurg 79, no. 6 (Jun 2008): 589-94. https://doi.org/10.1007/s00104-008-1548-0.

Stufe-3-Leitlinie Brustkrebs-Fruherkennung in Deutschland 2008 : Auszug aus der Kurzfassung: Handlungsempfehlungen. https://www.ncbi.nlm.nih.gov/pubmed/18463837.

"[Summary of the Updated Stage 3 Guideline for Early Detection of Breast Cancer in Germany 2008]." Rofo 180, no. 5 (May 2008): 455-65. https://doi.org/10.1055/s-2008-1027320.

Kurzfassung der aktualisierten stufe-3-leitlinie brustkrebs-fruherkennung in Deutschland 2008. https://www.ncbi.nlm.nih.gov/pubmed/18438746.

Albert, U. S., H. Altland, V. Duda, J. Engel, M. Geraedts, S. Heywang-Köbrunner, D. Hölzel, et al. "Kurzfassung Der Aktualisierten Stufe-3-Leitlinie Brustkrebs-Früherkennung in Deutschland 2008." Geburtshilfe und Frauenheilkunde 68, no. 3 (2008): 251-61. https://doi.org/10.1055/s-2008-1038511.

Albert, U. S., H. Altland, V. F. Duda, J. Engel, M. Geraedts, S. Heywang-Köbrunner, D. Hölzel, et al. "Brustkrebs-Früherkennung in Deutschland." Der Onkologe 14, no. 5 (2008): 461-77. https://doi.org/10.1007/s00761-008-1351-z.

Antoniou, A. C., A. B. Spurdle, O. M. Sinilnikova, S. Healey, K. A. Pooley, R. K. Schmutzler, B. Versmold, et al. "Common Breast Cancer-Predisposition Alleles Are Associated with Breast Cancer Risk in Brca1 and Brca2 Mutation Carriers." Am J Hum Genet 82, no. 4 (Apr 2008): 937-48. https://doi.org/10.1016/j.ajhg.2008.02.008. https://www.ncbi.nlm.nih.gov/pubmed/18355772

Bürki N., Schmutzler, R., „Hereditärer Brust- und Eierstockkrebs –Interdisziplinäre Beratung, Diagnostik und Therapie in der Schweiz.“ Schweizer Zeitschrift für Onkologie, (Jun 2008) Zur Publikation.

Engert, S., B. Wappenschmidt, B. Betz, K. Kast, M. Kutsche, H. Hellebrand, T. O. Goecke, et al. "Mlpa Screening in the Brca1 Gene from 1,506 German Hereditary Breast Cancer Cases: Novel Deletions, Frequent Involvement of Exon 17, and Occurrence in Single Early-Onset Cases." Hum Mutat 29, no. 7 (Jul 2008): 948-58. https://doi.org/10.1002/humu.20723. https://www.ncbi.nlm.nih.gov/pubmed/18431737.

Frank, B., S. H. Rigas, J. L. Bermejo, M. Wiestler, K. Wagner, K. Hemminki, M. W. Reed, et al. "The Casp8 -652 6n Del Promoter Polymorphism and Breast Cancer Risk: A Multicenter Study." Breast Cancer Res Treat 111, no. 1 (Sep 2008): 139-44. https://doi.org/10.1007/s10549-007-9752-z. https://www.ncbi.nlm.nih.gov/pubmed/17891485.

Frank, B., M. Wiestler, S. Kropp, K. Hemminki, A. B. Spurdle, C. Sutter, B. Wappenschmidt, et al. "Association of a Common Akap9 Variant with Breast Cancer Risk: A Collaborative Analysis." J Natl Cancer Inst 100, no. 6 (Mar 19 2008): 437-42. https://doi.org/10.1093/jnci/djn037. https://www.ncbi.nlm.nih.gov/pubmed/18334708.

Friederici, A. D., A. Pannekamp, C. J. Partsch, U. Ulmen, K. Oehler, R. Schmutzler, and V. Hesse. "Sex Hormone Testosterone Affects Language Organization in the Infant Brain." Neuroreport 19, no. 3 (Feb 12 2008): 283-6. https://doi.org/10.1097/WNR.0b013e3282f5105a. https://www.ncbi.nlm.nih.gov/pubmed/18303567.

Gossmann, A., C. Bangard, M. Warm, R. K. Schmutzler, P. Mallmann, and K. J. Lackner. "Real-Time Mr-Guided Wire Localization of Breast Lesions by Using an Open 1.0-T Imager: Initial Experience." Radiology 247, no. 2 (May 2008): 535-42. https://doi.org/10.1148/radiol.2472071039. https://www.ncbi.nlm.nih.gov/pubmed/18349317.

Heitmann, C., I. Richter-Heine, and A. M. Feller. "Brustrekonstruktion Durch Eigengewebe Bei Familiärer Disposition (Brca1+2 Trägerinnen)." [In De]. Senologie - Zeitschrift für Mammadiagnostik und -therapie 5, no. 03 (29.09.2008 2008): A64.

Lüdtke-Heckenkamp K., B.N., Schmutler R.K., „Familiärer Brust- und Eierstockkrebs Interdisziplinäres Betreuungskonzept in spezialisierten Zentren.“ Onkologie, (Feb 2008) Zur Publikation.

Osorio, A., M. Pollan, G. Pita, R. K. Schmutzler, B. Versmold, C. Engel, A. Meindl, et al. "An Evaluation of the Polymorphisms Ins16bp and Arg72pro in P53 as Breast Cancer Risk Modifiers in Brca1 and Brca2 Mutation Carriers." Br J Cancer 99, no. 6 (Sep 16 2008): 974-7. https://doi.org/10.1038/sj.bjc.6604624. https://www.ncbi.nlm.nih.gov/pubmed/18781154.

Rhiem, K., A. T. Nemat, R. K. Schmutzler, M. Krick, P. Mallmann, and M. Warm. "Vacuum-Sealing as a Treatment Option for Severe Anthracycline Extravasation in a Breast Cancer Patient." Breast Care (Basel) 3, no. 5 (2008): 347-48. https://doi.org/10.1159/000154141. https://www.ncbi.nlm.nih.gov/pubmed/20824030.

Schlehe, B., and R. Schmutzler. "[Hereditary Breast Cancer]." Chirurg 79, no. 11 (Nov 2008): 1047-54. https://doi.org/10.1007/s00104-008-1556-0. Hereditares Mammakarzinom. https://www.ncbi.nlm.nih.gov/pubmed/18854964.

Schmutzler, R.K., „Hereditäre Brustkrebserkrankung. Stufe-3-Leitlinie Brustkrebs-Früherkennung in Deutschland“ (2008) Zur Publikation.

Yang, R., B. Frank, K. Hemminki, C. R. Bartram, B. Wappenschmidt, C. Sutter, M. Kiechle, et al. "Snps in Ultraconserved Elements and Familial Breast Cancer Risk." Carcinogenesis 29, no. 2 (Feb 2008): 351-5. https://doi.org/10.1093/carcin/bgm290. https://www.ncbi.nlm.nih.gov/pubmed/18174240.

2007

Albert, U., H. Altland, V. Duda, J. Engel, M. Geraedts, S. Heywang-Köbrunner, D. Hölzel, et al. "Onkologie. Aktuelle Gesundheitsziele Zur Sekundärprävention Von Brustkrebs in Deutschland." Geburtshilfe und Frauenheilkunde 67, no. 09 (2007): 1026-29. https://doi.org/10.1055/s-2007-965775.

Antoniou, A. C., O. M. Sinilnikova, J. Simard, M. Leone, M. Dumont, S. L. Neuhausen, J. P. Struewing, et al. "Rad51 135g-->C Modifies Breast Cancer Risk among Brca2 Mutation Carriers: Results from a Combined Analysis of 19 Studies." Am J Hum Genet 81, no. 6 (Dec 2007): 1186-200. https://doi.org/10.1086/522611. https://www.ncbi.nlm.nih.gov/pubmed/17999359.

Chenevix-Trench, G., R. L. Milne, A. C. Antoniou, F. J. Couch, D. F. Easton, D. E. Goldgar, and Cimba. "An International Initiative to Identify Genetic Modifiers of Cancer Risk in Brca1 and Brca2 Mutation Carriers: The Consortium of Investigators of Modifiers of Brca1 and Brca2 (Cimba)." Breast Cancer Res 9, no. 2 (2007): 104. https://doi.org/10.1186/bcr1670. https://www.ncbi.nlm.nih.gov/pubmed/17466083.

Couch, F. J., O. Sinilnikova, R. A. Vierkant, V. S. Pankratz, Z. S. Fredericksen, D. Stoppa-Lyonnet, I. Coupier, et al. "Aurka F31i Polymorphism and Breast Cancer Risk in Brca1 and Brca2 Mutation Carriers: A Consortium of Investigators of Modifiers of Brca1/2 Study." Cancer Epidemiol Biomarkers Prev 16, no. 7 (Jul 2007): 1416-21. https://doi.org/10.1158/1055-9965.EPI-07-0129. https://www.ncbi.nlm.nih.gov/pubmed/17627006.

Easton, D. F., K. A. Pooley, A. M. Dunning, P. D. Pharoah, D. Thompson, D. G. Ballinger, J. P. Struewing, et al. "Genome-Wide Association Study Identifies Novel Breast Cancer Susceptibility Loci." Nature 447, no. 7148 (Jun 28 2007): 1087-93. https://doi.org/10.1038/nature05887. https://www.ncbi.nlm.nih.gov/pubmed/17529967.

Elsakov, P., L. Foretova, P. Goetz, J. W. B. de Groot, W. T. A. van der Graaf, G. Guler, K. Huebner, et al. "Discussion on the Use of Taxanes for Treatment of Breast Cancers in Brca1 Mutations Carriers." [In English]. Hereditary Cancer in Clinical Practice 5, no. 3 (Sep 15 2007): 119-43. Zur Publikation.

Frank, B., J. L. Bermejo, K. Hemminki, C. Sutter, B. Wappenschmidt, A. Meindl, M. Kiechle-Bahat, et al. "Copy Number Variant in the Candidate Tumor Suppressor Gene Mtus1 and Familial Breast Cancer Risk." Carcinogenesis 28, no. 7 (Jul 2007): 1442-5. https://doi.org/10.1093/carcin/bgm033. https://www.ncbi.nlm.nih.gov/pubmed/17301065.

Frank, B., K. Hemminki, A. Meindl, B. Wappenschmidt, C. Sutter, M. Kiechle, P. Bugert, et al. "Brip1 (Bach1) Variants and Familial Breast Cancer Risk: A Case-Control Study." BMC Cancer 7 (May 15 2007): 83. https://doi.org/10.1186/1471-2407-7-83. https://www.ncbi.nlm.nih.gov/pubmed/17504528.

Klein, A., R. Wessel, M. Graessmann, M. Jurgens, I. Petersen, R. Schmutzler, D. Niederacher, et al. "Comparison of Gene Expression Data from Human and Mouse Breast Cancers: Identification of a Conserved Breast Tumor Gene Set." Int J Cancer 121, no. 3 (Aug 1 2007): 683-8. https://doi.org/10.1002/ijc.22630. https://www.ncbi.nlm.nih.gov/pubmed/17410534.

Ramser, J., M. E. Ahearn, C. Lenski, K. O. Yariz, H. Hellebrand, M. von Rhein, R. D. Clark, et al. "Rare Missense and Synonymous Variants in Ube1 Are Associated with X-Linked Infantile Spinal Muscular Atrophy." Am J Hum Genet 82, no. 1 (Jan 2008): 188-93. https://doi.org/10.1016/j.ajhg.2007.09.009. https://www.ncbi.nlm.nih.gov/pubmed/18179898.

Rhiem, K., U. Flucke, C. Engel, B. Wappenschmidt, A. Reinecke-Luthge, R. Buttner, and R. K. Schmutzler. "Association of the Brca1 Missense Variant R1699w with a Malignant Phyllodes Tumor of the Breast." Cancer Genet Cytogenet 176, no. 1 (Jul 1 2007): 76-9. https://doi.org/10.1016/j.cancergencyto.2007.03.006. https://www.ncbi.nlm.nih.gov/pubmed/17574969.

Tchatchou, S., M. Wirtenberger, K. Hemminki, C. Sutter, A. Meindl, B. Wappenschmidt, M. Kiechle, et al. "Aurora Kinases a and B and Familial Breast Cancer Risk." Cancer Lett 247, no. 2 (Mar 18 2007): 266-72. https://doi.org/10.1016/j.canlet.2006.05.002. https://www.ncbi.nlm.nih.gov/pubmed/16762494.

Vaclavicek, A., J. L. Bermejo, R. K. Schmutzler, C. Sutter, B. Wappenschmidt, A. Meindl, M. Kiechle, et al. "Polymorphisms in the Janus Kinase 2 (Jak)/Signal Transducer and Activator of Transcription (Stat) Genes: Putative Association of the Stat Gene Region with Familial Breast Cancer." Endocr Relat Cancer 14, no. 2 (Jun 2007): 267-77. https://doi.org/10.1677/ERC-06-0077. https://www.ncbi.nlm.nih.gov/pubmed/17639043.

Vaclavicek, A., J. L. Bermejo, B. Wappenschmidt, A. Meindl, C. Sutter, R. K. Schmutzler, M. Kiechle, et al. "Genetic Variation in the Major Mitotic Checkpoint Genes Does Not Affect Familial Breast Cancer Risk." Breast Cancer Res Treat 106, no. 2 (Dec 2007): 205-13. https://doi.org/10.1007/s10549-007-9496-9. https://www.ncbi.nlm.nih.gov/pubmed/17268814.

Versmold, B., J. Felsberg, T. Mikeska, D. Ehrentraut, J. Kohler, J. A. Hampl, G. Rohn, et al. "Epigenetic Silencing of the Candidate Tumor Suppressor Gene Prox1 in Sporadic Breast Cancer." Int J Cancer 121, no. 3 (Aug 1 2007): 547-54. https://doi.org/10.1002/ijc.22705. https://www.ncbi.nlm.nih.gov/pubmed/17415710.

Wirtenberger, M., J. Schmutzhard, K. Hemminki, A. Meindl, C. Sutter, R. K. Schmutzler, B. Wappenschmidt, et al. "The Functional Genetic Variant Ile646val Located in the Kinase Binding Domain of the a-Kinase Anchoring Protein 10 Is Associated with Familial Breast Cancer." Carcinogenesis 28, no. 2 (Feb 2007): 423-6. https://doi.org/10.1093/carcin/bgl164. https://www.ncbi.nlm.nih.gov/pubmed/16956908.

2006

Bosse, K., K. Rhiem, B. Wappenschmidt, M. Hellmich, M. Madeja, M. Ortmann, P. Mallmann, and R. Schmutzler. "Screening for Ovarian Cancer by Transvaginal Ultrasound and Serum Ca125 Measurement in Women with a Familial Predisposition: A Prospective Cohort Study." Gynecol Oncol 103, no. 3 (Dec 2006): 1077-82. https://doi.org/10.1016/j.ygyno.2006.06.032. https://www.ncbi.nlm.nih.gov/pubmed/16904167.

Burwinkel, B., K. S. Shanmugam, K. Hemminki, A. Meindl, R. K. Schmutzler, C. Sutter, B. Wappenschmidt, et al. "Transcription Factor 7-Like 2 (Tcf7l2) Variant Is Associated with Familial Breast Cancer Risk: A Case-Control Study." BMC Cancer 6 (Nov 17 2006): 268. https://doi.org/10.1186/1471-2407-6-268. https://www.ncbi.nlm.nih.gov/pubmed/17109766.

Frank, B., K. Hemminki, A. Meindl, B. Wappenschmidt, R. Klaes, R. K. Schmutzler, M. Untch, et al. "Association of the Arlts1 Cys148arg Variant with Familial Breast Cancer Risk." Int J Cancer 118, no. 10 (May 15 2006): 2505-8. https://doi.org/10.1002/ijc.21687. https://www.ncbi.nlm.nih.gov/pubmed/16353159

Frank, B., K. Hemminki, B. Wappenschmidt, R. Klaes, A. Meindl, R. K. Schmutzler, P. Bugert, et al. "Variable Number of Tandem Repeats Polymorphism in the Smyd3 Promoter Region and the Risk of Familial Breast Cancer." Int J Cancer 118, no. 11 (Jun 1 2006): 2917-8. https://doi.org/10.1002/ijc.21696. https://www.ncbi.nlm.nih.gov/pubmed/16381023.

Frank, B., K. Hemminki, B. Wappenschmidt, A. Meindl, R. Klaes, R. K. Schmutzler, P. Bugert, et al. "Association of the Casp10 V410i Variant with Reduced Familial Breast Cancer Risk and Interaction with the Casp8 D302h Variant." Carcinogenesis 27, no. 3 (Mar 2006): 606-9. https://doi.org/10.1093/carcin/bgi248. https://www.ncbi.nlm.nih.gov/pubmed/16251207.

Schmutzler, R. K., K. Rhiem, P. Breuer, E. Wardelmann, M. Lehnert, S. Coburger, and B. Wappenschmidt. "Outcome of a Structured Surveillance Programme in Women with a Familial Predisposition for Breast Cancer." Eur J Cancer Prev 15, no. 6 (Dec 2006): 483-9. https://doi.org/10.1097/01.cej.0000220624.70234.14. https://www.ncbi.nlm.nih.gov/pubmed/17106326.

Schmutzler, Rita K. "Familial Breast Cancer – What Are the Choices, What Are the Questions?". Breast Care 1, no. 1 (2006): 6-7. https://doi.org/10.1159/000090908.

Vaclavicek, A., K. Hemminki, C. R. Bartram, K. Wagner, B. Wappenschmidt, A. Meindl, R. K. Schmutzler, et al. "Association of Prolactin and Its Receptor Gene Regions with Familial Breast Cancer." J Clin Endocrinol Metab 91, no. 4 (Apr 2006): 1513-9. https://doi.org/10.1210/jc.2005-1899. https://www.ncbi.nlm.nih.gov/pubmed/16434456.

Wagner, K., K. Hemminki, E. Grzybowska, R. Klaes, B. Burwinkel, P. Bugert, R. K. Schmutzler, et al. "Polymorphisms in Genes Involved in Gh1 Release and Their Association with Breast Cancer Risk." Carcinogenesis 27, no. 9 (Sep 2006): 1867-75. https://doi.org/10.1093/carcin/bgl036. https://www.ncbi.nlm.nih.gov/pubmed/16606630.

Wilkening, S., J. L. Bermejo, B. Burwinkel, R. Klaes, C. R. Bartram, A. Meindl, P. Bugert, et al. "The Single Nucleotide Polymorphism Ivs1+309 in Mouse Double Minute 2 Does Not Affect Risk of Familial Breast Cancer." Cancer Res 66, no. 2 (Jan 15 2006): 646-8. https://doi.org/10.1158/0008-5472.CAN-05-3168. https://www.ncbi.nlm.nih.gov/pubmed/16423991.

Wirtenberger, M., B. Frank, K. Hemminki, R. Klaes, R. K. Schmutzler, B. Wappenschmidt, A. Meindl, et al. "Interaction of Werner and Bloom Syndrome Genes with P53 in Familial Breast Cancer." Carcinogenesis 27, no. 8 (Aug 2006): 1655-60. https://doi.org/10.1093/carcin/bgi374. https://www.ncbi.nlm.nih.gov/pubmed/16501249

Wirtenberger, M., S. Tchatchou, K. Hemminki, R. Klaes, R. K. Schmutzler, J. L. Bermejo, B. Chen, et al. "Association of Genetic Variants in the Rho Guanine Nucleotide Exchange Factor Akap13 with Familial Breast Cancer." Carcinogenesis 27, no. 3 (Mar 2006): 593-8. https://doi.org/10.1093/carcin/bgi245. https://www.ncbi.nlm.nih.gov/pubmed/16234258.

Wirtenberger, M., S. Tchatchou, K. Hemminki, J. Schmutzhard, C. Sutter, R. K. Schmutzler, A. Meindl, et al. "Associations of Genetic Variants in the Estrogen Receptor Coactivators Ppargc1a, Ppargc1b and Ep300 with Familial Breast Cancer." Carcinogenesis 27, no. 11 (Nov 2006): 2201-8. https://doi.org/10.1093/carcin/bgl067. https://www.ncbi.nlm.nih.gov/pubmed/16704985

2005

Burwinkel, B., M. Wirtenberger, R. Klaes, R. K. Schmutzler, E. Grzybowska, A. Forsti, B. Frank, et al. "Association of Ncoa3 Polymorphisms with Breast Cancer Risk." Clin Cancer Res 11, no. 6 (Mar 15 2005): 2169-74. https://doi.org/10.1158/1078-0432.CCR-04-1621. https://www.ncbi.nlm.nih.gov/pubmed/15788663

Dahl, E., A. Sadr-Nabavi, E. Klopocki, B. Betz, S. Grube, R. Kreutzfeld, M. Himmelfarb, et al. "Systematic Identification and Molecular Characterization of Genes Differentially Expressed in Breast and Ovarian Cancer." J Pathol 205, no. 1 (Jan 2005): 21-8. https://doi.org/10.1002/path.1687. https://www.ncbi.nlm.nih.gov/pubmed/15586368.

Frank, B., J. L. Bermejo, K. Hemminki, R. Klaes, P. Bugert, B. Wappenschmidt, R. K. Schmutzler, and B. Burwinkel. "Re: Association of a Common Variant of the Casp8 Gene with Reduced Risk of Breast Cancer." J Natl Cancer Inst 97, no. 13 (Jul 6 2005): 1012; author reply 12-3. https://doi.org/10.1093/jnci/dji178. https://www.ncbi.nlm.nih.gov/pubmed/15998955.

Frank, B., K. Hemminki, J. L. Bermejo, R. Klaes, P. Bugert, B. Wappenschmidt, R. K. Schmutzler, and B. Burwinkel. "Tp53-Binding Protein Variants and Breast Cancer Risk: A Case-Control Study." Breast Cancer Res 7, no. 4 (2005): R502-5. https://doi.org/10.1186/bcr1038. https://www.ncbi.nlm.nih.gov/pubmed/15987456.

Frank, B., K. Hemminki, K. S. Shanmugam, A. Meindl, R. Klaes, R. K. Schmutzler, B. Wappenschmidt, et al. "Association of Death Receptor 4 Haplotype 626c-683c with an Increased Breast Cancer Risk." Carcinogenesis 26, no. 11 (Nov 2005): 1975-7. https://doi.org/10.1093/carcin/bgi164. https://www.ncbi.nlm.nih.gov/pubmed/15975957.

Frank, B., K. Hemminki, M. Wirtenberger, J. L. Bermejo, P. Bugert, R. Klaes, R. K. Schmutzler, et al. "The Rare Erbb2 Variant Ile654val Is Associated with an Increased Familial Breast Cancer Risk." Carcinogenesis 26, no. 3 (Mar 2005): 643-7. https://doi.org/10.1093/carcin/bgh342. https://www.ncbi.nlm.nih.gov/pubmed/15550452.

Lubiński, Jan. "Hormone Replacement Therapy Appears to Be Safe after Prophylactic Adnexectomy in Premenopausal Brca1/Brca2 Mutation Carriers. Reaction to the 'Letter to Readers' in Hereditary Cancer in Clinical Practice, 2005, 3 (2)." Hereditary Cancer in Clinical Practice 3, no. 3 (2005). https://doi.org/10.1186/1897-4287-3-3-87.

Seitz, S., R. Frege, A. Jacobsen, J. Weimer, W. Arnold, C. von Haefen, D. Niederacher, et al. "A Network of Clinically and Functionally Relevant Genes Is Involved in the Reversion of the Tumorigenic Phenotype of Mda-Mb-231 Breast Cancer Cells after Transfer of Human Chromosome 8." Oncogene 24, no. 5 (Jan 27 2005): 869-79. https://doi.org/10.1038/sj.onc.1208260. https://www.ncbi.nlm.nih.gov/pubmed/15580292.

Wappenschmidt, B., R. Fimmers, K. Rhiem, M. Brosig, E. Wardelmann, A. Meindl, N. Arnold, P. Mallmann, and R. K. Schmutzler. "Strong Evidence That the Common Variant S384f in Brca2 Has No Pathogenic Relevance in Hereditary Breast Cancer." Breast Cancer Res 7, no. 5 (2005): R775-9. https://doi.org/10.1186/bcr1291. https://www.ncbi.nlm.nih.gov/pubmed/16168123.

Wirtenberger, M., K. Hemminki, A. Forsti, R. Klaes, R. K. Schmutzler, E. Grzybowska, J. L. Bermejo, et al. "C-Myc Asn11ser Is Associated with Increased Risk for Familial Breast Cancer." Int J Cancer 117, no. 4 (Nov 20 2005): 638-42. https://doi.org/10.1002/ijc.21225. https://www.ncbi.nlm.nih.gov/pubmed/15929079.

2004

Dufault, M. R., B. Betz, B. Wappenschmidt, W. Hofmann, K. Bandick, A. Golla, A. Pietschmann, et al. "Limited Relevance of the Chek2 Gene in Hereditary Breast Cancer." Int J Cancer 110, no. 3 (Jun 20 2004): 320-5. https://doi.org/10.1002/ijc.20073. https://www.ncbi.nlm.nih.gov/pubmed/15095295.

Wappenschmidt, B., E. Wardelmann, A. Gehrig, T. Schondorf, N. Maass, G. Bonatz, A. M. Gassel, et al. "Pten Mutations Do Not Cause Nuclear Beta-Catenin Accumulation in Endometrial Carcinomas." Hum Pathol 35, no. 10 (Oct 2004): 1260-5. https://doi.org/10.1016/j.humpath.2004.06.007. https://www.ncbi.nlm.nih.gov/pubmed/15492994.

2003

"[Counselling, Genetic Testing and Prevention in Women with Hereditary Breast- and Ovarian Cancer. Interdisciplinary Recommendations of the Consortium "Hereditary Breast- and Ovarian Cancer" of the German Cancer Aid]."  (2003).

"Expression of the Tumor Suppressor Gene Pten Is Not Altered in the Progression of Ovarian Carcinomas and Does Not Correlate with P27(Kip1) Expression."  (2003).

Hubbel, V. F., K. Rhiem, M. Warm, P. Mallmann, and R. K. Schmutzler. "Recent Trends in Breast Cancer Incidence and Mortality in Europe and North America." [In German]. Gynakologe 36, no. 9 (Sep 2003): 746-+. https://doi.org/10.1007/s00129-003-1412-8. <Go to ISI>://WOS:000185664100002.

Morakkabati-Spitz, N., E. Sondermann, A. Schmiedel, C. Leutner, K. Riehm, R. Schmutzler, H. Schild, and C. K. Kuhl. "[Prevalence and Type of Incidental Extramammary Findings in Mri of the Breast]." Rofo 175, no. 2 (Feb 2003): 199-202. https://doi.org/10.1055/s-2003-37227. Haufigkeit und Spektrum von Zusatzbefunden ausserhalb des Brustdrusenparenchyms bei MR-mammographischen Untersuchungen. https://www.ncbi.nlm.nih.gov/pubmed/12584619.

Rhiem, K., A. Klein, M. Munch, R. Kreutzfeld, J. Ramser, E. Wardelmann, G. Schackert, et al. "Chromosomal Region 15q21.1 Is a Frequent Target of Allelic Imbalance in Advanced Breast Carcinomas." Int J Cancer 106, no. 1 (Aug 10 2003): 74-7. https://doi.org/10.1002/ijc.11169. https://www.ncbi.nlm.nih.gov/pubmed/12794759.

Schmutzler, R., B. Schlegelberger, A. Meindl, W. D. Gerber, M. Kiechle, Breast Hereditary, and German Cancer AiD Ovarian Cancer Consortium. "[Counselling, Genetic Testing and Prevention in Women with Hereditary Breast- and Ovarian Cancer. Interdisciplinary Recommendations of the Consortium "Hereditary Breast- and Ovarian Cancer" of the German Cancer Aid]." Zentralbl Gynakol 125, no. 12 (Dec 2003): 494-506. https://doi.org/10.1055/s-2003-44815.

Schöndorf, Thomas, Markus Hoopmann, Barbara Eversheim, Markus Valter, Martina Becker, Barbara Wappenschmidt, Uwe-Jochen Göhring, et al. "Expression of the Tumor Suppressor Gene Pten Is Not Altered in the Progression of Ovarian Carcinomas and Does Not Correlate with P27kip1 Expression." Oncology Reports  (2003). https://doi.org/10.3892/or.10.6.1717.

Ulrich, U., O. Richter, E. Wardelmann, M. Valter, R. Schmutzler, M. Sillem, M. Possover, and P. Mallmann. "[Endometriosis and Malignoma]." Zentralbl Gynakol 125, no. 7-8 (Jul-Aug 2003): 239-42. https://doi.org/10.1055/s-2003-42277. Endometriose und Malignom. https://www.ncbi.nlm.nih.gov/pubmed/14505256.

2002

Hofmann, W., B. Wappenschmidt, S. Berhane, R. Schmutzler, and S. Scherneck. "Detection of Large Rearrangements of Exons 13 and 22 in the Brca1 Gene in German Families." J Med Genet 39, no. 7 (Jul 2002): E36. https://doi.org/10.1136/jmg.39.7.e36. https://www.ncbi.nlm.nih.gov/pubmed/12114493.

Kempe, A., H. Engels, R. Schubert, A. Meindl, K. van der Ven, H. Plath, K. Rhiem, G. Schwanitz, and R. K. Schmutzler. "Familial Ovarian Dysgerminomas (Swyer Syndrome) in Females Associated with 46 Xy-Karyotype." Gynecological Endocrinology 16, no. 2 (2002): 107-11. https://doi.org/10.1080/gye.16.2.107.111.

Kiechle, M., Schmutzler, R. „Epidemiologie, Genetik und Prävention des Ovarialkarzinoms“ Der Onkologe (Nov 2002). Zur Publikation.

Meindl, A., Breast German Consortium for Hereditary, and Cancer Ovarian. "Comprehensive Analysis of 989 Patients with Breast or Ovarian Cancer Provides Brca1 and Brca2 Mutation Profiles and Frequencies for the German Population." Int J Cancer 97, no. 4 (Feb 1 2002): 472-80. https://doi.org/10.1002/ijc.1626. https://www.ncbi.nlm.nih.gov/pubmed/11802209.

Von Minckwitz, G., S. D. Costa, K. Brunnert, P. Dall, U. Nitz, I. Diel, N. Fersis, et al. "[Evidence-Based Recommendations on Treating Locoregional and Distant Metastases of Carcinomas of the Breast]." Zentralbl Gynakol 124, no. 5 (May 2002): 284-92. https://doi.org/10.1055/s-2002-34094. Evidenzbasierte Empfehlungen zur Behandlung von lokoregionar und fernmetastasierten Mammakarzinomen - Der Konsens der AGO-Organkommission "Mamma ". https://www.ncbi.nlm.nih.gov/pubmed/12232813.

2001

Kiechle, M., and R. Schmutzler. "[Prevention in Familial Breast Cancer Susceptibility]." Radiologe 41, no. 4 (Apr 2001): 366-70. https://doi.org/10.1007/s001170051015. Praventive Strategien bei familiarer Brustkrebspradisposition. https://www.ncbi.nlm.nih.gov/pubmed/11388058.

Schmutzler, R., Freihoff, D. „Molekulargenetische Alterationen in gynäkologischen Tumoren“ Medizinische Genetik 1 (2001). Zur Publikation.

2000

Kuhl, C. K., R. K. Schmutzler, C. C. Leutner, A. Kempe, E. Wardelmann, A. Hocke, M. Maringa, et al. "Breast Mr Imaging Screening in 192 Women Proved or Suspected to Be Carriers of a Breast Cancer Susceptibility Gene: Preliminary Results." Radiology 215, no. 1 (Apr 2000): 267-79. https://doi.org/10.1148/radiology.215.1.r00ap01267. https://www.ncbi.nlm.nih.gov/pubmed/10751498.

Tong, Dan, Elisabeth Kucera, Eva Schuster, Rita K. Schmutzler, Herwig Swoboda, Alexander Reinthaller, Sepp Leodolter, and Robert Zeillinger. "Loss of Heterozygosity (Loh) Atp53 Is Correlated with Loh Atbrca1 Andbrca2 in Various Human Malignant Tumors." International Journal of Cancer 88, no. 2 (2000): 319-22. https://doi.org/10.1002/1097-0215(20001015)88:2<319::Aid-ijc27>3.0.Co;2-x.